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Heterologous expression of natural product biosynthetic pathways is of rising interest to 
fungal bioactive compound discovery and engineering. However, most eukaryotic genes 
are regulated by individual regulatory elements and transcribed as monocistronic mRNA. 
Therefore, regardless of plasmid transformation or chromosomal integration of DNA, 
reconstruction and expression of biosynthetic gene clusters in the eukaryotic recipient 
require improved assembling pipeline of vectors and coordinated control of expression of 
multiple genes. Moreover, valuable medicine biosynthesis based on heterologous 
expression remains an ongoing challenge owing to the strict metabolic regulation in the 
chosen host. 
To circumvent these obstacles, a specialized vector was designed, for flexible but 
modularized construction of multiple genes as the starting point. In the scheme, TEV 
protease and its recognition site combined with a previously documented P2A-mediated 
expression system, allow expression of eukaryotic genes in a “polycistronic” mRNA by 
co-translational and post-translational cleavages. As another highlight, the split fluorescent 
protein was introduced for visualizing and rapid screening of fungal transformants. I 
further applied the system for the heterologous production of complex meroterpenoid 
austinoids and the simple indole alkaloid psilocybin in the filamentous fungus Aspergillus 
nidulans. Significantly, the latter one identified from the "magic mushroom" Psilocybe 
cubensis received great attention for its psychotropic characteristics, which is considered a 
breakthrough therapy in depressive disorder and late-stage cancer-induced depression. The 
production of this valuable pro-drug demands a controllable and scalable manner. Thus, 
the budding yeast Saccharomyces cerevisiae was chosen as the chassis for the biosynthesis 
of this tryptophan-derived compound in the additional study. To enrich the intracellular 
tryptophan (Trp), Trp degradative pathways have been suppressed through gene deletion. 
In this recombinant yeast, I tried to facilitate the function of cytochrome P450 (PsiH) in the 
psilocybin biosynthetic pathway by co-expression of a newly identified P450 reductase 
from the same species, as a supplementary investigation. In a more specific application, the 
intracellular Trp biosynthesis was abolished for the production of isotope labeled 
psilocybin. 
The result is an improved heterologous expression system for multiple genes promising 
fast assembly, synchronous transcription regulated by a sole promoter, and the quick yet 
reliable selection of correct mutants. On the basis of this new tool, the austinoid 
biosynthetic pathway has been rewired successfully in A. nidulans. Also, it represents the 
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first-time producing psilocybin heterologously using fermenting condition, from which the 
high titer 15.4 mg/g (110 mg/L) was achieved. Subsequently, the de-branching strategy 
was beneficial for the yield of psilocybin, which even lifted to 57 mg/g in the yeast cell-
based factory. Meanwhile, the Trp auxotrophic strain has been endowed with the capability 
to synthesize isotope-labeled psilocybin in an atom-economic manner.  
In conclusion, this practicable platform for multiple gene construction and heterologous 
expression paves the way in synthetic biology, as both filamentous fungi and yeast can be 
adapted for the natural product biosynthesis in a user-friendly way. Moreover, exemplified 
by the promoted amount of psilocybin produced in yeast, where the Trp flux has been 
redirected, I expect that this cell factory can act as an amenable workhorse to produce other 





















Die heterologe Expression von Biosynthesewegen von Naturstoffen ist von zunehmendem 
Interesse für die Identifizierung und Weiterentwicklung von bioaktiven Molekülen aus 
Pilzen. Allerdings wird der Großteil eukaryotischer Gene durch individuelle regulatorische 
Elemente gesteuert und als monocistronische mRNA transkribiert. Deshalb werden zur 
Rekonstruktion und Expression von biosynthetischen Genclustern im eukaryotischen 
Empfänger, unabhängig ob dies über Plasmid-Transformation oder chromosomaler 
Integration erfolgt, eine verbesserte Assemblierungspipeline der Vektoren und eine 
synchronisierte Transkription multipler Gene benötigt. Darüber hinaus bleibt die 
Biosynthese von wertvollen Medikamenten mittels heterologer Expression aufgrund der 
strengen Regulation des Stoffwechsels im ausgewählten Wirt eine ständige 
Herausforderung. 
Um diese Hindernisse zu überwinden, wurde ein spezieller Vektor entworfen, der für die 
flexible, aber modulare Kombination mehrerer Gene als Ausgangspunkt diente. Dabei wird 
die 'polycistronische' Expression eukaryotischer Gene durch co-translationale und post-
translationale Spaltungen der Polypeptidkette durch die TEV-Protease an ihrer 
Erkennungssequenz in Kombination mit dem zuvor beschriebenen P2A-vermittelten 
Expressionssystem ermöglicht. Als ein weiterer Höhepunkt wurde für das visuelle und 
schnelle Screening von Transformanten ein geteiltes fluoreszierendes Protein eingeführt. 
Ich habe dieses System für die heterologe Produktion von komplexen Monoterpenoid-
Austinoiden sowie von Psilocybin, einem einfachen Indol-Alkaloid, im filamentösen Pilz 
Aspergillus nidulans angewendet. Bemerkenswerterweise erhielt letzteres, identifiziert aus 
dem 'magic mushroom' Psilocybe cubensis, in letzter Zeit große Aufmerksamkeit für seine 
psychotropen Eigenschaften, die sowohl zu einem Durchbruch in der Therapie depressiver 
Störungen als auch zur Behandlung von Depressionen im Spätstadium von 
Krebserkrankungen führten. Die Herstellung dieses wertvollen Medikamentes erfordert 
eine kontrollierbare und skalierbare Methode. Daher wurde die Hefe Saccharomyces 
cerevisiae als Grundlage für die Biosynthese dieser von Tryptophan abgeleiteten 
Verbindungen in der hier präsentierten Studie ausgewählt. Um das intrazelluläre 
Tryptophan (Trp) anzureichern, wurden Trp-Abbauwege durch Deletion von Genen 
unterdrückt. Bei einer zusätzlichen Untersuchung habe ich versucht, in dieser 
rekombinanten Hefe die Funktion von einem Cytochrom P450 (PsiH) im Psilocybin 
Biosyntheseweg durch die Co-Expression einer neu identifizierten P450 Reduktase aus 
derselben Spezies zu ermöglichen. In einer spezifischeren Anwendung wurde die 
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intrazelluläre Biosynthese von Trp ausgeschaltet, um Isotop-markiertes Psilocybin zu 
bilden. 
Das Ergebnis ist ein verbessertes heterologes Expressionssystem für multiple Gene, 
welches eine schnelle Erzeugung des Expressionsvektors erlaubt, sowie eine 
synchronisierte Regulation durch einen einzelnen Promoter, und die schnelle und 
zuverlässige Auswahl korrekter Transformanten verspricht. Basierend auf diesem neuen 
System wurde die Austinoid-Biosynthese erfolgreich in Aspergillus nidulans ermöglicht. 
Dies war auch das erste Mal, dass Psilocybin heterolog und unter 
Fermentationsbedingungen hergestellt wurde, wobei ein hoher Titer von 15.4 mg/g (110 
mg/L) erreicht werden konnte. Anschließend konnte durch die angewendete de-branching 
Strategie die Ausbeute an Psilocybin in der Hefe-basierten Produktion sogar auf 57 mg/g 
gesteigert werden. Parallel wurde der auxotrophe Tryptophan-Stamm mit der Fähigkeit 
ausgestattet, isotopen-markiertes Psilocybin auf ökonomischem Wege zu synthetisieren. 
Zusammenfassend kann gesagt werden, dass diese praktikable Plattform für die 
Konstruktion and heterologe Expression multipler Gene den Weg in der synthetischen 
Biologie ebnet, da sowohl filamentöse Pilze als auch Hefen für diese benutzerfreundliche 
Methode der Naturstoffsynthese angepasst werden können. Zusätzlich ist zu erwarten, dass 
der in dieser Studie hergestellte Hefe-Produktionsstamm, dessen Tryptophan-
Produktionsweg umgeleitet und damit die Psilocybin-Produktion erhöht werden konnte, 
zukünftig auch für die heterologe Herstellung anderer Indolalkaloide mit hohem 














1.1 Fungal secondary metabolites 
Secondary metabolite (SM), or natural product, so far is a term to describe a compound 
with low molecular weight yet exhibiting a bioactive function. Even though SMs derive 
from primary metabolism, instead of conferring essential roles for survival and growth, 
they contribute as info-chemicals against environmental stresses, predation, competition, or 
assist self-fitness and communications among symbionts (Jensen, 2016; Keller, 2019). 
Although the detailed functions of SMs are still undercover, their hitherto explored mainly 
brought them into usage as a pharmaceutical resource.  
Fungi, as one of the major kingdoms, developed an abundance of SMs, many beneficial 
compounds among which were taken as antibiotics, antiparasitics, antitumoral agents, and 
so forth (Keller, 2019). The best-known case is penicillin which is widely applied as 
treatment of bacterial infections as far back as World War II (Quinn, 2013).  
Fungal SMs are commonly classified as polyketides, non-ribosomal peptides, terpenes, and 
indole alkaloids (Keller et al., 2005). This definition mainly takes into accord which type 
of core biosynthetic enzyme and which kind of initial building block are responsible for the 
biosynthesis. Polyketides are synthesized by non-iterative or iterative polyketide synthases 
(PKS), which are mainly iterative type I in fungi, such as lovastatin synthase (Hendrickson 
et al., 1999; Hertweck, 2009). With CoA-esters (e.g., acyl-CoA and malonyl-CoA) as 
building blocks, the structure elongation is carried out by repetitive Claisen thioester 
condensations and is similar to fatty acid biosynthesis. However, in contrast to the 
saturated and immutable fatty acid chain, the chemical structure of polyketides is more 
diversiform due to the optional reduction in each elongation, and the varying length of the 
chain. Distinct from polyketides, both non-ribosomal peptide and indole alkaloids are 
derived from amino acids (Keller et al., 2005). For example, the L-tryptophan (Trp) that 
derives from the shikimate pathway is required for the biosynthesis of terriquinone A and 
psilocybin (Scheme 1, ii and iii) (Fricke et al., 2019; Schneider et al., 2008). Dimethylallyl 
pyrophosphate (DMAPP) is the building block of terpenes (or isoprenes), and this 5-C 
isoprene unit originates from acyl-CoA through the mevalonate (Scheme 1B). The 
diversity of terpenes depends on the number of DMAPP in their construction. For example, 
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the farnesyl diphosphate (farnesyl-PP) that is involved in the austinol biosynthesis is 


































































































































Scheme 1. Examples of SM biosynthesis in fungi starting with the CoA-esters or shikimate 
pathway. Fungal SMs biosynthetic pathways employ cross-talk. (A) Farnesyl-PP not only serves 
the biosynthesis of terpenes/terpenoids, but joins the CoA-esters derived PKS biosynthesis of 3-5-
dimethylorsellinic acid towards austinol and its derivatives production (i). (B) The essential 
intermediate didemethyl-asterriquinone D (DDAQ D), which is produced from Trp by an NRPS 





bisindole alkaloid terrequinone A. (ii). Besides, (C) Trp can contribute to the formation of the 
simple indole alkaloid psilocybin (iii). The gray area indicates the primary metabolism. The dotted 
lines distinguish the pyruvate pathway, mevalonate pathway, and shikimate pathway. PKS: 
polyketide synthase; NRPS: non-ribosomal peptide synthetase; PT: prenyltransferase; AAT: amino 
acid transferase. 
According to the fungal SMs that were studied in my project, the biosyntheses of 
austinoids and psilocybin are described in more detail in the following sub-sections. 
1.1.1 Meroterpenoids and austinoid biosynthetic gene clusters  
Albeit fungal SMs being mainly grouped into four classes, there are SMs originating from 
mixed biosynthetic roots. One such is the hybridized polyketide-non-ribosomal peptide 
(PK-NRP) compound (e.g., equisetin from Fusarium spp.), an indole terpenoid generated 
from both the shikimate and mevalonate pathways (e.g., okaramine S from Aspergillus 
spp), as well as a particularly important group known as meroterpenoids (e.g., 
pyripyropene A from Aspergillus and Penicillium spp.) (Burmeister et al., 1974; Hu et al., 
2014; Petersen et al., 2014). 
Meroterpenoids derive from the terpenoid pathway and comprise a non-terpenoid starter 
unit that is mainly produced from PKS. The varying length and cyclization patterns of 
terpenoids and the prenylation followed by the epoxidation with different stereo-forms all 
contribute to the likewise abundant chemical structures of meroterpenoids, which lead to 
extensive bioactivities: anti-insect, anti-inflammation, immunosuppression, anti-
angiogenesis, among others (Matsuda & Abe, 2016). The biosynthesis of austinoids can 
demonstrate this structural complexity. 
Austinoids are a group of 3,5-demethylorsellinic acid derived meroterpenoids, where both 
austinol and its spontaneous-oxidized form dehydroaustinol are produced by Aspergillus 
nidulans (Lo et al., 2012), Aspergillus calidoustus (Valiante et al., 2017), and Penicillium 
brasilianum (Kataoka et al., 2011). The discovered biosynthetic gene cluster related to 
austinol production in A. nidulans revealed a proposed biosynthetic pathway towards the 
end-product austinol by heterologous expressions (Lo et al., 2012; Matsuda et al., 2013), in 
which AusE, as a multifunctional dioxygenase, catalyzes iterative oxidation steps and a 
spiro-lactone ring formation. Later, a gene cluster (scaffold 10, Fig. 1A) was identified in 
the P. brasilianum strain MG11, in which a gene encodes a dioxygenase, namely AusE’ 
(Matsuda et al., 2016). The functional study proved that AusE’ shares the same enzymatic 
activity as the AusE from A. nidulans. Interestingly, the additional aus genes from the 
scaffold 6 (Fig. 1A) has been identified in this P. brasilianum strain. The encoded enzymes 
AusP, AusR, and AusQ were presumed to tailor dehydroaustin and yield 
acetoxydehydroaustin as the final product, which does not exist in A. nidulans (Mattern et 
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al., 2017). Compared with the separated clusters discovered from A. nidulans and P. 
brasilianum, the recent study by Valiante et al. (2017) uncovered a more integrated 
biosynthetic gene cluster of austinoid that harbors 25 genes in total in the A. calidoustus 
strain SF006504 (Fig. 1A). A gene deletions study shows an extended austinoids 






































































































Fig. 1. The austinoid biosynthetic gene clusters and its extended biosynthetic pathway in A. 
calidoustus. (A) The gene cluster responsible for producing austinoids is broken and separated in 
both A. nidulans and P. brasilianum, while it is unabridged in A. calidoustus. The genes 
highlighted in sky blue are commonly shared in all three species, the yellow-colored ausU gene is 
found in A. nidulans and A. calidoustus, the pink-painted ausP gene only exists in A. calidoustus 
and P. brasilianum. Moreover, the green-marked genes are uniquely presented in A. calidoustus. 
Both A. nidulans and P. brasilianum have a remaining pseudogene similar to the missing PKS gene 
AusV. (B) Extended biosynthetic pathway in A. calidoustus from austinol (1). The color forms are 
inherited from the upper diagram. The PKS AusA-generated 3-5-dimethylorsellinic acid couples 
with mevalonate-derived farnesyl-phosphate to initiate the austinoid biosynthetic pathway. ausV 
gene encoding a non-iterative PKS bears the following domains: acyl carrier protein, keto-
reductase, enoyl-reductase, methyltransferase, dehydratase, (malonyl)acyltransferase, and β-
ketoacylsynthase. AusV-produced polyketide modifies the side chain of 1,2-dihydro-7-
dydroxydehydroaustin (5). By the heterologous expression of the genes ausP, ausO, ausT and ausV 
in A. nidulans, the products (compounds 2-7) in the elongated pathway were detected, which 
demonstrated that the genes ausR and ausQ are still functional in this species. The figure and the 





Notably, the genes encoding the enzymes involved in the biosynthesis of SMs are 
commonly colocalized in the genome as a group, which are called biosynthetic gene 
clusters (BGCs). At the same time, a recent review (Rokas et al., 2018) pointed out that the 
biosynthetic pathway is also unclustered/partially clustered, such as the genes involved in 
the dothistromin biosynthesis in Dothistroma septosporum are distributed over six different 
loci; besides, the same biosynthetic pathway can vary in the structure and gene content 
between species, which is exemplified by the biosynthesis of trichothecenes among the 
Fusarium spp. The comparison of aus gene clusters from A. nidulans and A. calidoustus 
indicated that the lack of extended production of austinoids in the former one is due to the 
lack of four key enzymes, namely O-acetyltransferase (AusP), progesterone 5-β-reductase 
like protein (AusT), dioxygenase (AusO), and a non-iterative PKS (AusV), although it 
includes genes encoding an O-acetyltransferase (AusQ) and a cytochrome P450 
monooxygenase (AusR) that are also essentially required in the pathway elongation.  
1.1.2 Trp-derived indole alkaloids and the psilocybin biosynthetic pathway 
Indole alkaloids have been well observed in plants, while fungi, typically Ascomycota and 
Basidiomycota, are also conferred as great resources of this class of bioactive compounds 
(Homer & Sperry, 2017; Xu et al., 2014). Using Trp or Trp derivatives, for example L-
tryptamine, indole-3-pyruvate (IPA), indole-3-glycerol-phosphate (IGP), or 4-
dimethylallyl tryptophan (4-DMAT), as a resource to donate an indole structure in 
alkaloids is a non-surprising strategy observed in fungal secondary metabolism (Scheme 
2). The indole ring of Trp can undergo electrophilic addition, such as prenylation (e.g., 4-
DMAT, Scheme 2) and methylation (e.g., physostigmine), as well as epoxidation (e.g., 
notoamide E) (Li et al., 2012; Liu et al., 2014; Metzger et al., 2009). These reactions 
modify the Trp into a more complicated structure within the biosynthetic pathway. Besides 
Trp, other amino acids, like L-proline, L-histidine, L-phenylalanine (Phe), and L-alanine, 
can be loaded to NRPS or hybridized PKS-NRPS to form dipeptide/tripeptide and hybrid 
indole alkaloids (Xu et al., 2014).  
With the structural diversity come various bioactivities. Emindoles derived from IGP as 
the representatives of indole diterpene alkaloids have an inhibitory effect on cancer cell 
lines (Xu et al., 2014). Ergot alkaloids, as a group of bioactive compounds that share an 
identical precursor 4-DMAT, have a broad range of pharmaceutical activities, including 
uterotonic activity, blood pressure modulation, and anti-migraine (Metzger et al., 2009). A 
prenylated indole-containing class called asterriquinone, presents special anti-retroviral, 
anti-tumor, and anti-diabetic activities (Schneider et al., 2008). Terrequinone A is shown as 
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an example in Scheme 1B. This group of compounds is synthesized from IPA. Last but not 
least, by using tryptamine as the starter unit, simple indole alkaloids are developed and 
considered as important neurotransmitters (Hamid et al., 2017), such as psilocybin, which 
is famous on account of its potential therapeutic value towards treatment-resistant 































Tryptophan synthases α/β Serine
DMAPP 
 
Scheme 2. Indole moieties from Trp catabolism and metabolism. With essential enzymes and 
substrate, the Trp precursor and its downstream derivatives are produced and used as the indole 
donors for indole alkaloids biosynthesis. PP: phosphate; DMAPP: dimethylallyl pyrophosphate. 
Psilocybin is widely found in the genus Psilocybe (“magic” mushrooms) (Fig. 2, left). It is 
easily dephosphorylated in the hepatic metabolism to form the psychotropic compound 
psilocin, which acts as an agonist of the neurotransmitter serotonin (5-HT), with high 
affinity to the human 5-HT2A and 5-HT2C receptors in the brain (Fricke et al., 2019; Lenz et 
al., 2020). Additionally, psilocybin was granted a status as a “breakthrough therapy” by the 
U.S. Food and Drug Administration and will soon enter phase III clinical trials. Currently, 
the company COMPASS Pathway is responsible for providing psilocybin for clinical trials; 
with the cost at 5 USD/mg. Therefore, there is a high demand for a suitable synthetic 
methodology that can reduce production costs for the pharmaceutical market. 
Although several reported chemical synthesis protocols of psilocin were established in the 
past to overcome the low natural production rate in the mushroom fruiting body, none of 
them can yet achieve more than 73% overall yield in an atom and step economic way 





requirement of an additional chemical synthesis step to produce psilocybin after the 
formation of psilocin. Recently, the corresponding biosynthetic gene cluster of psilocybin 
has been identified from Psilocybe cubensis and Psilocybe cyanescens (Fig. 2, right), and a 
biosynthetic strategy is considered to be an anticipated substitution to overcome this 
“bottle-neck”.  
PsiD: Tryptophan decarboxylase




Fig. 2. Psilocybin chemical structure and its biosynthetic gene cluster. The gene cluster scheme 
is modified from Frick et al., 2017, and the P. cubensis image is adjusted from a photograph made 
by Felix Blei (PM, HKI, Germany). 
In this genetic locus, three genes encoding the core enzymes, i.e., PsiD, PsiK, and PsiM, 
are essentially involved in psilocybin production. PsiD is a tryptophan decarboxylase, 
which connects the primary and secondary metabolism. An in vitro enzymatic study 
revealed that the necessary intermediate 4-hydroxytryptamine in psilocybin biosynthesis is 
either derived from Trp by decarboxylation and hydroxylation that is catalyzed by PsiD 
and cytochrome P450 monooxygenase (PsiH), or simply originates from 4-
hydroxytryptophan, which only needs PsiD in the reaction (Fricke et al., 2017). Moreover, 
PsiK catalyzes the phosphotransfer reaction at the C-4 position, yielding norbaeocystin, 
from which PsiM additionally catalyzes the N-methyl transfer step for the production of 
intermediate baeocystin, the shunt product norpsilocin, and the final product psilocybin.  
1.2 Genetic tools in heterologous expression  
In the post-genomic era, the number of available fungal genome sequences is steadily 
increasing. The functional annotation of this data provides much information about 
biosynthetic pathways towards known or unknown SMs. As mentioned in the beginning, 
SM formation is peculiar towards different species, and the triggers of gene transcription 
for SM production are varying, depending on their ecological systems (Brakhage, 2013; 
Keller, 2019). Therefore, the undiscovered BGCs require a suitable strategy, since many of 
them are silent under standard laboratory culture conditions. Likewise, for the discovered 
and valuable SMs, like psilocybin, a controllable system is demanded to break the 
domestic host's production limitations. The better unknown BGCs are elucidated, the 
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deeper our biochemical understanding of the enzymatic steps involved is and the more 
efficiently it can be applied. Heterologous expression, as one of the synthetic biology 
approaches, can help fulfill both needs (Mattern et al., 2015). The suitable choices of host 
as well as the genetic manipulation and transformation of the biosynthetic pathway in the 
chosen host are fundamental points that need to be considered. 
Previous reviews summarized the commonly used hosts for heterologous expression, 
including bacteria (e.g., Escherichia coli, Bacillus subtilis, and Streptomyces spp.), baker’s 
yeast (S. cerevisiae), and filamentous fungi (e.g., Aspergillus spp.) (Anyaogu & 
Mortensen, 2015; He et al., 2018). The fast life cycle, possibility of genetic manipulation, 
as well as the capacity of vector harboring, lead E. coli and S. cerevisiae to the preferred 
hosts. Nevertheless, they are not the ideal chassis for the synthesis of complex PKS-
derived SMs due to the insufficient conversion of essential secondary metabolite 
precursors and the difficulty in expressing certain plant enzymes, e.g., cytochrome P450, 
functionally (Kotopka et al., 2018). To circumvent this obstacle, besides additional 
chemical feeding or genetic modification in these simple microorganisms, filamentous 
fungi are the optimal alternative platforms for heterologous expression of large BGCs. 
Various genetic tools could be employed to introduce the required heterologous gene(s) in 
an amenable host. To assemble the required gene into a vector, methods associated with 
polymerase chain reaction (PCR) (e.g., Fusion PCR and seamless cloning techniques) 
combining yeast homologous recombination is a promising strategy that is widely applied. 
For the site-specific integration of DNA fragments based on homologous recombination, 
other toolboxes are used to minimize non-homologous end-joining (NHEJ), e.g., CRISPR-
Cas 9 activated double-strand DNA break and ku70/80 homologous gene knockout (Deng 
et al., 2017; Nayak et al., 2006). Although the gene randomly integrating into the genome 
might trigger the disruption of adjoining genes, ectopic construct integration of PKS genes 
via this NHEJ machinery in filamentous fungi benefited SMs biosynthesis, as reported in 
another review withal (Anyaogu & Mortensen, 2015). Depending on the host 
characteristics, the heterologous gene(s) can either be assembled in the specified (single or 
multiple copies) shuttle vector, or transferred into the chromosome, or both. In order to 
attain a satisfactory gene expression level, the promoter selection should be taken into 
account: an inducible promoter is controllable for the transcription induced at a suitable 
growth stage, and a constitutive promoter is active in the cell under any circumstances.  
The host species is also influencing the choice of the selective marker gene in the genetic 
transformation. The β-lactamase gene (bla) and the gene coding the aminoglycoside 3'-





maker genes for E. coli. The latter has a hybridized analog, namely KanMX (Wach et al., 
1994), that is utilized as a geneticin (G418) resistance gene in S. cerevisiae colony 
selection. Besides, yeast acquires a group of loci, such as URA3, HIS3, LEU2, TRP1, 
providing not only auxotrophic markers but also genomic integration positions (Kotopka et 
al., 2018). Similarly, the orotidine-5’-decarboxylase gene PyrG from Aspergillus spp. has 
an equal function to URA3. Thus, it is a prevalent auxotrophic marker for heterologous 
expression in filamentous fungi (Dohn et al., 2018; Richter et al., 2014; Zhu et al., 2013). 
Besides, L-arginine (Arg) auxotrophic marker ArgB cassettes, pyrithiamine resistance gene 
ptrA, and hygromycin resistance genes hph, have been reported as efficient selective 
makers that are frequently used in the model fungus Aspergillus nidulans (He et al., 2019; 
Upshall, 1986). Although the auxotrophic marker gene might interrupt the host metabolism 
when it is overexpressed, yet, for the industrial-preferred strains, the 
auxotrophic/nutritional selective marker is more acceptable in the food-grade application 
(Mignon et al., 2015). 
1.2.1 Connecting well-known SMs to unknown gene clusters 
The biosynthetic pathway of some SMs discovered in the past remains unclear and could 
be clarified by combining the use of bioinformatics tools with heterologous expression. 
Genome mining tools can analyze the open reading frames (ORFs) from the draft genome 
sequence once the genome information of a fungal species is available. The alignment with 
other similar genes and catalytic domains can result from BLAST (Basic Local Alignment 
Search Tool from NCBI), and the putative BGCs that are generated by other gene cluster 
predictors (e.g., antiSMASH 5.0 and MIBiG 2.0) will provide the possible gene cluster 
candidates for the target SM (Blin et al., 2019; Kautsar et al., 2019). After chemical 
structure analysis of this known compound, the possible enzymatic reactions involved in 
biosynthesis could be assumed, especially for NRPs which have a clear composition of 
amino acids and corresponding adenylation domains. Upon the prediction, the individual 
gene in the cluster candidates could be focused on, and the target genes can be 
reconstructed and expressed in a heterologous host for further compound determination. 
This is one of the strategies to link the well-studied bioactive product with its original gene 
cluster. 
The identification of the psilocybin gene cluster is one of the examples following this 
approach. The compound structure requires an aromatic amino acid decarboxylase, 
hydroxylase, methyltransferase, kinase, and omits any PKS or NRPS in the gene cluster. In 
both P. cubensis and P. cyanescens, each has one locus that carries genes that fit this 
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requirement and there is a high similarity between them. Therefore, four genes encoding 
enzymes were heterologously expressed in E. coli separately and purified for enzymatic 
reactivity, by which the proposed biosynthetic pathway of psilocybin was successfully 
verified (Fricke et al., 2017). 
Another approach is to heterologously express the entire PKS gene cluster in a filamentous 
fungus. To prepare a suitable host with low secondary metabolic background, the 
researchers in the Wang lab deleted seven well-known gene clusters from A. nidulans 
using homologous recombination based on the loop-out strategy. They created the strain 
LO30080 as an ideal platform for heterologous expression (Chiang et al., 2013). Upon this 
unique strain, they clarified the new gene cluster of the earlier-discovered SM citreoviridin 
(Lin et al., 2016). Earlier C13 labelling studies revealed the possible precursor of 
citreoviridin and the required CoA-esters building blocks. In parallel, a structurally similar 
compound aurovertin was reported, that was synthesized by a highly reducing PKS (HR-
PKS) (Mao et al., 2015). Hence, an HR-PKS cluster was isolated from the citreoviridin-
producing Aspergillus aureoterreus, in which genes encoding methyltransferase, 
hydroxylase, and monooxygenase are promising for the methyl groups in the structure and 
required bisepoxidation. Based on the strain LO30080, several A. nidulans mutants were 
constructed by introducing ctvA, ctvB, ctvC, and ctvD into the genome, through which the 
citreoviridin biosynthetic pathway was elucidated. 
1.2.2 Identification of novel SMs 
To discover a novel SM from a cryptic gene cluster, which is different from the above 
mentioned concept, requires a combination of tools and approaches. On the one hand, we 
have to consider the size of target genes and the possible alternative splicing within the 
pre-mRNA transcription during the reconstruction of the gene cluster. On the other hand, 
as with the silent gene cluster, whether the gene is mutated is another point merits special 
attention. Like in the austinoids biosynthesis study, only a pseudogene residue was 
identified in the austinol gene cluster from A. nidulans that has a certain similarity with the 
PKS gene ausV in A. calidoustus (Mattern et al., 2017). As with the example of 
citreoviridin shown above, there is another Aspergillus terreus strain NIH2624, which 
harbors an analogous gene cluster sharing about 90~95% similarity with the ctv gene 
cluster in A. aureoterreus CBS503.65. However, by heterologous expression of the 
putative PKS gene (ATEG_09617) that was isolated from this NIH2624 strain, the 
expected compound has not been detected (Lin et al., 2016), likely due to genetic mutation 





Although with relatively high difficulty, there are cases achieving to activate the silent 
gene clusters using artificial chromosomes and metabolic scoring systems based on 
heterologous expression (Bok et al., 2015; Clevenger et al., 2017; Harvey et al., 2018). 
This strategy constructs a large library of artificial shuttle vectors and transforms them into 
a suitable host for heterologous expression. The extracted samples are measured using 
high-resolution mass spectrometry. The dereplication of known SMs allows high-
throughput screening of unknown gene clusters and filtering of novel SMs. The highlights 
of the work from Harvey et al. (2018) are: 1) the yeast shuttle vectors carrying gene 
clusters were introduced to the S. cerevisiae host, through which both growth and protein 
expression have been improved. This strain optimization included expression of fungal 
cytochrome P450 and phosphopantetheinyl transferase encoded by npgA; 2) the selected 
gene clusters from both ascomycetes and basidiomycetes offer more possibilities to 
address unknown SMs. Except using an yeast platform, the other example is harnessing 
non-modified A. nidulans (Bok et al., 2015). In this study, a fungal-E. coli shuttle vector 
features the fungal replicating element AMA1 (Gems et al., 1991) and a commercial bias-
free linear vector allowed the E. coli-based vector construction and large size BGCs 
heterologous expression in fungi. Both methods discovered more than ten unknown SMs 
from the BGCs library. Although the remaining one-fourth of cryptic gene clusters are still 
not elucidated in both types of methodologies, they offer a quick selection of unknown 
gene clusters containing still fully functional enzymes in their sequences.  
1.3 Multigene expression systems for SM biosynthesis 
In synthetic biology, multiple gene expression strategies are in high demand for both, 
heterologous production and homologous expression, as there are generally multiple genes 
in any given BGC. In several reported approaches for protein co-expression (Mansouri & 
Berger, 2014; Szymczak & Vignali, 2005), the multigene carrier could be a shuttle 
vector/artificial chromosome or the genomic DNA, depending on the host type. An 
ePathBrick expression vector (Xu et al., 2012) contains restriction sites of isocaudamers 
(AvrII, XbaI, SpeI, and NheI) located before the T7 promoter, and before/after the T7 
terminator in the vector. This design allows multiple genes to iteratively assemble in one 
shuttle vector in a monocistronic operon or pseudo-operon configuration. Moreover, this 
expression vector was adopted by Adams et al. for psilocybin heterologous production in 
E. coli (Adams et al., 2019).  
As an eukaryotic host, the yeast S. cerevisiae and filamentous fungi Aspergillus spp. can 
use the locus-directed genomic integration method that is promoted by homologous 
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recombination, as a group of selective marker loci in these species has been well-
characterized (Chiang et al., 2013; Kotopka et al., 2018). Nevertheless, this method 
consumes marker genes that are limited in filamentous fungi during genetic 
transformation; hence, the marker recycling design can enable the repeated usage of one or 
two selective markers. Zhang et al. reported a recycled system in Aspergillus oryzae, 
namely Cre-loxP mediated self-excision (Zhang et al., 2017). It features two mutated loxP 
sites (34 bp of each) that are spaced by an A. nidulans selective marker adeA gene fused 
with the cre gene encoding Cre recombinase in the shuttle plasmid. This plasmid also 
harbors the gene intended to be expressed in the genome. In theory, after genomic 
integration, the expressed Cre can recognize the loxP sites with the same sequence 
direction and delete the DNA fragment between the sites. Therefore, the same selective 
marker can be used again for several genetic manipulations. 
Apart from “one ORF with one promoter”, the “polycistronic” manner known from 
prokaryotes can be acquired for multigene expression in the eukaryotic host by inserting 
cleavage sites between the genes. As both were discovered from the picornavirus family, 
the internal ribosomal entry site and the 2A peptide have been adopted from multiprotein 
expression, and the latter is more attractive as it has a shorter sequence (18~22 bp) and has 
non-protease dependent cleavage (Koh et al., 2013; Szymczak & Vignali, 2005). This 
ribosomal recoding is due to the conserved C-terminal end of 2A peptides (D-X-E-X-N-P-
G-P). During translation, the ribosome skips the peptide bond formation between glycine 
and proline and start the translation with proline as first residue continually (Sharma et al., 
2012), which guarantees the simultaneous co-expression of multiple proteins. To evaluate 
the best version of 2A sequences, preview comparison among several 2A peptides 
demonstrated that P2A has the highest cleavage efficiency in eukaryotic models (Daniels et 
al., 2014; Kim et al., 2011). Intriguingly, an advanced study showed that exchanging the 
last amino acid from proline to alanine did not prevent the ribosomal recoding process in 
Aspergillus niger using P2A (Schuetze & Meyer, 2017), yet this result stands out in 
contrast to the other study using F2A (Sharma et al., 2012). This might also suggest the 
high efficiency of P2A. Additionally, the efficiency screening of twenty-two 2A peptides 
in the yeast S. cerevisiae has been done by analyzing the intensity of expressed protein in a 
western blot after the 2A-mediated ‘cleavage’ (Souza-Moreira et al., 2018), where P2A 
had 85% ‘cleavage’ efficiency. The above assessments affirm the capacity of P2A in both 
budding yeast and Aspergillus spp. Importantly, the co-expressed multiple proteins, 
including one large PKS and four tailoring enzymes, after P2A-mediated cleavage still 





This quantification on the protein level indicates the considerable productivity of multiple 
proteins by P2A-involved co-translation. 
The elegant application of P2A is heterologously expressing the entire gene cluster of the 
classical fungal-derived antibiotic penicillin under one inducible promoter in A. nidulans 
(Unkles et al., 2014). Although the 2A sequence length is shorter than other splicing sites 
for protein co-expression, the attached 2A tag at the C-terminal end might influence the 
folding of some enzymes, even abrogate their activity. This negative effect was observed 
in P2A tag fused acetyltransferase AusP for austinoids heterologous production in A. 
nidulans (Mattern et al., 2017). Hence, ausP had to be assembled in an additional plasmid 
for fungal transformation. 
More and more strategies are available in this research field and are beneficial for strain 
engineering and optimization. Hybridizing these ideas can improve the host capacity to 
bear even more genes for valuable compound production. 
1.4 Yeast cell factories for valuable SMs production  
Unlike total chemical synthesis, cell-based biosynthesis can omit expensive or complicated 
feedstocks, toxic wastes, and inflexible synthetic routines. Various kinds of high-value 
products, including biopharmaceuticals, biofuels, biochemicals, and SMs, are provided 
commercially by microorganisms that serve as cell factories (Souza-Moreira et al., 2018). 
However, in contrast to petrochemical companies, biotech companies using fermenters for 
their production only occupied little of the global economic market based on statistical data 
(Davy et al., 2017). We can imagine that, once this new type of green manufacturing holds 
a reliable, renewable, and controllable production system, it has considerable market space 
to expand into. 
Long historical development, the most well-studied eukaryotic genome, available genetic 
editing, and being generally recognized as safe (GRAS) status, have paved the way for the 
yeast S. cerevisiae to become the most widely used cell factory by far (Baghban et al., 
2018; Souza-Moreira et al., 2018). Companies like Evolva and Amyris Inc. focus on 
deliverable plant SMs using S. cerevisiae yeast cell factories, e.g., health care bioactive 
resveratrol and anti-malarial/anti-cancer prodrug artemisinic acid (Wong et al., 2017; Xia 
et al., 2017). As a unicellular model ascomycete fungus, baker's yeast combines the easy 
cultivation and rapid growth of bacteria with the capacity of featuring the necessary post-
translational modifications of eukaryotes. Although budding yeast indeed has a few 
weaknesses, such as codon preference, incomplete phosphopantetheinyl transferase 
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collection, and different intron splicing (He et al., 2018); metabolic engineering can 
optimize strains to meet those requirements.  
1.4.1 Metabolic engineering  
In early 1998, people started to create recombinant yeast S. cerevisiae strains for the 
improvement of vinification (Puig et al., 1998). Designing and engineering the metabolic 
pathway is a crucial part of the construction of a robust yeast cell factory. The first critical 
step is to equip the heterologous biosynthetic pathway with the endogenous primary 
metabolism in yeast. Depending on the type of end-product, arranging the enzymes active 
in between as the bridge to tune the primary metabolic flux(es) towards particular synthetic 
pathways and reach the desired SMs is possible, if sometimes complex. 
An outstanding example is the complete biosynthesis of pain-releasing medicine opioids in 
engineered S. cerevisiae as whole-cell biocatalyst (Galanie et al., 2015). Without additional 
chemical supplements, the pathway starts from simple sugars and involves numerous 
enzymes (>20 in total) derived from plants, mammals, bacteria, and yeast. Although this 
study only obtained a trace amount much lower than the commercial requirement, it still 
provides several metabolic engineering strategies that could benefit other yeast cell 
factories.  
1.4.1.1 Substrate/precursor enrichment in the biosynthetic pathway 
As mentioned, CoA-esters and aromatic amino acids, i.e., L-tyrosine (Tyr), Phe, and Trp, 
are the key materials in the formation of PKs, NRPs, phenolic compounds and alkaloids 
(Lian et al., 2014; Nielsen, 2015). However, the carbon metabolic flux towards these units 
is highly regulated on the gene and protein level. Besides engineering the upstream 
pathway to enhance the intracellular substrate pool, another feasible approach is to de-
branch the side-pathways that constitutively consume the needed precursor. Circumventing 
the other superfluous side paths can be achieved by either introducing a heterologous 
enzyme(s) shortening the passageway or prohibiting the enzyme(s) catalyzing precursor 
degradation.  
Some studies introduced an engineered bypass to convert pyruvate to acetyl-CoA in the 
cytosol with high efficiency, redirecting the carbon flux towards the acetyl-CoA 
accumulation in the yeast for terpenoids or flavonoids bioconversion. (Lian et al., 2014; 
Liu et al., 2017a). By excluding the mitochondrial targeting sequences from the protein, 
Lian et al. constructed a cytosolically localized pyruvate dehydrogenase, since this one-
step reaction only occurs in the mitochondria, and the synthesized acetyl-CoA cannot be 





by overexpressing a protein complex comprising of an endogenous acetaldehyde 
dehydrogenase and a heterologous acetyl-CoA synthetase mutant with increased enzyme 
activity, which catalyzed a two steps conversion from pyruvate-derived acetaldehyde to 
acetate, and then formed the acetyl-CoA. In both cases, the desired products increased 
significantly, indicating that the reconstructed bypass circumvents the limit of cellular 
compartmentalization.  
Similarly, this strategy works for a Tyr-derived substrate. For example, a point-mutated 
cytochrome P450 was made by DeLoache et al. which has only hydroxylase activity 
without oxidase function. This engineered enzyme repressed the Tyr-formed substrate, 
namely L-3,4-dihydroxyphenylalanine, toward the side pathway, therefore enhancing the 
further synthesis of (S)-reticuline, a benzylisoquinoline alkaloid from plants (DeLoache et 
al., 2015). For the Phe supplement, the degradation of Phe can be blocked by the deletion 
of ARO10, which encodes a phenylpyruvate decarboxylase. Hence, with such a strategy, 
through p-coumaric acid, the downstream production of resveratrol has been upregulated 
by about 23% in the yeast S. cerevisiae (Li et al., 2016).  
Besides the Tyr-Phe branch in shikimate-derived pathways, the Trp intracellular pool in 
yeast is benefited by Trp biosynthesis and uptake of extraneous supplement. Nevertheless, 
the Trp level in yeast is not sufficient to produce the desired compound in a high level. 
Because the intracellular Trp is kept in a dynamic balance strictly regulated by its 
biosynthetic enzymes, typically the anthranilate synthase, which has a feedback inhibition 
response (Miozzari et al., 1978). Thus, repressing Trp catabolism might fuel the 
intercellular Trp pool and enrich the Trp-derived SM biosynthesis in yeast. 
In conclusion, to develop an overproducing strain that can overcome the tight regulation of 
intracellular levels, the possible optimizations cover gene/protein engineering, 
reconstruction of the biosynthetic pathway, and redirection or regulation of metabolic 
fluxes that include the substrate, precursor, product and byproduct (Davy et al., 2017). A 
fine-tuned system in a yeast-based factory can balance the healthy growth of cells and the 
considerable yield of the desired product. This could be achieved further by considering 
carbon source selection, CO2 concentration, and ethanol effects, in large-scale 
fermentation. 
1.5 Aim of the thesis 
Fungal SMs are formed in a limited amount in their original species. Thus, taking 
advantage of synthetic biology and metabolic engineering of the host is a powerful strategy 
to produce bioactive compounds in a controllable, scalable, and environmentally 
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considerate manner. On the one hand, the premise of this idea is that a feasible system for 
reconstruction and heterologous expression of the target gene cluster is necessary. 
Nevertheless, the modularized assembling, the “polycistronic” expression of multiple 
genes, and the fast screening of correct mutants are hard to achieve simultaneously for the 
eukaryotic host using the vector-based methods reported previously. On the other hand, the 
microbial host requires genetic modifications to serve as the amenable chassis for the 
desired product. The idea of baker’s yeast as the workhorse for the biosynthesis of 
heterologous SMs is being vigorously developed. Past lessons have taught us that the 
successful metabolic engineering of yeast requires a platform strain, which can be used for 
the same class of SMs (Nielsen, 2015). Upon this theory, a tryptophan-enriched “platform” 
strain is needed for indole alkaloid production. Therefore, based on the demands, there 
were three aims for this work.  
The first aim was to update a previously documented 2A-system (Unkles et al., 2014) for 
polycistronic expression of multiple genes. A standardized assembly pipeline and reliable 
but rapid selection method needed to be equipped to this system, which should be 
evaluated by heterologous expression of a large-sized gene cluster. 
The second scope was to exploit this improved system for the heterologous production of 
the valuable pro-drug psilocybin in filamentous fungi. This compound remains at trace 
amount levels in the native ‘magic’ mushrooms producing it and holds high demand in the 
pharmaceutical market.  
The last goal was to metabolically engineer the anabolic pathways of Trp in the budding 
yeast for the enrichment of the intracellular Trp pool. By combining the biosynthetic 
pathway with the recombinant yeast, the titer of psilocybin will be quantified, which acts 












2.1 Development of a heterologous expression platform for multigene expression 
Multiple genes assembly for heterologous expression was feasibly achieved by our smart 
cloning strategy based on the designed plasmid, namely, pV2A-T (please see Methods and 
Materials Section 4.2.1.2). It was built for four primary purposes: 1) a flexible assembly of 
requested genes; 2) co-expression of multi-genes with only one promoter/terminator and 
one selective marker; 3) reliable fluorescence-based screening of completed ectopic 
integration and expression of genes; 4) and separation of the residual tag from expressed 
protein.  
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Fig. 3. The machinery of the 2A C-terminal tags that need to be removed from enzymes after 
translation. In the 2A system, each essential gene is assembled with the tev site and the sequence 
coding 2A peptide. The artificial polycistron is transcribed in the heterologous host, and ‘cleavage’ 
of polypeptides is done by the ribosome “stop-carry on” manner, which is triggered by the 2A 
peptide. Subsequently, the attached 2A tag is cleaved from each key enzyme after translation. 
The twice-repeated sequences encoding 2A peptides were spaced by one restriction site 
EcoRV, which allows the insertion of the target gene in this backbone vector. Two rarely 
used restriction sites PmeI and SwaI that were introduced directly near the 2A sequences 
and inside the antibiotic-resistant marker KanR, are supposed to assemble the bicistronic or 
the polycistronic construct in a repeatable manner (shown in Methods and Materials 
Section 4.2.1.2). This method was utilized successfully for multiple genes overexpression 
cases mentioned in this study. In the heterologous host, during translation, the ribosome 
processes the “stop-carry on” machinery, by which polypeptides are formed (Fig. 3). 
Afterwards, the linear epitope, termed tev cleavage site (ENLYFQG), can be recognized by 
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the tobacco etch virus (TEV) peptidase (TEVp), which was co-produced with other key 
enzymes during translation. The cleavage occurs between Q and G (Kapust et al., 2001), in 
order to remove the attached 2A peptide.  
2.1.1 Function of TEVp elucidated by immunoblot assay 
The TEVp-mediated cleavage of 2A tag in vivo was primarily assessed in the model yeast 
S. cerevisiae by the use of immunoblot. In the host, mRuby and the TEVp coding sequence 
flanked by split-YFP fragments were co-expressed in the strain tSH18, which was 
compared with strains tSH16 and tSH17 that omit the gene coding TEVp (Fig. 4A). The 
tSH00 strain contains the empty vector pYES2 as an uracil prototrophic control strain. The 
anti-2A antibody was used to detect the remaining 2A peptide in total protein extracts of 
strains tSH00, tSH16, tSH17, and tSH18. Since it is unnecessary to introduce the tev site 
after VenusN in the design of the pV2A-T vector, the Venus-N is always fused with 2A tag 
in vivo after translation. Indeed, the band of Venus-N (~31 kDa) was detected from protein 
extracts of strains tSH16, tSH17, and tSH18 in the immunoblot (Fig. 4B), although the 
Venus-N band is relatively weak in the sample of tSH16. The sample of tSH17 shows a 
second significant band with a size of about 27 kDa equivalent to the mRUBY, which was 
not detected in the tSH18 protein extract sample as the 2A tags were removed from 
mRUBY proteins. This result proves the high efficiency of cleavage by TEVp in vivo. 




































Fig. 4. 2A tag is cleaved off in vivo as known by western blot using anti-2A antibody. Figure 
modified from Hoefgen et al., 2018. (A) Shows the construction of each plasmid that was 
transferred into yeast BY4741 forming strains tSH16, tSH17, and tSH18. (B) Heterologously 
produced TEVp was not detected in tSH18 by western blot (theoretical molecular mass: ~27 kDa) 
reveals the 2A tag attached to itself can be obliterated, and the same is true for mRUBY. At the 
same time, the tSH17 failed to clean the C-terminal 2A peptide when the gene coding for TEV 





2.1.2 Joined Venus-N and Venus-C observed in the nucleus via fluorescence 
microscopy 
One of the highlights in our heterologous expression platform is the YFP-based 
fluorescence screening system, in which the split-YFP, i.e., Venus-N and Venus-C 
subunits, can join when all the introduced genes are ultimately expressed from the 
beginning to the end without a break/stop in between and are translated (Fig. 5). A 34 
residue leucine zipper motif (Magliery et al., 2005) was introduced to each subunit of split-
YFP but in an antiparallel orientation: one leucine zipper domain (LZD) LzA is added at 
the C-terminus of VenusN, and the N-terminus of VenusC is modified by another leucine 
zipper helix B (LzB). Besides, the SV40 constitutive nuclear localization signal (NLS) 
(Kalderon et al., 1984) was additionally affiliated to the N-terminal part of VenusN and 
before LzB in the VenusC, separately. 
 
Fig. 5. Co-localization and dimerization 
model of split-YFP in the nucleus. Figure 
modified from Hoefgen et al., 2018. YFP was 
split between the eighth and the ninth beta-
sheets to generate the N-terminus (VenusN) 
and C-terminus (VenusC). Both subunits co-
locate in the nucleus, and this pair of Venus 
fragments can form the complete and 
functional YFP through two alpha-helices of 
leucine zippers, which have a dimer structure. 
Protein data bank (PDB) ID of YFP, LZD and 
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Fig. 6. Fluorescence scan for strain tSH17(A) and tSH18(B). Figure modified from Hoefgen et 
al., 2018. Comparing with the bright field (i), the Hoechst stain (presented in false blue color) 
indicates the position of nuclei in the yeast cells (ii). Using our developed heterologous expression 
method, the mRUBY and split-YFP proteins were produced completely and correctly in both 
strains, indicated by the accumulated YFP signal (iii; emission wavelengths of λ = 527 nm) in the 
nuclei (presented in false green color) and the red fluorescence (presented in false red color) 
suffuses in the cytoplasm (iv; emission wavelengths of λ = 605 nm). Scale bars: 10 µm. 
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Indeed, besides the immunoblot results, the Hoechst stained nuclei (Fig. 6A ii and 6B ii) 
acted as the references for the YFP-fluorescent pictures of strains tSH17 and tSH18 (Fig. 
6A iii and 6B iii). This indicates the YFP-signals were observed only in the nuclei of yeast 
cells and the red fluorescence was pervaded the whole cells (Fig. 6A iv and 6B iv). 
Compared with these two strains, a much weaker YFP signal was detected in the cells of 
strain tSH16 (result is not shown), which corresponds to the slight band of Venus-N shown 
in the line of strain tSH16 in the western blot. And the reason of this result is not clear. 
2.2 Developed expression system tested by completing austinoids production in A. 
nidulans 
The utility of this developed pV2A-T system in the eukaryotic host was verified by 
completing the austinoids production in A. nidulans via expressing four aus genes isolated 
from A. calidoustus, including AusP, AusO, AusT, and a large gene AusV (Mattern et al., 
2017).  
The TEV and aus gene cluster were constructed based on the pV2A-T assembling manner, 
as previously described, and formed a ~14.4 kb polycistronic construct including the genes 
of split-YFP subunits. The multigene expression in the strain NidtJL02 was controlled by 
the D-xylose-inducing promoter xylP (Zadra, 2000) in the host A. nidulans; TEV and genes 
for split-YFP in strain NidtJL01 were heterologously co-expressed under the control of a 
tetracycline-inducible promoter in the Teton system (Meyer et al., 2011) (Fig. 7). Since the 
ArgB was used as Arg auxotrophic marker for transformation-based ectopic integrations, 
strain NidtJL01 serves as the blank control, having an Arg prototrophic background. 
xylP







Fig. 7. Ectopic integration of polycistronic genes in A. nidulans. Strain NidtJL01, as the blank 
control, only has a TEV sequence and genes for the split-YFP subunits, which were constructed in 
the pV2A-T backbone and expressed under the control of the Teton promoter. NidtJL02 carries the 
aus gene cluster with TEV flanked by split-YFP genes, and the expression of these multiple genes 
is driven by the xylP promoter. 
2.2.1 Fluorescence-based screening of NidtJL01 and NidtJL02 A. nidulans 
transformants 
After the transformation of aus genes in the gDNA of A. nidulans, the obtained 
transformants of NidtJL01 (~30 colonies) and NidtJL02 (~20 colonies) were inspected by 





transformants (NidtJL02-V2 and V15), while strain NidtJL01 has more than twenty 
transformants exhibiting a yellow fluorescent signal. This phenomenon is reasonable, as 
we always observe that the longer polycistronic construct is more likely to be damaged 
than the shorter one during ectopic integration. Since the screening time using fluorescence 
microscopy was held to about one hour, this type of methodology is convenient regarding 
timesaving. 
The positive transformants can easily be confirmed using fluorescence imaging, on account 
of the co-localization of Venus-N and Venus-C in the nuclei of fungi (Fig. 8A). The dot-
like fluorescence only showed in the positive mutants (Fig. 8A, panels v and vi), while for 
the negative control strain RMS011, no fluorescence was detected. Additionally, this 
unique feature of fluorescence is distinguishable from the auto-fluorescence background in 
fungal mycelium. 
 
Fig. 8. Fluorescence microscopy imaging of strains RMS011, NidtJL01, and NidtJL02. The 
YFP fluorescent screening for mycelia grown on agar plates (A): The wild type (wt) strain 
RMS011 shows no fluorescence (panel iv) while the genetically modified A. nidulans strains with 
the correct integration of multiple genes exhibit particular fluorescence that only accumulates in the 
nuclei (panels v and vi). Panels i, ii, and iii are mycelia observed under bright field. Additionally, 
the merged images of the white light channel and light emissions at λ = 527 nm show mycelia 
grown in AMM broth (B): i) A. nidulans RMS011, ii) Positive control strain NidtJL01; different 
transformants V2 iii) and V15 iv) of strain NidtJL02, which harbors the aus gene cluster. The 
fluorescence is represented in false green color. 
Fluorescence intensity varies among the positive transformants. The transformants of strain 
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NidtJL01 (Fig. 8A, panel v) with positive YFP signal showed a stronger fluorescence 
compared to the signal-positive transformants of NidtJL02 (Fig. 8A, panel vi). In 
NidtJL02, only two mutants showed significant nucleic localization visible as fluorescent 
dots (Fig. 8B, panels iii and iv), in which V15 has higher fluorescence intensity than V2. 
This variability of fluorescence intensity might be due to the different inducible promoters 
(xylP and Teton) that were used in the two strains, as well as the size of polycistronic genes 
that were inserted in the fungal genome. 
2.2.2 Confirming the integration of the aus gene cluster in genomic DNA using 
southern blot 
To assess the efficiency of YFP-based fluorescence screening, a southern blot experiment 
was performed, as confirmation for the A. nidulans RMS011 transformation with plasmid 
pJL009. Four probes were prepared to examine the correct integration of the long 
polycistronic construct carrying the aus gene cluster. The southern blot indicated that each 
V2, V3, or V15 transformant individually obtains a single copy of pJL009 in its genome 
(Fig. 9B). Note, too, that only V2 and V15 exhibit YFP fluorescence, while the V3 mutant 
did not show any signal. This result confirmed the fluorescence-positive mutants. 
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Fig. 9. Southern blot analysis of A. nidulans mutants of strain NidtJL02. (A) Schematic map of 
linearized pJL009 plasmid, in which multiple DraI restriction sites are marked. In the graph, the 
probes are indicated with a black bar, Venus N (vN), and Venus C (vC) are showing in yellow. The 
other genetic features, like argB cassette, URA3, KanR, and yeast 2µ origin of replication (ori) 





3345 bp, and for the DNA sequence, which can hybridize with probes P2, P3, and P4 is about 10 
kb. Two fluorescence-negative transformants V3 and V4 were picked together with the signal-
positive mutants V2 and V15 for the test. The extracted gDNA of these four mutants was digested 
with DraI, and blotting, was hybridized with four probes (B) which detect i) the xylP promoter, ii) 
TEVp coding gene, iii) ausO , and iv) a part of ausV. The left lane of (B) is the 1kb marker (Bioline, 
Germany). 
2.2.3 Production of austinoids detected by HRMS 
As described in the introduction part (Section 1.1.1), compared to A. calidoustus, the 
fungus A. nidulans carries a similar austinoid metabolic pathway, yet the latter one is  
missing ausP, ausO, ausT, and AusV (Valiante et al., 2017). Based on the machinery of 
split-YFP screening, the transformed mutant with a positive fluorescent feature is expected 
to produce the enzymes AusP, AusO, AusT, and the PKS AusV, and these enzymes can 
complete the biosynthetic pathway of austinoid in the host A. nidulans (Fig. 10A). The 
YFP-fluorescence positive mutants V2 and V15 of strain NidtJL02 were cultured in the 
complex medium supplied with inducer D-xylose (Mattern et al., 2017). Compared with the 
negative control strain NidtJL01, these two mutants produced the extended compounds 1-6 
(Fig. 10B). However, the last compound calidodehydroaustin (7) was not detected, 
probably because the precursor compound precalidodehydroaustin (6) was significantly 
lower compared to the amount it was detected in the previous report (Mattern et al., 2017), 












A. nidulans NidtJL01 A. nidulans NidtJL02-V2 A. nidulans NidtJL02-V15
 
Fig. 10. Extended austinoid metabolic pathway through heterologous expression of ausP, 
ausO, ausT, and ausV. Figure modified from Hoefgen et al., 2018. (A) Austinoid metabolic 
pathway ends with austinol (1) in A. nidulans; while the heterologous expression of additional aus 
genes can reconstitute the further steps that exist in the fungus A. calidoustus and produce the other 
meroterpenoids (compounds 2-7). Domestic enzymes in A. nidulans are marked with blue color, 
and the introduced enzymes are indicated in black color. (B) Merged extracted ion chromatograms 
(EICs) of strains NidtJL02 (V2 and V15) and NidtJL01 are shown. Observed m/z [M + H]+ of 
compounds 1-6 (list in Table 1) correspond to the peaks 1-6 in the EICs. 
What is noteworthy is that the emerging intermediates 2 to 6 indicate the AusP activity was 
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maintained after removing the 2A tag at the C-terminal site by TEVp in vivo. Moreover, 
the transformant NidtJL02-V3 showing a positive result in the southern blot assay cannot 
produce the compound 6 overall (data not shown), likely because the PKS gene ausV was 
not expressed correctly. 
Table 1. The exact masses of austinoids detected in the strain NidtJL02  
Compound Chemical Formula Expected m/z  
[M + H]+ 
Observed m/z  
[M + H]+ Austinol 1 C25H31O8 459.2018 459.2011 
Austin 2 C27H33O9 501.2124 501.2110 
Dehydroaustin 3 C27H31O9 499.1968 499.1955 
7-Hydroxydehydroaustin 4 C27H31O10 515.1917 515.1906 
1,2-Dihydro-7-hydroxydehydroaustin 5 C27H33O10 517.2073 517.2056 
Precalidodehydroaustin 6 C32H39O11 599.2486 599.2479 
Calidodehydroaustin 7 C32H39O12 615.2436 Not detected 
 
This rewired biosynthetic pathway of austinoid in the heterologous host A. nidulans 
demonstrates the practicability of this developed platform, by which the correct assembly 
and expression of the polycistronic construct, even with the long size of gene like ausV 
(~8.1 kb), can be achieved. The TEVp-associated cleavage was proven to restore the 
activity of the expressed enzymes in A. nidulans, and the split-YFP technique minimizes 
the false positive results shown in the southern blot assay. 
2.3 Heterologous production of psilocybin in filamentous fungi 
In nature, the psilocybin quantity in the fruiting body varies between 0.5~2% dry weight 
among twenty-three mushroom species (Mahmood, 2013). To obtain this valuable prodrug 
in a more straightforward manner, several methodologies have been previously established, 
including total synthesis and enzymatic catalysis in vitro (Fricke et al., 2019). 
Nevertheless, a more suitable, controllable, and scalable method is always needed for such 
a useful bioactive compound. Especially a strategy like pharmaceutical fermentation is 
more adaptable to fit the good manufacturing practice (GMP) guidelines, which is 
preferable for the industry. 
For a broader application of this developed pV2A-T system, we transferred the psilocybin 
biosynthetic pathway from the higher fungus P. cubensis entirely into the mold A. 
nidulans. In this case, the psilocybin can be simply produced heterologously, using 
convenient shaking cultures. The cDNA of four essential genes encoding PsiH, PsiD, PsiK, 
and PsiM (Fricke et al., 2017) were assembled into the pV2A-T expression system as a 
polycistronic construct, namely pJF36. The expression of this psi gene cluster was 
regulated by the tetracycline-induced Teton promoter (Meyer et al., 2011). After the genetic 





on by adding doxycycline (Dox), which is the analogue of tetracycline.  
2.3.1 Positive mutants indicated by YFP fluorescence signal 
 
Fig. 11. Fluorescence screening of the psilocybin-producing strain NidtJF03. A. nidulans host 
strain RMS011 (A) is the negative reference for the positive mutants 1-5 (B-F) of NidtJF03. The 
overlapping images show the merged channels of bright light and light emissions at λ = 527 nm. 
The fluorescence is presented in a false green color. 
Since previous experiments have confirmed the efficiency of split-YFP subunits, the only 
further screening required for the obtained A. nidulans recombinants of NidtJF03 was 
YFP-based fluorescence microscopy. Because the size of the psilocybin gene cluster 
construct is smaller (~7.4 kb) compared with the austinoid gene cluster, the number of 
positive mutants was more - five out of twenty-four showed fluorescence (Fig. 11, B-F). 
Although all of these five transformants had the positive signal, the signal intensity varied. 
The first mutant exhibited the highest intensity (Fig. 11B), while the fourth and the fifth 
presented weaker patterns (Fig. 11E and 11F). 
2.3.2 Quantification of psilocybin based on standard curves 
All five fluorescence-positive mutants of NidtJF03 were first grown in a medium with Dox 
supplied as an inducer for psilocybin heterologous production. Each methanol-extracted 
sample was injected in ultra-high-performance liquid chromatography (UHPLC) for 
chromatographic analysis. The observed curves can be seen in Fig. 12A. Mutants 
NidtJF03_1, NidtJF03_3, and NidtJF03_5 had a higher yield of psilocybin compared to the 
other transformants, stating that fluorescence intensity is not directly related to the amount 
of product generated. This phenomenon was also shown before in the austinoids 
production strain NidtJL02, in which the mutant V2 performed better compared to V15 
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Fig. 12. Psilocybin quantification method. (A) Chromatographic analyses of five positive 
mutants (1-5) of A. nidulans NidtJF03 (Figure is modified from Hoefgen et al., 2018). After 
cultivation in AMM medium under shaking conditions, the five fluorescence-positive 
transformants were chosen for the psilocybin extraction, which was analyzed using UHPLC. The 
chromatograms were extracted at λ = 280 nm, showing the peaks corresponding to psilocybin, 
which is marked with a dashed line at 2.2 min retention time, referring to the authentic standard. 
The area under the curve (AUC) of the psilocybin standard corresponds to 70ng. (B) Established 
standard curve of psilocybin for quantification. 
To quantify the titer of psilocybin heterologously produced in A. nidulans, a standard curve 
was generated using authentic psilocybin (Fig. 12B). Among all the mutants we obtained, 
in this measurement, the best producing strain NidtJF03_3 yielded psilocybin at a level up 
to 110 mg/L, equivalent to 1.5% of dry mycelial mass weight (15.4 mg/g) (Fig. 13D). 
Baeocystin, the precursor of psilocybin, was also measured, and the titer is marginally 
lower than the amount of psilocybin (data not shown). The m/z values of psilocybin and 
baeocystin were checked by high-resolution mass spectrometry (HRMS), and only a trace 
amount of psilocybin was detected in the culture of strain NidtJF03 in the absence of Dox 
(Fig. 13B), verifying that the Teton system is turned off under non-inducing conditions. 
This is the first report of psilocybin being heterologously produced in a filamentous fungus 
at such a high titer, at that time, without any optimization. As opposite to the chemical 
synthesis and enzymatic production, using microorganisms to process psilocybin under 
fermenting conditions from relatively simple biochemical precursors, e.g. Trp, provides an 
advantage for reproducible and scalable manufacturing, which can be controlled and 







Fig. 13. Heterologous production of psilocybin in A. nidulans. (A) Identified biosynthetic 
pathway of psilocybin in P. cubensis. The precursor Trp is indicated in blue color. (B) The blank 
strain NidtJL01 and psilocybin-producing strain NidtJF03 were both cultured in AMM medium 
under Teton-inducing conditions (i and iii) and the non-inducing condition (Tet-; ii and iv). The 
DAD chromatograms were extracted at λ = 280 nm. The peaks reflect the compound baeocystin 
(12) and our target product psilocybin (13) with the exact mass m/z 285.0997 [M + H]+ detected 
using HRMS shown in positive mode (C). (D) Produced psilocybin (13) calculated in relative 
concentrations (% dry mycelial mass weight) for the two strains NidtJL01 and NidtJF03 grown in 
Tet+ and Tet- conditions as described above. The error bar represents the standard deviation. 
2.4 Budding yeast engineered as a cell factory for production of Trp-derived 
psilocybin 
Utilizing our developed heterologous expression system, in the convenient shaking culture, 
filamentous fungus A. nidulans achieved a high yield of psilocybin. However, to develop a 
more simplified and environment-friendly, yet alternative strategy for in vivo biosynthesis 
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of this valuable pro-drug with a higher titer is very meaningful. In this advanced project on 
Trp-derived biosynthesis, we harness an even simpler model organism as a cell factory - 
the budding yeast S. cerevisiae. Not only is yeast a simple microorganism that has been 
used for fermentation throughout history and easy to clean after manipulation in the 
industry, but it is also a eukaryotic species capable of synthesizing SMs. 
Psilocybin biosynthesis originates from Trp (Fig. 14C). Avoiding Trp degradation in order 
to enrich its intracellular pool in S. cerevisiae is our strategy. Besides for protein synthesis, 
Trp is effused through Ehrlich and kynurenine (KYN) bypasses in S. cerevisiae (Fig. 15) 
(Dickinson et al., 2003; Panozzo et al., 2002; Toyn et al., 2000). A century before, Ehrlich 
proposed the catabolism of amino acids through transamination, decarboxylation, and 
reduction/oxidation (Ehrlich, 1907). Indeed, one way of Trp degradation via indole-3-
pyruvate perfectly fits this theory. Among the predicted aminotransferases (AATs) in 
yeast, namely Aro8, Aro9, Bna3, Bat1p, Bat2p, and Yer152Cp, Aro8 and Aro9 play the 
dominant roles in the first transamination using glucose as a carbon source, which was 
revealed by several studies in the evaluation of gene expression levels, catalytic activity 
and cell growth (Hazelwood et al., 2008; Rząd et al., 2017). 
 
Fig. 14. Schematic and simplified overview of Trp catabolism and metabolism. (A) In yeast, 
two degradative pathways were relatively well-studied in Trp catabolism, among which the 
aminotransferases Aro8 and Aro9 catalyze the deamination of Trp to generate the indole-3-pyruvic 
acid, as well as involve in the KYN pathway to catalyze an irreversible deamination of KYN to KA 
(Ohashi et al., 2017). In this pathway, the indoleamine 2,3-dioxygenase Bna2 catalyzes the first 
step of this KYN pathway (Panozzo et al., 2002). (B) Besides, the KYN pathway also supplies the 
de novo NAD+ synthesis through quinolinic acid, and this pathway contains a branching point 
towards anthranilate that is the precursor of the biosynthesis of Trp, in which Trp4 catalyzes the 
first essential step (Kurnasov et al., 2003; Toyn et al., 2000). (C) With four key enzymes PsiD, 
PsiK, PsiH, and PsiM, psilocybin is derived from Trp. The dashed lines indicate the minor 
production of norpsilocin, which is either spontaneously dephosphorylated from baeocystin or 
enzymatically formed from the 4-hydroxytryptamine in the shunt steps. L-Glu: glutamic acid; Phe: 





nicotinamide adenine dinucleotide; PRPP: 5-phospho-α-D-ribose-1-diphosphate; PPi: Diphosphate; 
SAH: S-adenosyl-L-homocysteine; SAM: S-adenosyl-L-methionine. 
As opposite to the other AATs, Aro8 and Aro9 are classed as aromatic amino acid 
aminotransferase I and II with a broad-substrate specificity (Hazelwood et al., 2008). 
Especially Aro8 has shown activity towards L-lysine (Lys), L-histidine, and three aromatic 
amino acids in the yeast Candida albicans (Rząd et al., 2017). Interestingly, the same 
research also discovered a concentration-dependent catalyzing phenomenon - Aro8 and 
Aro9 (typically for Aro9) mainly function in the catabolism when corresponding amino 
























Fig. 15. Schematic view of the Ehrlich pathway and kynurenine bypass in S. cerevisiae for 
Trp degradation. The catabolism of the aromatic amino acid Trp leads to the formation of ‘fusel 
alcohol’ (the mixture of several alcohols) and the biosynthesis of NAD+, the latter one is also 
incorporated by nicotinic acid (Dickinson et al., 2003; Ohashi et al., 2017; Panozzo et al., 2002). 
The correlated enzymes are marked by a black frame. 
Additionally, the functions of these two AATs have been proven in the KYN degradation 
pathway for kynurenic acid (KA) construction (Fig. 15) (Ohashi et al., 2017). Panozzo et 
al. (2002) discovered a series of Bna enzymes in the KYN pathway, where Bna2 as an 
indoleamine 2,3-dioxygenase (IDO) catalyzes the first step.  
Based on this knowledge, a debranching design for Trp accumulation in yeast targeted and 
destroyed the AATs and IDO, i.e., Aro8, Aro9, and Bna2, in the first step of both 
degrading processes (Fig. 14A). 
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2.4.1 Diagnostic PCR confirms the deletion of ARO8 and BNA2 
In our deletion strategy, based on homologous recombination, the genes required to be 
deleted were replaced by autotrophic marker genes (LEU2 and HIS3), which have various 
sizes. Each deletion event was checked by diagnostic PCR using specific primer pairs, and 
the amplified DNA fragment band was contrasted to the band generated from the negative 
control strain (Fig. 16). Through amplification of specific DNA fragments, PCR can detect 
genetic mutation(s), e.g., deletion and insertion, and reveal their positions and sizes via 
electrophoresis (Karim, 2019).  
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Fig. 16. Diagnostic PCR strategies and electrophoresis gel results to confirm the ARO8 and 
BNA2 deletions. (A) ΔARO8_LEU2 fragment (2.11 kb) was amplified from colonies of the Δaro8 
strain in the colony PCR, which contrasted with the DNA fragment (2.52 kb) amplified from the 
negative control (NC) strain. The visible bands with different sizes were observed in the 
electrophoresis gel picture, indicating the ARO8 gene was deleted in both colonies T1 and T4 of 
strain YtSJ01. (B) To check the Δbna2 feature in the Δaro8/Δaro9 background, three pairs of 
primers were utilized. The reverse primer of the first pair specifically attaches to the sense strain of 
BNA2; hence, one band (~1 kb) shows up in the gel picture regarding the NC. The second or third 
pair of primers can only be used to obtain the HIS3 with 5’ flanking region or with 3’ flanking 
region, correspondingly. Indeed, the bands generated from positive transformants T14 and T16, yet 
not shown in the NC, prove the successful construction of the triple deletion strain YtSJ02.  
When the length of the introduced marker gene significant differs from the deleted gene, 
i.e., ARO8 and LEU2, the site-directed deletion event was confirmed only using the outer 
primer pair (Fig. 16A) in the PCR setup. Alternately, after HIS3 replaced BNA2, the sizes 





transformants with correct deletion events in this situation, we designed primers which 
specifically bind to the target genes for the PCR diagnosis (Fig. 16B). The obtained gel 
electrophoresis pictures confirmed that the transformants T1 and T4 of strain YtSJ01 
(Δaro8/Δaro9), as well as the transformants T14 and T16 of strain YtSJ02 
(Δaro8/Δaro9/Δbna2) are carrying the proper deletion features. 
2.4.2 Strain with Δaro8, Δaro9, and Δbna2 is sensitive towards Trp  
Constructed strains YtSJ01 (Δaro8/Δaro9) and YtSJ02 (Δaro8/Δaro9/Δbna2) together 
with the commercial yeast strains BY4741 (wt), Y01965 (Δaro9), Y04569 (Δaro8), and 
Y02556 (Δbna2) were assessed using various concentrations of Trp. Since the Trp 
degradation capacity is deficient at different degrees among these strains, we investigated 
whether the YtSJ01 and the YtSJ02 were sensitive to a higher amount of Trp supplied in 
the medium based on the exhibited phenotype. 
Consequently, a single ARO9 deletion resulted in a mutant more sensitive to elevated Trp 
concentrations (>5 mM) when compared to other single deletions of ARO8 or BNA2. The 
concomitant deletion of ARO8 in the Δaro9 background even enhanced this sensitivity 
(Fig. 17). This observation confirmed a previous study (Ohashi et al., 2017) showing that 
Aro8 and Aro9 are the dominating enzymes acting to detoxify excessive Trp in the cell. 
Especially, compared to Aro8, the effect of Aro9 in the detoxification of excess Trp is 
stronger.  










Fig. 17. Growth phenotype of Trp catabolism deficient mutants. The indicated cells were 
grown for 3 days in the absence or presence of Trp in a concentration gradient: 1 mM, 5 mM, and 
10 mM. The commercial yeast nitrogen base that was used for synthetic defined (SD) agar 
preparation contains nicotinic acid; therefore, the Δbna2 strain is viable in the assay plates. Two 
independent colonies of Δaro8/Δaro9 mutant and Δaro8/Δaro9/Δbna2 mutant were both tested, 
but due to the identical phenotype they show, only one colony of each strain is presented in the 
figure. 
Yet, the previous study did not construct and test the triple mutant Δaro8/Δaro9/Δbna2. In 
this assay, there is only a slight distinction of phenotype between double deletion strain 
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and triple deletion strain. From the result, the abolished Bna2 in the triple deletion mutant 
allowed for slightly better growth than the double mutant Δaro8/Δaro9. The Trp 
breakdown through the KYN pathway is initiated by the heme-dependent indoleamine 2,3-
dioxygenase Bna2 (Panozzo et al., 2002). Bna2 converts the Trp to N-formyl-L-
kynurenine, which is required for anthranilate production in intracellular Trp biosynthesis. 
Therefore, I assume that this additional BNA2 deletion not only attenuated the Trp 
catabolism but also minimized the intracellular supplement of Trp. In other words, the Trp 
level in the triple deletion strain might be slightly lower than in the double mutant strain 
Δaro8/Δaro9 at a certain growth stage, i.e., in or after the stationary phase.  
2.4.3 YFP-based fluorescence screening and PCR diagnosis of yeast transformants  
The wt strain BY4741 and other genetically modified yeast strains that were transformed 
with the expression vector pJF34 or pJF77 need essential screening to obtain positive 
transformants. Transcription elongation factor1 promoter (TEF1p) assembled in the 
plasmids allows the constitutive expression of the following genes without the need of an 
inducer.  
The obtained transformants of each strain were screened first based on YFP-signal; only 
the colonies with the correct transcribed and translated polycistron showing the nucleic 
fluorescence (Fig. 18A) were picked for the further confirmation. Although we claimed 
that the YFP-based fluorescence screening is a feasible method to select positive 
transformants (Hoefgen et al., 2018), afterwards, we also observed that genes were 
removed from the polycistronic construct during transformation.  
This problem is most likely due to the repeated 2A peptide sequences in the polycistronic 
construct, which could induce homologous recombination in the yeast. Hence, to avoid this 
case, all the fluorescence-positive colonies containing pJF34 or pJF77 were further 
analyzed via colony PCR. The plasmids pJF34 (Fig. 18C, i) and pJF77 (Fig. 18C, ii) were 
both constructed in the pV2A-T system for psilocybin heterologous production. pJF77 was 
constructed for the co-expression of gene pcCPR with the psi gene cluster, which is 
described in detail in Section 2.4.6. In the electrophoresis gel results, the colonies carrying 
the expected band were defined as the correct mutants (Fig. 18C), while a few of the others 
presented bands lower than the reference band indicated the negative mutants (data not 
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Fig. 18. YFP-based fluorescence screening and colony PCR applied to confirm the complete 
expression of polycistronic genes in the yeast strains. The fluorescence is represented in green 
false color. (A) The negative control strain is tSH00 (i) and does not show fluorescence, while 
fluorescent nuclei (ii) indicate positive transformants when transformed with pFJ34. (B) As 
examples, the five fluorescence screening fields showed the merged channels of bright light and 
light emissions at λ = 527 nm for the fluorescence-positive yeast cells of strains YtSJ07 (i), YtJL04 
(ii), YtJL06 (iii), YtJL08 (iv), and YtJL10 (v). (C) Colony PCR was adopted to check the integrity 
of the transformed plasmid. The expected band amplified from plasmid pJF34 (i) is about 5.4 kb, 
and the band generated from plasmid pJF77 is about 7.7 kb. The amplified band from each 
transformant was referred to the band shown in the plasmid lane (positive control). The gene drawn 
on the schematic diagram does not represent in the actual size scale. M: 1 kb marker (Bioline, 
Germany), T: lane of represented positive transformant. 
2.4.4 Production of psilocybin in the triple deletion strain bearing Δaro8/Δaro9/Δbna2 
Before we quantified the yield of psilocybin in the yeast mutants, the authentic psilocybin, 
baeocystin, norpsilocin, and Trp had been measured using UHPLC-MS as a reference in 
order to standardize the related retention times (Fig. 19) and exact masses m/z [M+H]+.  
To learn more about the intracellular metabolic fluxes, we not only intended to quantify the 
titer of psilocybin but also to measure the psilocybin precursor, namely, baeocystin, the 
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shunt metabolite norpsilocin, the branch-point KYN and its derivative product KA in the 
Trp catabolism. So, besides the previously achieved standard curve of psilocybin (Fig. 
12B), the other standard curves of baeocystin, norpsilocin, KYN, and KA, were generated 
(Fig. 20).  
UPLC Chromatogram

















Fig. 19. Overlapped UHPLC chromatograms of psilocybin, baeocystin, norpsilocin, and Trp. 
1 mM of each sample was injected and measured. The chromatograms were extracted at λ = 280. 
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Fig. 20. Standard calibration curves of baeocystin, norpsilocin, KYN, and KA. The serially 
diluted solutions of the authentic compounds were injected in the UHPLC, and the related AUC in 





The yeast cell concentration in liquid culture can be monitored based on the optical density 
(OD) at λ = 600nm. In order to investigate whether the growth status of transgenic yeast 
strains (S. cerevisiae  pJF34) with Δaro8/Δaro9 and Δaro8/Δaro9/Δbna2 genotype 
backgrounds are influenced when the intracellular Trp degradation is inefficient, the OD600 
of the BY4741 strain, double mutant Δaro8/Δaro9, and the triple mutant 
Δaro8/Δaro9/Δbna2 were measured at different time points, i.e., 6 h, 24 h, and 48 h, 
during shaking cultivation.  
The drawn graph roughly represents the growth curves of these strains (Fig. 21). The 
growth of Δaro8/Δaro9 and Δaro8/Δaro9/Δbna2 mutants were more attenuated than the 
growth of wt BY4741, which indicates that the abolition of the Trp catabolic pathways 























Fig. 21. The growth of yeast cultures in a minimal medium. Every two independent 
transformants of the BY4741  pJF34 (YtSJ08), double mutant Δaro8/Δaro9  pJF34 (YtSJ06), 
and the triple mutant Δaro8/Δaro9/Δbna2  pJF34 (YtSJ07), were grown in the uracil/uridine 
omitted SD medium (SD-Ura) with 1 mM Trp supplementation for 48 h under shaking conditions 
(180 rpm). The initial OD600 was 0.5. Three biological replicates were performed for each 
transformant, and the error bars represent the standard deviation.  
In our pre-experiment for the incubation time of main cultivation, the wt BY4741 strain 
harboring the expression vector pJF34 were cultured for 24 h, 48 h, and 72 h, individually, 
and the titer of psilocybin was the highest in the extracted sample from the 48 h cultivation 
(data not shown). Therefore, we fixed the time of the main cultivation at 2 days for the 
psilocybin production in yeast.  
The yeast cultivation is shown in Methods and Materials Section 4.5.2. The quantified 
psilocybin, baeocystin and norpsilocin were calculated in mg/g dry biomass and are shown 
in Fig. 22. In the analyzed result, the psilocybin titer in the Δaro8, Δaro9, and Δbna2 
single deletion strains was virtually identical to that in the wt control. Contrary to this, the 
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yield of psilocybin increased to 46 mg/g biomass in the strain which has parallel deficiency 
for both ARO8 and ARO9. The psilocybin production even prominently accelerated about 
five-fold more in the strain with additional repression of the Bna2-mediated catabolic 
pathway, and it reached a yield of 57±3 mg/g biomass (Fig. 22). Moreover, baeocystin 
production performed with a similar tendency among these strains. The accumulation of 
this psilocybin precursor was significantly enhanced in the double mutant Δaro8/Δaro9 
and the triple mutant Δaro8/Δaro9/Δbna2. This phenomenon conforms to the expected 
consequence of disabled competition of Trp usage via ARO8, ARO9, and BNA2 deletion. 
Curiously, as the shunt product, norpsilocin formation dropped down in all the gene-
mutated strains compared to the wt BY4741, and it was lower than 0.2 mg/g biomass in the 
triple deletion strain. It suggests that, when the intracellular Trp is redundant, the trend of 
metabolic flux in the psilocybin biosynthetic pathway is more toward the production of the 












































Fig. 22. Production of psilocybin, baeocystin, and norpsilocin in engineered yeast strains with 
repressed catabolism of Trp. The strains were grown in SD -Ura +1 mM Trp for 48 h, and error 
bars represent the standard deviation. The student’s t-test (* = p<0.05, ** = p<0.01) was performed 
using two independent mutants and three biological replicates for each strain. 
Additionally, the successful deletion of ARO8, ARO9 or/and BNA2 was proven by the 
quantified KYN and KA. The significantly decreased KA in the Δaro8 or Δaro9 single 
deletion mutant, as well as the undetectable KA in the strain Δaro8/Δaro9, verified that the 
formation of KA derived from KYN is catalyzed by both Aro8 and Aro9 that complement 
each other as AAT (Fig. 23). This obtained data of KA production is coincident to the 





KYN in the strain Δaro8/Δaro9 was about nine-fold higher than it was detected in the wt 
strain, which was not observed in our experiment (Fig. 23). The statistical analysis 
suggested that there is no significant difference between the wt strain and the strain with 
double deletion of ARO8 and ARO9 for the KYN amount. From my perspective, this 
observation might be due to the introduced psilocybin biosynthetic pathway in the yeast 
strain. We could presume that the more stringently Trp catabolism is blocked, the better the 








































Fig. 23. Production of KYN and KA in engineered yeast strains with repressed catabolism of 
Trp. The strains were grown in SD-Ura + 1 mM Trp for 48 h, and error bars represent the standard 
deviation. The student’s t-test (* = p<0.05, ** = p<0.01) was performed using two independent 
mutants and three biological replicates for each strain. 
2.4.5 Biosynthesis of isotope-labeled psilocybin 
As a valuable drug candidate, intensive pharmacological and physiological research of 
psilocybin has been ongoing recently, leading to an increased demand for a traceable 
version of this compound. Thus, it is worth to apply our yeast expression system to 
produce stable isotope-labeled psilocybin. Additionally, this specific application can 
provide a repeatable strategy for the labelling of other bioactive Trp-derived indole 
alkaloids with the highest chemical conversion efficiency. To construct the demanded 
strain that is only viable relies on the extracellular Trp supplement, we deleted the gene 
coding Trp4 (TrpD) enzyme, which catalyzes the phosphoribosylation of anthranilate en 
route to Trp (Miozzari et al., 1978; Toyn et al., 2000) (Fig. 14B). Therefore, the 
elimination of TRP4 results in an auxotrophic strain and allows the yeast strain to take Trp 
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up only extracellularly.  
In the beginning, we presumed that the Trp catabolism impaired strain 
Δaro8/Δaro9/Δbna2 with the fourth deletion of TRP4 may produce the comparable titer of 
psilocybin as the amount shown in the previous test. However, in this quadruple deletion 
strain, both catabolism and metabolism of Trp are depleted, it is hard to conclude the 
consequence. Hence, we investigated the psilocybin production in both the quadruple 
deletion strain and TRP4 single deletion strain compared to the yield from the 
Δaro8/Δaro9/Δbna2 triple mutant, which served as the positive control. 
2.4.5.1 Diagnostic PCR confirms the deletion of TRP4 
Applying the same strategy described in Section 2.4.1, the TRP4 was replaced by the 
autotrophic marker gene MET15. The deletion event was checked by diagnostic PCR using 
specific primer pairs, followed by the treatment of restriction enzyme XbaI. The fragment 
bands were contrasted to the bands generated from the negative control strain (Fig. 24). 
The obtained gel electrophoresis pictures confirmed that the transformants T3 and T4 of 
strain YtJL07 (Δaro8/Δaro9/Δbna2/Δtrp4) are carrying the proper deletion features. 
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Fig. 24. Diagnostic PCR strategy and electrophoresis gel result to confirm the TRP4 deletion. 
As an alternative method, restriction enzyme digestion of PCR-amplified DNA fragments was 
applied to control the deletion of TRP4, since the solo restriction site of XbaI exists in the 
auxotrophic marker MET15 that was used to replace the TRP4. After restriction digestion of the 
PCR products, samples were loaded and run through an agarose gel, and bands were generated in 
the lanes of transformants T3 and T4, indicating the successful deletion of TRP4, while T2 has an 
additional upper band which is identical to the band shown in the NC. 
2.4.5.2 Production of psilocybin in the Δtrp4 strains 
Not surprisingly, the amount of psilocybin in the Δaro8/Δaro9/Δbna2/Δtrp4 quadruple 
strain vastly dropped down, contrasted with it in the triple deletion mutant, yet it was still 
slightly higher than in the Δtrp4 single mutant (Fig. 25). Likely, the repression of the Trp 
anabolic and catabolic pathways deplete the intracellular pool of Trp, thus lowering the 
Trp-derived product, psilocybin, although the supplied Trp in the culture medium was 
overloaded. Under these circumstances, we chose the Δtrp4 single mutant for the further 
















































Fig. 25. Production of psilocybin, baeocystin, and norpsilocin in the mutants with abolished 
Trp catabolism and metabolism. The strains were grown in SD-Ura + 1 mM Trp for 48 h, and 
error bars represent the standard deviation. Statistical analysis was performed by student’s t-test (* 
= p<0.05, ** = p<0.01) using three biological replicates for each strain. 
2.4.5.3 UHPLC-MS measurement of [13C10]psilocybin, [13C10]baeocystin and 
[13C10]norpsilocin in the Δtrp4 strain 
 
Fig. 26. Production of psilocybin in the Δtrp4 single mutant incubated with non-isotope 
labeled Trp (upper panels) and with L-[13C11]tryptophan (lower panels). The strains were 
grown in SD-Ura + 1 mM Trp or 1 mM L-[13C11]Trp for 48 h. Peaks correspond to the following 
masses: psilocybin m/z 285.0998 [M+H]+, baeocystin, m/z 271.0844 [M+H]+, norpsilocin, m/z 
191.1180 [M+H]+, [13C10]psilocybin m/z 295.1336 [M+H]+, [13C10]baeocystin, m/z 281.1179 
[M+H]+, and [13C10]norpsilocin, m/z 201.1516 [M+H]+. 
The Δtrp4 single mutant transformed with pJF34 (strain YtJL10) was cultivated for 48 h in 
SD medium-Ura under addition of either 1 mM of Trp or L-[13C11]tryptophan, exclusively. 
High-resolution MS-based chemical analyses of both extracted samples undoubtedly 
showed that only [13C10]psilocybin had been produced and identified in the culture that was 
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only supplied fully labeled Trp. [13C10]psilocybin presented exact mass m/z 295.1336 
[M+H]+ compared with unlabeled psilocybin, i.e., by 10 mass units (Fig. 26). The akin 
phenomenon existed in the detection of [13C10]baeocystin (m/z 281.1179 [M+H]
+) and 
[13C10]norpsilocin (m/z 201.1516 [M+H]
+). In conclusion, the yeast strain with a Δtrp4 
genotype allows an atom-economic production of stable-isotope labeled [13C10]psilocybin. 
2.4.6 pcCPR co-expression with psi gene cluster in the triple deletion strain 
The last point for strain improvement was focusing on cytochrome P450 (CYP) catalyzed 
hydroxylation, which is a rate-limiting step in the psilocybin biosynthetic pathway. CYP 
has versatile capabilities for diverse oxidative reactions, where the monooxygenation is the 
most common one (Hrycay & Bandiera, 2015). The catalytic reaction strongly depends on 
the available cofactor NADPH and the efficient redox partner, namely NADPH-
cytochrome P450 reductase (CPR). Both CYP and CPR are anchored in the endoplasmic 
reticulum (ER) membrane by its membrane-binding domain and form the complex; 
therefore, two electrons are shuttled from NADPH to the heme active site in the P450 
enzyme via flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN) in CPR 
(Cederbaum, 2015; Xia et al., 2019). To provide valid CPR additionally is one way to 
enhance the electron transfer for heterologously expressed CYP in this rate-limiting 
catalyzation (Li et al., 2018; Lundemo & Woodley, 2015). Indeed, co-expression of CPR 
with CYP has been applied for the biosynthesis of alkaloids, terpenoid, and flavonoid at a 
high titer in the yeast cell (Ignea et al., 2016; Leonard et al., 2005; Li & Smolke, 2016; 
Trenchard & Smolke, 2015).  
In the psilocybin biosynthetic pathway, psiH encodes the CYP monooxygenase (Fig. 14C) 
that catalyzes hydroxylation selectively at 4-position of tryptamine to build 4-
hydroxytryptamine (Fricke et al., 2017). Transferring the above idea to our application, 
accordingly, we identified the unique putative gene encoding CPR in the same species P. 
cubensis (pcCPR). We hypothesized that the co-expression of pcCPR cDNA with the psi 
gene cluster in the yeast host might upregulate the yield of the final product psilocybin. To 
investigate this hypothesis, two yeast strains YtJL04 and YtJL06 were obtained as shown 
in Fig. 27. Thus, the expression of pcPCR either was regulated by the native MET15p 
promoter in the genomic DNA or was expressed in the vector under the control of the 
constitutive TEF1p promoter. The diagnostic PCR confirmed the genetic integration of 
pcCPR in the strain YtJL04, and the result is shown in the below Section 2.4.6.1. The 
integrity of the transformed expression vector in strain YtJL04 or YtJL06 was confirmed 





Section 2.4.3, Fig. 18). 




Fig. 27. Co-expression of pcCPR with psiH for psilocybin production. (A) In the triple deletion 
mutant with the pJF34 plasmid, pcCPR was integrated into the genomic DNA and expressed under 
the control of the MET15 native promoter MET15p. (B) pcCPR co-expressed with PsiH (CYP) 
controlled by the strong constitutive promoter TEF1p in the high copy number vector pJF77. The 
gene drawn on the schematic diagram does not represent in the actual size scale. 
2.4.6.1 Diagnostic PCR confirms the genomic integration of the pcCPR gene at the 
MET15 locus 
To integrate the pcCPR into the yeast genomic DNA, the last unused auxotrophic marker 
gene MET15 was utilized, which was connected to pcCPR with the 2A peptide sequence 






5‘ flank 3‘ flank
5‘ flank 3‘ flank
MET15
6 kb






Fig. 28. pcCPR_2A_MET15 genetic integration verified by diagnostic PCR. In the diagram, 
pcCPR and MET15 were fused by tev cleavage site (blue) and 2A sequence (red). The expected size 
of the PCR-amplified fragment from the correct transformants is 5.82 kb, and there is no additional 
band with 1.12 kb length as in the NC. Hence, T1 and T4 are positive colonies of strain YtJL02. 
The constructed pcCPR_2A_MET15 DNA fragment includes two flanking regions, which 
are homologous to the upstream and downstream sequences of the MET15 gene and was 
inserted into the MET15 locus under the control of the MET15p promoter. To verify the 
successful genetic integration of pcCPR, the outer pair of primers was used for the PCR 
diagnosis of yeast colonies. The result shown in the agarose gel indicated that the correct 
transformants (T1 and T4) with the expected band (~6 kb) contrast to the band in the NC 
lane (~1 kb) (Fig. 28).  
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2.4.6.2 Production of psilocybin in the strains YtJL04 and YtJL06 
Psilocybin production was evaluated in both strains and compared with the performance of 
the Δaro8/Δaro9/Δbna2 triple mutant that was set as the positive control. Against our 
expectations, in both strains, the titer of psilocybin declined, and the amount was lower 
than 10 mg/g biomass (Fig. 29), which is the average yield of it in the wild-type 
background strain YtSJ08. Theoretically, as the redox partner, CPR oxidizes the NADPH 
to NADP+ and provides the electrons to CYP (Li et al., 2018). Therefore, the co-expression 
of cognate pcCPR with PsiH is supposed to strengthen the oxidation of tryptamine and 
















































Fig. 29. Production of psilocybin, baeocystin, and norpsilocin in the yeast strains YtSJ06, 
YtJL04, and YtJL06. The strains were grown in SD-Ura + 1 mM Trp for 48 h, and error bars 
represent the standard deviation. Statistical analysis was performed by student’s t-test (* = p<0.05, 
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This negative regulation of co-expression of the psiH and pcCPR might occur due to 
various reasons. As a common strategy to enhance the activity of CYP, the harmful sides 
of overexpressed CPR were studied and reported. The large excess of CPR present might 
result in uncoupled redox activity, and the release of reactive oxygen species (ROS) that 
are toxic to the cell and reduce the yield of the desired compound (Bassard et al., 2012; 
Paddon et al., 2013). This could be one of the reasons explaining the low production of 
psilocybin since the pcCPR is expressed from the strong promoter TEF1p on the high-copy 
plasmid (2µ plasmid) in one of the constructed strains, YtJL06. However, the alike result 
from another strain YtJL04 might suggest a different reason. pcCPR in this mutant is 
integrated as a single copy in the genome and regulated under the regulable MET15p 
promoter, which could be repressed by high exogenous methionine (Met) as feedback 
inhibition (Cherest et al., 1969). In our SD culture medium, 0.2 mM of Met is supplied, 
and this concentration is enough to partially decrease the expression of the MET15p-
downstream gene (Mumberg et al., 1994). This may lead to an unbalanced coupling of 

















Synthetic biology is a discipline that focuses on engineering a microbe as amenable chassis 
to host a value-added product (Keasling, 2008). The construction of a cell-based producer 
requires powerful genetic tools that can handle multiple genes coding key enzymes to 
complete the biosynthetic pathway in a cellular environment. In parallel, metabolic 
engineering is needed to direct metabolic flux, such as chemical building blocks or start 
materials towards the desired compound via a central metabolic pathway. In this work, the 
biosynthetic applications upon a heterologous expression platform contributed to both 
aspects. However, questions that occurred during the study need to be addressed (Fig. 31). 
The capability of a multigene assembly system, the combination of TEVp and 2A in 
polycistronic expression, and the reliability of fluorescence-based screening are discussed 
from the perspective of producer construction in Section 3.1. Plus, in the experiments 
involving yeast metabolic engineering, the probable causes of unexpected results, 
particularly in co-expression of CYP/CPR and redirection of Trp metabolic flux, as well as 
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3.1 A user-friendly platform for multigene expression 
3.1.1 Modularization of DNA assembly and pV2A-T based construction 
DNA assembly methodology is necessary for cloning and constructing a gene cluster, 
typically when the PKS gene has a long and highly repetitive DNA sequence, which is not 
ideal for gene synthesis. As the vitally important toolkit in the field of molecular biology 
nowadays, the vector is constitutively developed and adapted for its expanding applications 
in biosynthesis. In the past, there were many assembling systems designed for vector-based 
multiple gene expression, which can mainly be grouped into two directions: a Cre/loxP 
mediated recombination and endonuclease-mediated cloning approach. For example, Kriz 
et al. reported a Multi-Label system using a loxP sequence to combine two plasmids into 
one in vitro (Kriz et al., 2010); yet each round requires a new selective marker gene that 
limits the number of genes for expression. This kind of system usually requires a 
complicated assembly design, depending on the orientation of the loxP sites and the 
expression of Cre. Besides, each fusion of plasmids doubles the size of the next-stage 
plasmid, which demands a cut-ligation step to remove the redundant sequence (Lin et al., 
2003). Therefore, a modular-type operation is the new trend for an assembling system, in 
which enzyme digestion plus ligation or seamless cloning is still the favored strategy. 
Using two restriction sites alternately has been employed to minimize the number of 
enzymes in an assembly line, the BpiI/BsaI or SapI/BsaI-joined toolkit based on the idea of 
Golden Gate method have been applied, mostly (Binder et al., 2014; Engler et al., 2014; 
Taylor et al., 2019; Vecchione & Fritz, 2019). However, these toolkits always have two 
vectors to fit two different construction features. Otherwise, the pair of enzymes cannot be 
harnessed repeatedly on several levels’ assemblage. In contrast, a most wildly applied 
method is the BioBrick system that has compatible cohesive ends resulting from XbaI and 
SpeI digestion. And it allows an iterative assembly (Knight, 2003; Shetty et al., 2008). This 
method was developed in many other versions, such as ePathBrick (Xu et al., 2012). It 
standardizes the use of four isocaudamer restriction enzymes in one vector and ends up 
with six different ligations that can meet the different expression demands, as mentioned in 
the introduction. However, the digestion and ligation of isocaudamers might result in 
asymmetrical sequences that may stop the enzyme cleavage for the next round. 
Additionally, the more isocaudamers are used, the higher the possibility of unwanted cuts, 
since it does not depend on homologous fragments for ligation, and the identical 6 bp 
restriction site can frequently be found in the gene that needs to be assembled. 
Hence, in the pV2A-T backbone (see Methods and Materials Section 4.2.1.2), only the 
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PmeI and SwaI restriction sites are necessary for assembly, which is more user-friendly. 
The PmeI and SwaI were chosen because both isoschizomers have 8-bp recognition sites, 
which are present in a low frequency in the genes. However, the PmeI and SwaI restriction 
sites need to be removed from the gene that needs to be assembled, if the recognition sites 
are present in the DNA sequence. Once every gene of interest is isolated and assembled in 
pV2A-T, the obtained plasmid can act as the acceptor vector by being digested with SwaI, 
or serve as the donor by being treated with PmeI. Because of the vector design, the gene in 
the acceptor vector is always constructed in front of the donor vector's gene. Thus, the gene 
order can be arranged flexibly according to the chosen enzyme. After restriction digestion, 
the recombination is according to the homologous regions, i.e., the 2A peptide sequence 
and a part of the kanamycin-resistant gene sequence. After each ligation, these restriction 
sites reset again, which enables the next round of assembly. Repeating this digestion and 
ligation with PmeI and SwaI, the bicistronic or polycistronic construct can be built feasibly 
as from the assembling pipeline (shown in Methods and Materials Section 4.2.1.2). Plus, 
the pair of PmeI/SwaI synthesized in the KanR gene avoids some incorrect assembling 
events, as the proper reconstruction of this gene functions as the selective marker for the 
colony. Furthermore, this method saves not only time in the PCR but also the primers 
during cloning, since each target gene only needs a forward primer and reverse primer with 
homologous tails for the PCR amplification in the beginning step.  
Moreover, the pV2A-T plasmid presents a single PacI restriction site in front of the ATG 
start codon, which allows the additional insertion of a selective marker cassette, a suitable 
promoter, and other essential elements. This feature promises that the plasmid can be either 
adapted to an expression vector in the yeast cell factory or integrated into the genome of 
various hosts. The heterologous expressions of the austinoid gene cluster and psilocybin 
gene cluster were achieved using this pV2A-T plasmid, which reveals that the capability of 
this plasmid can reach ~25 kb, in which the size of the polycistron is up to 14.2 kb. This 
does not exploit the limits of this method, although we observed that the number of E. coli 
colonies was lower after seamless cloning when the size of multiple genes was larger than 
26 kb.  
3.1.2 Using the 2A peptide in multigene expression 
As opposed to the E. coli expression platform taking the ribosomal binding site to connect 
multiple genes in a ‘polycistron’ expression (Xu et al., 2012), the 2A peptide sequence was 
introduced to mediate co-translational cleavage of an artificial polycistronic construct in 





it holds attention because of its short size, high efficiency for ribosome skipping, and need 
of a single promoter.  
In this work, P2A-led expression has been used for bioactive compound production and 
strain engineering, indicating the versatile applications of this short peptide. Typically, the 
bicistronic expression system, where the selective marker gene is located after a target 
gene, can minimize the number of false-positive transformants growing on the selective 
plates, because some frameshift mutations can destroy the conserved motif GDVEXNPGP, 
which results in unsuccessful skipping of the ribosome and wrong translation of the 
downstream protein. 
Despite the advantages of 2A peptides, the widespread application requires more 
systematic studies of position effects, gene number limitation, and transportation or 
targeting of co-expressed proteins. The position effects have been observed in some 
investigations in the past. In the bicistronic construct, the protein expression is significantly 
lower at the second position using fluorescent proteins as reporters (Liu et al., 2017b), yet 
the expression level highly depends on the protein itself, as it was observed in another 
study (Wang et al., 2015). For the tricistronic construct, the position influence was tested 
by luciferase expression using P2A, and the protein expression was negatively regulated at 
the first position (Schuetze & Meyer, 2017). Conversely, Liu et al. found that the first 
position had the best performance, and the second one was the worst when they co-
expressed three different fluorescent proteins, in which P2A was used to space the first two 
genes and T2A was utilized to link the last. The same study also revealed that no matter 
whether mixed 2A peptides or the identical 2A peptide (P2A) were employed, the 
expression level was continuously dropping from the 5' side toward 3' end in the 
quadcistronic construct. Therefore, the activity of expressed multiprotein from the 
polycistronic construct can vary depending on the gene number, the sort order in the 
construct, and the type of protein. 
 In the heterologous expression of the austinoid gene cluster mediated by P2A, the last 
compound calidodehydroaustin (7) that is formed by AusO, has not been detected. Since 
the largest PKS gene ausV was assembled at the 3’ end of the construct, i.e., the fifth 
position, the expression of AusV could be the lowest compared to other co-expressed 
enzymes, according to this position effect. Although the AusV expression level was not 
quantified, the production of the AusV-associated compound precalidodehydroaustin (6) 
was dramatically lower than detected from another strain cultivation, in which AusV was 
located at the third position based on P2A-connected quadcistron (Mattern et al., 2017). 
Therefore, as the precursor of compound (7), low-yielded (6) might not be enough to fuel 
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the biosynthesis of the final product. It seems that the position effects are the limitation of 
the 2A system, while further research could take it as an advantage to mediate the strength 
of gene expression. 
Besides, the limiting number of genes in the 2A system is still not determined. Up to eight 
discrete proteins have been expressed upon 2A-mediated ‘self-cleavage’ in yeast for the 
co-expression of the psi gene cluster with pcCPR. After genetic transformation, it was 
observed that when the P2A peptide DNA fragment links more genes, there is a higher 
possibility of gene deletion in the transformed cells. This phenomenon might be due to the 
homologous recombination machinery in the engineered fungal hosts. Fortunately, this 
gene-removed event can be easily checked using diagnostic PCR. 
Last, whether the expressed SMs biosynthetic enzymes formed by 2A-mediated co-
translation can still be transferred into the host's destined locations needs greater 
understanding. Typically, an enzyme that involves SMs synthesis is correctly 
compartmentalized in specific subcellular units that can promise pathway efficiency, e.g., a 
high penicillin production has been observed when the number of peroxisomes increased in 
the strains of Penicillium chrysogenum (Meijer et al., 2010). Therefore, this is a node 
worth considering in synthetic biology. Usually, the nascent peptide synthesis through  the 
ribosome and then the precursor protein is either translocated in the lumen of the ER or 
incorporated into the ER membrane itself and transferred to vesicles in the Golgi mediated 
exocytosis at the hyphal tip and the septum (Kistler & Broz, 2015; Riquelme & Sánchez-
León, 2014). A previous study noticed that when the protein upstream of 2A was led by the 
signal recognition particle (SRP)-dependent signal sequence and localized in the Golgi, 
even when the mitochondrial targeting signal or NLS was added before the next gene, the 
encoded second protein only localized within the ER (de Felipe & Ryan, 2004). The 
correct localization in mitochondria and nucleus happened to the second protein when the 
SRP-dependent signal was removed from the first gene in the bicistronic construct. From 
this report, the post-translational signal present in the first gene of the 2A-associated 
polycistron seems vital for the transfer of the remaining discrete proteins. In our 
applications, the polycistronic constructs always start with the VenusN subunit, in which 
the N-terminus was modified by an NLS. Although both synthesized austinoids and 
psilocybin in our applications can indicate the correctly expressed enzymes, whether the 
nascent proteins generate from the 2A-mediated ribosome skipping is due to co-





3.1.3 Addition of TEVp to the 2A system 
As the protease identified from the tobacco etch virus, TEVp is one of the most commonly 
used tools for peptide-bond cleavage in biotechnology, as it is cofactors-independent, 
highly sequence-specific, and can recognize a seven-amino-acid motif peptide substrate 
(Sanchez & Ting, 2020).  
A combination of 2A and TEVp is an innovative idea in our application. Generally, after 
2A-cleavage, except for the first-formed peptide, the other mature peptides have a proline 
at the N-terminus, and this feature can enhance protein half-life (Varshavsky, 2011). 
However, as a technical drawback in the later process, the remaining ~20 amino acids of 
the 2A peptide fused at the C-terminus of the protein interfere with the enzymatic function 
that has been documented (Mattern et al., 2017; Subramanian et al., 2017). In the 
assessment of this developed heterologous expression system, assisted by TEVp cleavage, 
2A-free AusP kept its enzymatic activity, therefore, can assemble with other aus genes in 
one polycistron to save marker genes for fungal transformation. Besides, to reduce the 
autoproteolysis of TEVp per se, the gene encoding the TEVp mutant S291V (Kapust et al., 
2001) was equipped in the pV2A-T, where this TEV gene was followed by 2A. In the 
immunoblot analysis, no additional band refers to 27 kb in the lane of strain YtSH18 (Fig. 
4B), also proving that the 2A-tag was wholly cleaned from TEVp by its ‘self-cleavage’ 
efficiently.  
Commonly, TEVp is applied in fusion protein cleavage and purification, as it is better 
characterized compared to other proteases, e.g., different TEVp variants with strengthened 
catalytic activity have been adopted for one-step on-resin cleavage and purification 
(Waugh, 2011; Zhu et al., 2017). In contrast to the application of TEVp for multiprotein 
cleavage, it is also applied in multiprotein expression in E. coli and in mammalian cells 
(Chen et al., 2010). One recent application using TEVp and its recognition site in 
polyproteins demonstrated that the thirteen nitrogen fixation genes have been grouped in 
four giant genes connected by the TEV site, and enabled the synthesis of active nitrogenase 
in non-diazotrophic E. coli (Yang et al., 2018).  
Nevertheless, the reported applications of TEVp in synthetic biology were few, maybe due 
to some technical drawbacks when using TEVp alone in multigene expression. On the one 
hand, despite it has specific cleavage performance, the catalytic turnover of TEVp is 
significantly lower than other proteases (for example, trypsin and subtilisin) (Sanchez & 
Ting, 2020). This might not be promising for the several cleavage actions in a large 
polyprotein. Indeed, the unexpected protein fractions presented in the western blot analysis 
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represented uncut tri-chimeric and bi-chimeric proteins when using a TEV-based system 
for the heterologous expression of tri-cistronic constructs in yeast (Ghiaci et al., 2014). On 
the other hand, although all proteins can be expressed at an equimolar level, they are 
localized in the same subcellular compartment. Even though the additional targeting 
sequences would assist TEVp localization in the nucleus, mitochondria, peroxisome, or ER 
(Cesaratto et al., 2016), it is hard to fulfill all the requirements of SM synthetic enzymes 
having diverse localizations within the cell. Moreover, fusion protein cleavage in vivo 
might negatively influence the foldability and stability of the downstream proteins (Shih et 
al., 2005). Therefore, using TEVp exclusively in SM biosynthesis has inescapable 
limitations. In our heterologous expression platform, 2A-leaded co-translational ‘cleavage’ 
happens before the mature protein formation, and TEVp performs the later cut-off of the 
2A-tag, which avoids this structural interference.  
To be cautious, the remnant of the recognition site is attached at the C-terminus as the E-
N-L-Y-F-Q tail after TEVp cleavage. The extra chain includes six amino acids, and though 
it is shorter than the 2A peptide tag, can still down-regulate enzyme activity, since the 
tailing tolerance varies with different proteins. For example, the activity of nitrogenase 
cofactor maturase NifB decreased by 30% with the ENLYFQ-tail, and the NifK as the beta 
subunit of molybdenum-iron protein cannot tolerate this C-terminal tail (Yang et al., 2018). 
Hence, before using the pV2A-T expression system for a known biosynthetic pathway, 
evaluating the tailing tolerance of key enzymes is an option.  
3.1.4 Joined YFP indicates the complete expression of genes  
In the past, southern blot hybridization was a widely used and reliable method to verify the 
genome's alteration after fungal transformation. Nonetheless, it is very laborious and time-
consuming to handle a large number of transformants. As a highlight innovation in our 
developed platform, the fluorescence-based screening system based on the association of 
split-YFP subunits enormously shortens the workload and allows for high-throughput 
testing. This idea was adopted from bimolecular fluorescence complementation assays for 
protein-protein interaction (Kudla & Bock, 2016). The split position of “Venus” YFP was 
decided between the eighth and the ninth beta-sheets for Venus-N and Venus-C fragments 
because the split fragments with about a 2:1 size ratio can reduce the self-assembly (Romei 
& Boxer, 2019). The genes encoding these subunits are located separately at each end of 
the polycistronic construct, granting that the translational efficiency can be examined 
visually, which differs from the southern blot assay that only analyzes the modification at 





Two additional features modified the split-YFP further, to strengthen the application. For 
more efficient, specific, and essentially irreversible interaction of the two subunits, the 
antiparallel leucine zippers, as the ubiquitous domains benefiting the edge-edge interaction 
(Magliery et al., 2005), were introduced to drive the reassembly. Meanwhile, the post-
translational signal sequence, namely NLS (Kalderon et al., 1984), added to both Venus-N 
and –C, orientates the YFP only targets in the cell nucleus. The rejoined subunits provide 
the dot-like fluorescence in the mycelia, which can easily be observed and distinguished 
from the fungal autofluorescence background to omit a false-positive result. For example, 
during the microscope screening, the strain with a dim view indicated negative 
transformants, while the mycelia filled with fluorescence diffusion has been revealed as 
incorrect mutant in the experiments. 
The reliability of this design has been confirmed by southern blot assay of A. nidulans 
NidtJL02 mutants. Intriguingly, mutant NidtJL02-V3, that passed the southern blot 
analysis, has been proven as a false-positive transformant by fluorescence screening and 
HRMS measurement of chemical extracts. This indicates that the YFP-based approach is 
more dependable than the southern blot test. In the initial expectation, the fluorescence can 
be observed in the nuclei only when the whole polycistronic gene is entirely transformed 
and translated. Unexpectedly, we also experienced that the mutants harboring damaged 
polycistronic constructs showed fluorescent signal. I presumed that this was owing to 
either the broken gene not influencing the codon reading of the ORF or the entire gene loss 
not interfering with the ribosome skipping during translation. This observation adjusted the 
estimate of ‘correct’ transformant. Hence, the presence of a fluorescent signal can affirm 
the complete translation of transformed genes, and the PCR diagnosis can prove whether 
the entire polycistronic construct is transformed and expressed as expected. This updated 
strategy has been successfully used for the transformant screening of yeast strains 
harboring pJF34 or pJF77 giant expression vector. 
Interestingly, from the observation, the intensity of the YFP signal is correlative to the size 
of the assembled genes. This phenomenon could be used to evaluate the maximum 
capacity of polycistronic expression in eukaryotes. However, the signal strength is not 
directly linked to the production amount of the expected compound in the biosynthesis. 
3.2 Biosynthesis of Trp-derived psilocybin in the cell-based factory 
The discovery of the psilocybin biosynthetic pathway triggered cell-free enzymatic 
biosynthesis and cell-based heterologous biosynthetic methods for psilocybin production. 
By supplementation of L-serine, pyridoxal phosphate (PLP), β-subunit in the tryptophan 
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synthase (TrpB), and three critical enzymes, i.e., PsiD, PsiK, and PsiM, psilocybin was 
successfully obtained in a one-pot enzymatic reaction in vitro (Blei et al., 2018). Because 
the TrpB can catalyze the PLP-dependent condensation of 4-hydroxytryptophan and L-
serine to form 4-hydroxytryptamine. In the same year, using the pV2A-T based system, the 
filamentous fungus A. nidulans was harnessed for the first time to produce this valuable 
compound heterologously in a high titer without any optimization (Hoefgen et al., 2018). 
Later on, the idea of a one-pot enzymatic reaction was transferred by Adams et al. (2019) 
and applied on the E. coli cell factory. Differing from this, in the heterologous expression 
system, psiD, psiK, and psiM were placed separately in three expression vectors with 
middle, high, and low copy numbers in the E. coli strain, which has the overexpressed 
native tryptophan synthase TrpAB. After fermentation optimization, this bacterial strain 
achieved up to 1.16 g/L titer of psilocybin. However, due to the impossibility of 
functionally producing the cytochrome P450 monooxygenase involved in psilocybin 
biosynthesis, namely PsiH, E. coli production was achieved by using 4-hydroxyindole in 
the growth medium.  
A strategy of supplying several starting substrates might be uncompetitive compared to the 
total chemical synthesis when considering the economic cost. Thus, the yeast S. cerevisiae 
was considered as an alternative type of cell-based factory. In parallel with our further 
study in the genetically modified S. cerevisiae, a research group from Denmark recently 
published their work, in which the psilocybin was likewise yielded in the baker’s yeast and 
obtained 627 mg/L in a fed-batch fermentation (Milne et al., 2020). In yeast engineering, 
they enhanced the shikimate pathway and Trp biosynthetic pathway to accumulate 
intracellular Trp levels and to upregulate psilocybin titer from 130 mg/L to 200 mg/L. Our 
work targeted the degradation pathways of precursor in order to elevate the psilocybin 
yield in the recombinant yeast. As both biosynthetic strategies achieved large-scale yield, 
these ideas provide Trp-enriched yeast platforms. It is an additional advantage in metabolic 
engineering, because bioprocessing can be modified for the production of other Trp-
derived analogs with clarified biosynthetic pathways.  
For the better comprehension of the yeast strains constructed in our work, some 
unexpected results and the further possible optimization are discussed in the subsections 
below. 
3.2.1 The consequences of redirected intracellular Trp flux 
Although baker’s yeast is the most well-studied microorganism, the gene deletions 





understanding for the better engineering of a cell factory. In yeast, Trp levels are dynamic 
through different growth stages, as a bunch of enzymes regulate the metabolism and 
catabolism. In our study, the Δaro8/Δaro9/Δbna2 triple mutant gained increased 
psilocybin production, and a downregulated yield came from additional deprivation of the 
Trp biosynthesis.  
In the Δaro8/Δaro9/Δbna2 triple mutant, the deficient Aro8 and Aro9 not only knockdown 
the Trp degradation, but also switch off the Tyr and Phe intracellular production, since 
both enzymes catalyze the last transamination step of biosynthesis of these amino acids 
(Iraqui et al., 1998). These changes all somehow redirect the bypasses and lead chorismic 
acid mainly towards the Trp pool.  
Another phenomenon is that a low OD600 value of the Δaro8/Δaro9 or 
Δaro8/Δaro9/Δbna2 mutants has been shown during yeast cultivation (Fig. 21). Mutants 
that have a lower biomass accumulation than the wild type might be subject to impaired 
biosynthesis of a number of amino acids and the NAD+ production through the KYN 
pathway. Besides catalyzing the formation of Tyr and Phe with Aro9, Aro8 features a 
broad substrate specificity, and underlies the biosynthesis of Lys (Bulfer et al., 2013). The 
salvage biosynthesis pathway from nicotinic acid is more important than the de novo 
pathway from Trp catabolism for the NAD+ synthesis; however, the latter one is initiated 
by Bna2 and also cannot be neglected. Typically, the high NAD+/NADH ratio can 
stimulate respiration for biomass accumulation with adenosine triphosphate (ATP) (Sporty 
et al., 2009; Xu & Tsurugi, 2006). For this reason, the NAD+/NADH ratio might be 
decreased in the aerobic culture of the Δaro8/Δaro9/Δbna2 mutant, thus slowing the 
growth. Although growth impairment is not measured in our work, the result might be 
equivalent to a recent test by Deed et al., where a delayed log phase has been observed in 
the yeast commercial strain F15 with the Δaro8/Δaro9 genotype. This strain needed twice 
the time compared to the wild type to reach the log phase (Deed et al., 2019). Thus, the 
biomass of the triple mutant could be ‘restored’ when the fermentation time is prolonged, 
which suggests a necessary optimization of fermentation for future tests. 
As a thought-provoking point, how deeply the Ehrlich pathway is affected by Δaro8 is 
unclear, since the alcohol yield was not determined. In the Δaro8/Δaro9 double mutant, 
two distinct AATs, i.e., mitochondrial Twt1p (Bat1p or Eca39p) and cytosolic Twt2p 
(Bat2p or Eca40p), might facilitate the transamination for the first step in the Ehrlich 
pathway, in a low level (Hazelwood et al., 2008). Aro10 is a dominant decarboxylase 
catalyzing the second step, which is the only irreversible process in the pathway. It has 
been noticed that ARO10 is consistently upregulated in the Δaro8 yeast strain when 
 
58  
cultured in a medium with ammonium as a nitrogen source (Romagnoli et al., 2015). This 
might result in a higher yield of alcoholic products, although we defined the cultivation in 
the aerobic condition.  
If this hypothesis is correct, it is reasonable that the additional deletion of TRP4 negatively 
impacted the yeast strain with the Δaro8/Δaro9/Δbna2 background. Regardless of the 
equal significance of each enzyme implicated in Trp biosynthesis, only the deletion of 
TRP1 or TRP4 lowers the ethanol stress tolerance of yeast and leaves the cell sensitive to 
alcohols including ethanol, L-propanol and L-pentanol (Fujita et al., 2006). In this work, 
yeast cultures were performed in aerobic conditions, while the samples had an alcohol 
smell during harvest after 48 h fermentation, despite ethanol formation was not being 
measured in our study. The ethanol production is possible due to the short-term Crabtree 
effect with 1% glucose supplied as a carbon source (Hommes, 1966). 6% ethanol in the 
yeast culture can cause a decrease of the growth rate by half for BY4741 (Kubota et al., 
2004). A similar phenomenon presented for the BY4742 strain with 5% ethanol and an 
additional single TRP4 gene knockout showed an even delayed growth rate (Hirasawa et 
al., 2007). Besides, ethanol also alters intracellular metabolism (Hu et al., 2007). Upon the 
above information, the low production of psilocybin in the Δaro8/Δaro9/Δbna2/Δtrp4 
quadruple mutant can be explained by the impact of self-produced ethanol, since this strain 
has a low ethanol tolerance. 
The second possibility of this consequence might occur relative to the limitation of Trp 
uptake through the membrane-associated permease. Tat2p permease is a Trp-specific 
carrier found by Schmidt et al. in the Δtrp1 cells, which depends on the uptake of Trp from 
the growth medium (Schmidt et al., 1994). However, the sorting of Tat2p depends on the 
Trp concentration in the medium. Umebayashi and Nakano discovered that the GFP-
labeled Tat2p mainly targeted the vacuole and perivacuolar late endosomes rather than the 
plasma membrane when the cell presented in the medium containing 1 mM Trp 
(Umebayashi & Nakano, 2003). This phenomenon was observed in both Trp prototrophic 
and auxotrophic strains. Therefore, I can infer that in the main culture supplied with 1 mM 
Trp, the Trp biosynthetic pathway is the dominant route to support the Trp requirement for 
psilocybin production. Predictably, in the quadruple deletion mutant this route is defective, 
and the supplied Trp in the medium was utilized in a low rate via Tat2p. Thus, the 
intracellular Trp in the quadruple deletion mutant makes it hard to afford psilocybin 
production compared to the triple deletion strain Δaro8/Δaro9/Δbna2. Yet, whether the 
intracellular Trp concentration affects the transcriptional level of TAT2 is still not known.  





which does not alter the ethanol tolerance of yeast and blocks the formation of Trp in vivo, 
since Trp3 is a bifunctional synthase that catalyzes two steps reactions in the Trp 
biosynthetic pathway in the S. cerevisiae (Fujita et al., 2006; Miozzari et al., 1978). For the 
second bottleneck, if it is possible to overexpress the TAT2 in the Δpep12 mutant 
background, the efficient Trp shuttle might be restored, and the cell can even grow in a 
high Trp environment. As from the syntaxins family, Pep12p is responsible for docking of 
Golgi-derived transport vesicles at the late endosome, and Δpep12 can inhibit sorting to the 
endosome and redirect the vacuolar proteins to the cell membrane (Becherer et al., 1996). 
The Tat2p is indeed localized in the cell membrane in the Δpep12 mutant, despite the high 
Trp concentration supplied in the medium (Umebayashi & Nakano, 2003).  
The consequences of redirected metabolic flux in the recombinant yeast is hard to predict 
due to the dynamic amino acid pools in the living cell. The realistic regulation of genes 
implicated in amino acid anabolic processes are very complex. For example, yeast contains 
at least six aminotransferases, four decarboxylases, six alcohol dehydrogenases involved in 
the Ehrlich pathway (Hazelwood et al., 2008; Ohashi et al., 2017). Plus, the expression 
level of the genes encoding these enzymes vary depending on different growth status, other 
intracellular amino acids (nitrogen source), and carbon sources (Dickinson et al., 2003). 
The permeases responding to these amino acids’ uptake are also impacted by the culture 
temperature, extracellular nutrition, the protein kinase TOR (target of rapamycin), 
ergosterol biosynthesis, as well as the Ssy1p-Ptr3p-Ssy5 membrane sensor (Daicho et al., 
2009; Fernandes et al., 2015; Forsberg & Ljungdahl, 2001; Umebayashi & Nakano, 2003). 
Therefore, to engineer a biosynthetic pathway in the cell factory requires thorough thought.  
3.2.2 Coupling CYP with a suitable redox partner 
To investigate whether the endogenous pcCPR can facilitate the catalytic efficiency of 
monooxygenase PsiH in this rate-limited reaction, both strains YtJL04 and YtJL06 have 
been constructed to express pcCPR in a low and lofty level. However, the psilocybin 
production strikingly dropped in both mutants with a Δaro8/Δaro9/Δbna2 genotype 
background (Fig. 29). Intriguingly, after we documented this result, an opposite outcome 
has been published, in which the co-expression of pcCPR and psiH has achieved an 
increased yield of psilocybin in yeast (Milne et al., 2020). This result revealed the positive 
effect of pcCPR to its homologous CYP. Since the experiment designs between these two 
studies are different, I presume the contrasting phenomenon might be due to three 
alternative points in their study: 1) both psiH and pcCPR were codon-optimized; thus the 
encoded enzymes performed better; 2) Trp intracellular level was enhanced by “pushing” 
 
60  
the Trp biosynthetic pathway, which created a different metabolic background; 3) and both 
psiH and pcCPR had one-copy integrated into the yeast genome that was induced by the 
strong TEF1p.  
Among these three points, the last one reveals that the function of PsiH can be assisted by 
the co-expression of pcCPR equivalently. This indicates that the ratio of formed CYP and 
its CPR is a critical point. In the strain YtJL04, psiH was constructed with other psi genes 
as a polycistron regulated by TEF1p, yet the expression of pcCPR was controlled by the 
promoter MET15p, which is not constitutive. In this situation, PsiH was expressed higher 
than the amount of pcCPR. For the strain YtJL06, both psiH and pcCPR were assembled in 
the 2A-mediated polycistronic construct. Owing to the position effects, the expressed PsiH 
and pcCPR also have difficulties matching the optimal ratio.  
A previous in vitro study based on Nanodisc revealed that high CPR:CYP ratios positively 
influence the rate of CYP catalysis (Grinkova et al., 2010). However, we cannot directly 
transfer this idea to the in vivo study because of the different microenvironment of the cell. 
Zhao et al. (2016) observed that the pool coupling of CYP and CPR could overproduce 
reactive oxygen species, significantly affecting yeast cells. Moreover, both CYP and CPR 
are usually insoluble and ER anchored proteins, thus over-yield of these enzymes can 
induce a disordered ER. Traced by confocal microscopy, the overexpressed CPR led to the 
perturbation and swelling of the ER network (Bassard et al., 2012). Similarly, 
overexpressed CYP from a high-copy number plasmid caused an abnormal morphology of 
the ER, the loss of plasmid, and the low yield of the target product (Trenchard & Smolke, 
2015). This may explain the downregulated production of psilocybin in YtJL04 and 
YtJL06 since both strains express either psiH or pcCPR, or both use high-copy number 
plasmids. 
Hence, to ensure functional heterologous expression, the balance of CYP and CPR has to 
be considered. To compromise the expression level of CYP and CPR, one option is to fuse 
the CPR C-terminal part with CYP in yeast (Zhao et al., 2016), which led to 4.5-times 
higher yield of terpenoid protopanaxadiol. Alternatively, one-copy genomic integration of 
CPR either controlled by the weaker promoter GAL3p or a constitutive promoter has been 
documented to enhance the heterologous production of artemisinin or tropane alkaloids in 
the yeast S. cerevisiae, respectively (Paddon et al., 2013; Srinivasan & Smolke, 2019). 
Interestingly, in the latter example, the desired products had higher titer when the CPR was 
expressed from the genome compared with a low-copy-number plasmid. Last but not least, 
to express several CPR candidates individually with the target CYP is a considerable 





al., 2016).  
To assess different CPRs for one CYP is a considerable approach for yeast metabolic 
engineering. In most cases, the yeast S. cerevisiae endogenous CPR (scCPR) was not 
sufficient and required a comparison study to screen for the most suitable CPR from the 
list. In collaboration with CYPs identified from three different plants for the biosynthesis 
of sanguinarine, the native scCPR performed inefficiently compared with other exotic 
CPRs, in which CPR (ATR1) from Arabidopsis thaliana had the best performance 
(Trenchard & Smolke, 2015). In another case, the best product conversion rate has been 
achieved by coupling the Fusarium oxysporum CYP with its homologous CPR rather than 
with scCPR or CPR from C. albicans for the benzoate hydroxylation (Durairaj et al., 
2015). Therefore, the compatibility between a selected CPR and CYP, which influences 
the coupling efficiency in electron transfer (Ebrecht et al., 2019), needs to be explored. 
Besides harnessing the CPR/CYP pair in known bioactive compound production, their 
coupling application might also assist the discovery of unknown SMs, because a large 
number of CYPs are involved in SM biosynthetic pathways. Usually, only a single gene 
encoding CPR can be found in the majority of species, in contrast to numerous CYPs in a 
single organism. Typically, in the reported genetic annotation results, basidiomycetes 
Phanerochaete chrysosporium and Sporobolomyces roseus, present only one 
oxidoreductase-coding gene that belongs to the CPR family (Lah et al., 2008; Warrilow et 
al., 2002). This phenomenon is shown as well in filamentous fungi, including a large 
number of Aspergillus spp. (Lah et al., 2008). Therefore, over-expression of the orphan 
CPR might enhance the enzymatic activity of a wide range of CYPs and result in an 
increased formation of SMs, which could simplify metabolomic screening.  
3.2.3 Other possible modifications to optimize psilocybin production 
In this work, psilocybin production in yeast was increased by minimizing Trp 
dissimilation. To deliver an even better result, additional engineering strategies can be 
taken into account. 
To enhance the stability and catalytic function of the essential enzyme, we could optimize 
codon usage of the corresponding gene or replace it with a more efficient one. Codon 
usage bias ubiquitously exists in the eukaryotic and prokaryotic genome, which highly 
relates to the gene transcriptional level, translational elongation speed, as well as the co-
translational protein folding (Trotta, 2013; Zhou et al., 2016). However, the preferred 
codon could be non-optimal and optimal, and the same is true for the uncommon codon 
(Presnyak et al., 2015). The same study in yeast suggested that the optimal codon 
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significantly enhances mRNA stability, mRNA half-life, efficiency of ribosome 
translocation, and protein output without changing the ribosome occupancy. Codon 
optimization can be applied for heterologous genes involved in the pathway. For example, 
the codon-optimized gene TyrH encoding a Tyr hydroxylase facilitated the Tyr flux 
towards L-3,4-dihydroxyphenylalanine (L-DOPA) formation and increased the production 
of the alkaloid drug noscapine 2.5-fold (Li et al., 2018). Furthermore, in the biosynthetic 
pathway reconstruction, the key enzyme can be substituted to a synonymous one with a 
higher catalytic efficiency in the engineered host. Protein library construction screening or 
comparison has been performed for the Tyr hydroxylase (DeLoache et al., 2015), the 
CYP76AD1W13L F309L mutant given the L-DOPA titer 2.8-fold of the wild type enzyme. 
Besides, Milne et al. (2020) also substituted the PsiD with the more efficient tryptophan 
decarboxylase CrTdc from Catharanthus roseus for psilocybin production in yeast. 
Besides making the changes to the enzyme itself, a mixed idea of “push-and-block” can 
guide the core-node substrate towards the target product more comprehensively in the cell 
factory. The idea includes overexpression of genes in the biosynthetic pathway, optimizing 
the catalytic-limiting enzyme, increasing precursor supply, and decreasing degradation of 
pathway intermediates. For instance, it has been applied to promote the production of the 
pharmaceutical compounds phenylethanediol, stilbenoids, and strictosidine in engineered 
yeasts (Brown et al., 2015; Li et al., 2016; Yuan et al., 2019). In our yeast platform strain, 
besides to “block” the Trp degradation pathway to enrich the intracellular pool of Trp, we 
can additionally enhance the PsiK production in future studies, as this enzyme not only 
helps to enrich the intermediate norbaeocystin but also 'repairs' psilocin back to psilocybin 
(Fricke et al., 2020).  
Apart from these common ideas that intensify each step to get the high production, tuning 
metabolic fluxes in the biosynthetic pathway by controlling expression levels of genes has 
the potential to maximize the target product. In all of our strains, the psi gene cluster has 
been assembled in a pV2A-T-managed “polycistron” with a fixed gene order. In this 
condition, although the expression level of each gene cannot be adjusted individually, we 
can still rearrange the gene's position in a 2A-based co-translation to figure out which 
permutation has the best balance of gene expression levels in our future work. Moreover, 
when the gene expression depends on the shuttle plasmid, the plasmid stability and copy 
number are the other factors that influence the final product in the timeline. As observed, 
the strain that conveys a large size plasmid or high-copy number plasmid has the burden, 
which decreased cell growth rate and desired metabolites (Da Silva & Srikrishnan, 2012). 





promoters can be switched according to different hosts and genes that are supposed to be 
expressed. Karim et al. deeply investigated the influences of these elements in growth rate 
and plasmid copy number (Karim et al., 2013). Although the ori is subject to the plasmid 
copy number, both the selective marker and promoter strength determined the plasmid load 
in the cell. Thus, further investigation can locate these elements, as they all affect the gene 
expression level through ‘plasmid load’ in the S. cerevisiae haploid strain BY4741. 
Except taking a vector for heterologous expression, each biosynthetic gene can be 
introduced into the genomic DNA and regulated individually under distinct promoters for 
an even finer adjustment. The TEF1p promoter has been employed in all the yeast-based 
expression systems in our work, since it is a strong and constitutive promoter. Yet, to 
control each target gene precisely for the optimization of metabolic flux in a eukaryotic 
host, the optimal expression level could be found by screening suitable promoters with 
various strengths from the library (Choi et al., 2019). For example, Lu and Jeffries selected 
6-phosphogluconate dehydrogenase promoter (GND2p) and hexokinase isoenzyme 2 
promoter (HXK2p) that represented relatively weaker and stronger strength and tested them 
for three different gene expressions (Lu & Jeffries, 2007). By this they defined the best 
combination for the highest ethanol production in the xylose-metabolizing yeast strain. 
Noteworthy, the strength of the promoter is varies depending on carbon sources usage and 
metabolic modes shift between oxidative and fermentative growth. The study performed by 
Sun et al. suggested a consistent strength order of group promoters despite glucose and 
oxygen supplementation: TEF1p > PYK1p ~ TDH3p > CYC1p ~ ADH1p (Sun et al., 2012). 
Hence, according to this collected data, we can optimize the expression of psi genes by 
testing these promoters.  
Last, the inducible promoter can be equipped for psiD expression, since PsiD is the first 
enzyme ‘switch’ to turn on psilocybin biosynthesis. The frequently used GALp family (Lv 
et al., 2016; Peng et al., 2017), including GAL1/10p, GAL2p, and GAL7p, provides wide 
options. In the wild-type strain, expression levels are regulated by the galactose 
concentration; in the Δgal80 background strain, the expression levels are controlled by the 
glucose concentration (Peng et al., 2018). Besides, a newly reported cyanamide hydratase 
promoter (DDI2p) that is induced by cyanamide can be considered, as it has higher 
strength compared to GALp (Wang et al., 2019). Nevertheless, the strength of an inducible 
promoter is more challenging to determine, because the inducer concentration, induction 
time, and growth conditions would impact the outcomes. Thus, all of these factors have to 
be considered before starting.  
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3.3 Concluding remarks 
First of all, to fulfill the need for reconstructing the pathway of a SM in a fast and 
straightforward manner, a user-friendly tool has been developed in this work for multigene 
heterologous expression. The time-saving screening of positive transformants that employs 
the split-YFP, guaranteed the complete expression of multigene irrespective of assembled 
in the vector or integration in the genomic DNA. The practicability of this method was 
indicated by heterologous expression of the aus gene cluster from one polycistron and the 
rewiring of austinoids biosynthesis in A. nidulans.  
Secondly, this developed system was harnessed for heterologous production of the 
psychotropic compound psilocybin in filamentous fungi, which was the first-time 
biosynthesizing this valuable prodrug in fermentation condition and had a considerable 
yield. Beyond the application in the biosynthesis of known and treasured SMs, this vector 
technology has the compatibility for the elucidation of unknown synthetic pathways in the 
future. 
Finally, a reduced expenditure of Trp in the primary metabolism promised the yield of 
psilocybin in a high titer from the engineered yeast. Such yeast strains can serve as the 
platform to benefit other Trp derivatives that are of interest. Furthermore, blocking the Trp 
biosynthesis allowed the atom-economic production of stable isotope-labeled psilocybin. 
This acquired knowledge from the model yeast can be transferred to the industrially 














Methods and Materials 
4.1 Strains used in this work 
4.1.1 Bacterial and S. cerevisiae strains  
Table 2. Wild type and mutant strains of E. coli and S. cerevisiae used in this study. 
Strain Genotype References 
E. coli DH5α 
deoR endA1 recA1 relA1 gyrA96 hsdR17(rk-mk+) supE44 thi-1 
Δ(lacZYA argFV169) Φ80lacZΔM15 F- γ - Bioline 
BY4741 MATa; Δhis3; Δleu2; Δmet15; Δura3 Euroscarf 
S. cerevisiae 




tSH00 BY4741; URA3 (Hoefgen et al., 2018) 
S. cerevisiae 
tSH16 BY4741; TEF1p-VenusN/VenusC; URA3 (Hoefgen et al., 2018) 
S. cerevisiae 
tSH17 BY4741; TEF1p-VenusN/mRuby/VenusC; URA3 (Hoefgen et al., 2018) 
S. cerevisiae 
tSH18 BY4741; TEF1p-VenusN/TEV/mRuby/VenusC; URA3 (Hoefgen et al., 2018) 
S. cerevisiae 
Y01965  BY4741; MATa; Δhis3; Δleu2; Δmet15; Δura3; Δaro9::kanMX4 Euroscarf 
S. cerevisiae 
Y04569  BY4741, MATa; Δhis3; Δleu2; Δmet15; Δura3; Δaro8::kanMX4 Euroscarf 
S. cerevisiae 
Y02556  BY4741, MATa; Δhis3; Δleu2; Δmet15; Δura3; Δbna2::kanMX4 Euroscarf 
S. cerevisiae 
YtSJ01  Y01965, Δaro8::LEU2 This study 
S. cerevisiae 
YtSJ02  YtSJ01, Δbna2::HIS3 This study 
S. cerevisiae 
YtSJ03  Y04569; TEF1p-VenusN/tev/psiH/psiD/psiK/psiM/VenusC; URA3 This study 
S. cerevisiae 
YtSJ04  Y01965; TEF1p-VenusN/tev/psiH/psiD/psiK/psiM/VenusC; URA3 This study 
S. cerevisiae 
YtSJ05  Y02556; TEF1p-VenusN/tev/psiH/psiD/psiK/psiM/VenusC; URA3 This study 
S. cerevisiae 
YtSJ06 YtSJ01; TEF1p-VenusN/tev/psiH/psiD/psiK/psiM/VenusC; URA3 This study 
S. cerevisiae 
YtSJ07  YtSJ02; TEF1p-VenusN/tev/psiH/psiD/psiK/psiM/VenusC; URA3 This study 
S. cerevisiae 
YtSJ08  BY4741; TEF1p-VenusN/tev/psiH/psiD/psiK/psiM/VenusC; URA3 This study 
S. cerevisiae 
YtJL02  YtSJ02; Δmet15::pcCPR:2A:MET15 This study 
S. cerevisiae 






URA3 This study 
S. cerevisiae 
YtJL07 YtSJ02; Δtrp4::MET15 This study 
S. cerevisiae 
Y04191 BY4741; MATa; Δhis3; Δleu2; Δmet15; Δura3; Δtrp4::kanMX4 Euroscarf 
S. cerevisiae 
YtJL08  YtJL07; TEF1p-VenusN/tev/psiH/psiD/psiK/psiM/VenusC; URA3 This study 
S. cerevisiae 
YtJL10 Y04191; TEF1p-VenusN/tev/psiH/psiD/psiK/psiM/VenusC; URA3 This study 
 
4.1.2 Aspergillus spp. strains 
Table 3. Wild type and mutant strains of Aspergillus spp. were generated in this study. 
Strain Genotype References 
A. calidoustus 
SF006504 Wild type (Horn et al., 2016) 
A. nidulans 
RMS011 pabaA1, yA2; argB::trpCAB; veAl, trpC801 (Stringer et al., 1991) 
A. nidulans 
NidtJL01 RMS011; Teton-VenusN/tev/VenusC; argB This study 
A. nidulans 
NidtJL02 RMS011; xylP-VenusN/tev/ausP/ausO/ausT/ausV/VenusC; argB This study 
A. nidulans 
NidtJF03 RMS011; Teton-VenusN/tev/psiH/psiD/psiK/psiM/VenusC; argB This study 
 
4.2. Molecular biology and genetics methods 
4.2.1 Construction of expression vectors  
All plasmids that were constructed during this study are listed in Table 4.  
Table 4. Plasmids used in this study. 
Plasmid name Relevant features References 
pUC19 ori, ampR (Yanisch-Perron et al., 1985) 
pACYC177 kanR (Schottel et al., 1981) 
pRK793 TEV (Kapust et al., 2001) 
pYes2 ampR, URA3, 2µ Life Technologies 
pYesTef2 pYes2, TEF1p, eGfp (Hoefgen et al., 2018) 
pV2A Split-YFP, 2A peptides, kanR (Hoefgen et al., 2018) 
pV2A-T pV2A, tev cleavage site (Hoefgen et al., 2018) 
pSH001 pV2A-T, TEV (Hoefgen et al., 2018) 
mRuby-N1 mRuby Addgene #54581 
pSH012 pYes2, xylP, lacZ, argB (Hoefgen et al., 2018) 





pSH014 pV2A-T, mRuby (Hoefgen et al., 2018) 
pSH015 pSH001, mRuby (Hoefgen et al., 2018) 
pSH016 pV2A-T, TEF1p, URA3 (Hoefgen et al., 2018) 
pSH017 pSH014, TEF1p, URA3 (Hoefgen et al., 2018) 
pSH018 pSH015, TEF1p, URA3 (Hoefgen et al., 2018) 
pJL001 pV2A-T, ausP (Hoefgen et al., 2018) 
pJL002 pV2A-T, ausO (Hoefgen et al., 2018) 
pJL003 pV2A-T, ausT (Hoefgen et al., 2018) 
pJL004 pV2A-T, ausV (Hoefgen et al., 2018) 
pJL005 pV2A-T, TEV, ausP (Hoefgen et al., 2018) 
pJL006 pV2A-T, ausO, ausT (Hoefgen et al., 2018) 
pJL007 pV2A-T, TEV, ausP, ausO, ausT (Hoefgen et al., 2018) 
pJL008 pV2A-T, TEV, ausP, ausO, ausT, ausV (Hoefgen et al., 2018) 
pJL009 pJL008, xylP, argB, URA3 (Hoefgen et al., 2018) 
pJL010 pSH001, Teton, argB, URA3 (Hoefgen et al., 2018) 
pFB13 pET28a(+), psiM (Fricke et al., 2017) 
pJF23 pET28a(+), psiD (Fricke et al., 2017) 
pJF24 pET28a(+), psiK (Fricke et al., 2017) 
pJF25 pSM-Xpress, psiH (Fricke et al., 2017) 
pJF26 pV2A-T, psiH (Hoefgen et al., 2018) 
pJF27 pV2A-T, psiD (Hoefgen et al., 2018) 
pJF28 pV2A-T, psiK (Hoefgen et al., 2018) 
pJF29 pV2A-T, psiM (Hoefgen et al., 2018) 
pJF30 pV2A-T, psiH, psiD (Hoefgen et al., 2018) 
pJF31 pV2A-T, psiK, psiM (Hoefgen et al., 2018) 
pJF32 pV2A-T, psiH, psiD, psiK, psiM (Hoefgen et al., 2018) 
pJF33 pV2A-T, TEV, psiH, psiD, psiK, psiM (Hoefgen et al., 2018) 
pJF34 pJF33, TEF1p, URA3 This study 
pJF36 pJF33, Teton, argB, URA3 (Hoefgen et al., 2018) 
pV2A-T_pcCPR pV2A-T, pcCPR This study 
pJF77 pJF34, pcCPR This study 
pΔbna2 pYes2, HIS3 This study 
 
Seamless cloning methods were used for plasmid construction, including circular 
polymerase extension cloning (CPEC) (Quan & Tian, 2009), Gibson (Gibson et al., 2009), 
In-Fusion (Takara, Germany), and GeneArt (Life technologies, Germany). For plasmid 
amplification, E. coli DH5α strain (Bioline, Germany) was used according to the 
manufacturer’s instructions. For the pYes2-derived plasmids and all the final expression 
vectors used for the transformation of S. cerevisiae and Aspergillus spp., the assembly was 
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achieved with transformation-associated recombination (TAR) cloning in S. cerevisiae 
based on a protocol described before (Kouprina & Larionov, 2008). All the restriction 
endonucleases used in this work were purchased from the NEB (Germany). Purification of 
plasmids and DNA fragments was done using the GeneJet Plasmid Miniprep Kit and  
GeneJet Gel Extractions Kit (ThermoFisher Scientific, Germany). 
4.2.1.1 List of oligonucleotides used for PCR 
PCR amplification of targeted genes and DNA fragments as probes for hybridization in 
southern blot analysis was processed by employing the Phusion Flash High-Fidelity PCR 
Master Mix (Thermo Scientific, Germany). Colony PCR was carried out by using the 
MyTaq PCR Red Mix (Bioline, Germany). PCR pipetting and cycling instructions were set 
up according to the manufacturers’ instructions. The annealing temperature and elongation 
time of each PCR were given according to the Tm of the used oligonucleotides and the size 
of the amplified fragment. Utilized oligonucleotide primer pairs are listed below in Table 
5. 
Table 5. Oligonucleotides used for PCR. 
No. Primer Name Sequence 5’-3’ 
1 pACYC_SwaI2_R ATGTTGGAATTTAAATGCGGCCTCGAGCAAGACG 
2 pACYC_SwaI2_F TTGCTCGAGGCCGCATTTAAATTCCAACATGGATGC 
3 pACYC_PmeI2_R TCAGCCAGTTTAAACGGACCATCTCATCTGTAACATC 
4 pACYC_PmeI2_F CAGATGAGATGGTCCGTTTAAACTGGCTGACGGAATTTATGC 
5 pV2A_1F TTAAGGGATTTTGGTCTTAATTAAATGGATAAAGC 
6 pV2A_2R ACGCAGACCGTTCCGAGCTATCAGAGTAAAGAAGAG 
7 pV2A_3F TTTACTCTGATAGCTCGGAACGGTCTGCGTTGTCG 
8 pV2A_4R GATACCGCTCGCCGCGTCAAGTCAGCGTAATGCTC 
9 pV2A_5F TTACGCTGACTTGACGCGGCGAGCGGTATCAGCTC 





12 pV2A-T_R CCGGGATATCAGGGCCAGGGTTTTC 
13 pV2AT_tev_F GGCGACGTTGAAGAAAACCCTGGCCCTGATGGAGAAAGCTTGTTTAAGGG 
14 pV2AT_tev_R CATCGCACCTTGAAAATAAAGATTTTCGATGCGACGGCGACGACGATTC 
15 pV2A_mRuby_F GGCGACGTTGAAGAAAACCCTGGCCCTGATATGAACAGCCTGATCAAAGA
AAAC 
16 pV2A_mRuby_R CATCGCACCTTGAAAATAAAGATTTTCGATCCCTCCGCCCAGGCCGGCG 
17 ura3T_p2A_F GAAAACTCACGTTAAGGGATTTTGGTCTTACTCTTCCTTTTTCAATGGG 
18 Tef_pV2A_R CTCGGGAATTAATTCCGCTTTATCCATTTATTTGTAATTAAAACTTAGATTA
G 
19 pV2AT_ausP_fw GCGACGTTGAAGAAAACCCTGGCCCTGATATGGAGGTCGTCCGTTATTTC 





21 pV2AT_ausO_fw GGCGACGTTGAAGAAAACCCTGGCCCTGATATGAAAATTCCAGACAATCC 
22 pV2AT_ausO_rv CATCGCACCTTGAAAATAAAGATTTTCGATTCCAGCCATGGTTTGATTAC 
23 pV2AT_ausT_fw GCGACGTTGAAGAAAACCCTGGCCCTGATATGGTCGACAAGTCAAACAAG 
24 pV2AT_ausT_rv CATCGCACCTTGAAAATAAAGATTTTCGATGCACTGATGCAAAACATCCC 
25 pV2AT_ausV_fw GGCGACGTTGAAGAAAACCCTGGCCCTGATATGGCAGGAACTGACAGCTC 
26 pV2AT_ausV_rv CATCGCACCTTGAAAATAAAGATTTTCGATCGTAGCTACGTGGCTTGATC 
27 Pv2A_ArgB_FW GAAAACTCACGTTAAGGGATTTTGGTCTTATGTCGACGGCGACGGAGCGC 
28 targB_ura3_RV GGCCAGCAAAACTAATCTAGACTGATGATGCAGTG 
29 targB_ura3_FW CATCATCAGTCTAGATTAGTTTTGCTGGCCGCATC 
30 XylP_Pv2A_RV CTCGGGAATTAATTCCGCTTTATCCATTTAGGTTGGTTCTTCGAGTCGAT 
31 TetOn_VenusN_RV CTCGGGAATTAATTCCGCTTTATCCATTTATGTGATGTGATGGAGTTGAG 
32 oJF65 GAAAACCCTGGCCCTATGATCGCTGTACTATTCTC 
33 oJF66 AAAATAAAGATTTTCGGGTCCGGATACCG 
34 oJF67 GAAAACCCTGGCCCTATGCAGGTGATACCCGCGTG 
35 oJF68 AAAATAAAGATTTTCAGCCTTTAGAGCAGCGACGA 
36 oJF69 GAAAACCCTGGCCCTATGGCGTTCGATCTCAAGAC 
37 oJF70 AAAATAAAGATTTTCCGCAGTGGATGATTCCTTC 
38 oJF71 GAAAACCCTGGCCCTATGCATATCAGAAATCCTTAC 
39 oJF72 AAAATAAAGATTTTCGAAAAGAGAGCTGAGCTC 
40 probe_Pxyl_F ACGACTTTGGTGATCTGATAGG 
41 probe_Pxyl_R CGGGAATTAATTCCGCTTTATC 
42 probe_TEV_F AGGCCCTGAAGAAGGAGCTC 
43 probe_TEV_R GTTGAGTCGCTTCCTTAACTGG 
44 AC-SB-53-fwd AACTTTGTGGAAGGCAGTGG 
45 AC-SB-53-rev GGTTTGATTACTCCTCAGCC 
46 probe_AusV_F CTCAATACGACAATGTACTCC 
47 probe_AusV_R GAGTAGTGTTGGAATTCAAAG 
48 aro8-Leu2-1 GTCAGGGGTTCGAGCCCCC 
49 aro8-Leu2-2 ATCTTCTTAGGGGCAGACATGATAGTAACGATCGGTTGTC 
50 aro8-Leu2-3 GACAACCGATCGTTACTATCATGTCTGCCCCTAAGAAGATC 
51 aro8-Leu2-4 TCTTCCAACGTATTTACCTCTTTAAGCAAGGATTTTCTTAACTTC 
52 aro8-Leu2-5 TTAAGAAAATCCTTGCTTAAAGAGGTAAATACGTTGGAAG 
53 aro8-Leu2-6 GGAAAATGATTTGGGTTCG 
54 bna2_5F GTAATACGACTCACTATAGGGAATATTCCAAACCCGGTCAACAACGC 
55 bna2_5R AGAACAACAAGAAAAGCATTTCATATTATCGGCGTTGACTCTTTCTT 
56 bna2_3F AAGAAAATTGCGGGAAAGGACTGTGTTCATTATACATTTTATTAACG 
57 bna2_3R GACATAACTAATTACATGATGCGGCCCCTCCAGTCTGGAAATCAAATC 
58 bna2_5diag CCGAACTTGAAGGCACCTTGG 
59 bna2_diag_R CCCATGATGTGGCGAGATACAG 
60 bna2_3diag GTCCGTACTGAATTTGACCGGG 
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61 his3_Prom_F AACACAGTCCTTTCCCGCAA 
62 his3_Term_R AATATGAAATGCTTTTCTTG 
63 Met15_2A_F TGGCGACGTTGAAGAAAACCCTGGCCCTATGCCATCTCATTTCGATACTG 
64 Met15_CPR_R GACGAAAACGTCTGAGGAAGAGGAGGCCATTGTATGGATGGGGGTAATAG 
65 Met15_Fl_F CTCCTCGAGGATTTAGGAATC 
66 Met15_Fl_R CCCATACTTTCAACGATGAGC 
67 PcCPR_F ATGGCCTCCTCTTCCTCAGAC 
68 2AP_R AGGGCCAGGGTTTTCTTCAAC 
69 PcCPR_pV_F GCGACGTTGAAGAAAACCCTGGCCCTGATATGGCCTCCTCTTCCTCAGAC 
70 PcCPR_pV_R ATCGCACCTTGAAAATAAAGATTTTCGATACTCCAGACATCCAACATGAG 
71 met15_F ATGCCATCTCATTTCGATACTG 
72 met15_R TCATGGTTTTTGGCCAGCG 
73 trp4-972_F CATTGGTGGTGGTGACTCTG 





77 Tev_3_fw CAGCCAGTTAAGGAAGCGACTC 
78 VenusC_ana2_RV CTCCACCTTGCGCTTCTTCTTG 
 
4.2.1.2 pV2A-T vector and plasmids for co-expression of mRUBY with TEVp 
The core plasmid pV2A-T (Fig. 32B) was designed to contain the following features: 1) 
the cutting sites of the rarely used restriction enzymes PmeI and SwaI; 2) two nearby short 
oligo sequences coding for 2A peptides that are spaced by a unique EcoRV cleavage site; 
3) sequence-optimized split-YFP gene (VenusN and VenusC) flanks of the 2A peptide 
genes; 4) a single restriction site of PacI located directly before the start codon of VenusN; 
5) the ori site; and 6) a selective marker gene.  
A parent plasmid pV2A was first constructed with three DNA fragments: an ori, a 
kanamycin-resistant gene aph (KanR), and a synthetic DNA fragment. Primers [1]/[2] and 
[3]/[4] were used to create the PmeI and SwaI restriction sites in the KanR of the 
pACYC177 plasmid (Schottel et al., 1981) by PCR-mutagenesis, and then the region 
including the modified KanR was amplified with primers [7]/[8]. The ori was directly 
amplified from pUC19 (Yanisch-Perron et al., 1985) using primer pair [9]/[10]. The DNA 
fragment harboring the sequences encoding split-YFP subunits, 2A segments with PmeI 
and SwaI, and the A. nidulans TrpC terminator was synthesized (Biomatik, Canada) and 
amplified with primers [5]/[6]. Based on seamless cloning, these three fragments were 





introduce a 30 bp specific tev site and a single EcoRV restriction site that can be used for a 
blunt-end cloning strategy in later applications. This PCR product was treated with EcoRV 
and ligated using the T4 DNA ligase (NEB, Germany) to achieve the backbone plasmid 
pV2A-T. 
 
Fig. 32. Schematic structure of the pV2A-T design and cloning strategy. (A) Individual 
assembly of each gene of interest in the pV2A-T plasmid. (i) Isolation of the target genes by PCR 
using the primer pairs with 30 bp overhangs, which are homologous to both ends of the EcoRV-
linearized pV2A-T (ii). Because of the homologous regions of the 2A peptide sequence (red) and 
the tev cleavage site (blue), every single gene can integrate into the pV2A-T backbone. (B) 
Overview of the pV2A-T backbone design and construction. (C) Artificial assembly line of a 
polycistronic operon in the pV2A-T system. (i) According to the designed order of genes in the 
polycistronic construct, each gene assembled in the pV2A-T plasmid is restriction digested with 
SwaI (as an acceptor) or PmeI (as a donor). (ii) Gene in the donor fragment is fused after the gene 
from acceptor fragment by seamless cloning. The homologous tails regions (marked with elliptical 
circles) generated automatically after SwaI or PmeI treatment. (iii) After the fusion of two genes, 
this built plasmid contains the restriction sites of SwaI and PmeI, as before. By repetition of the 
same step, a third gene is added to form that the vector has a tricistronic construct (iv). Step iii and 
step iv can be replicated several times for the multi-genes assembling purpose. (v) The essential 
DNA elements for gene expression in the host can be inserted at the PacI restriction site located 
directly before the VenusN to generate the final expression plasmid (vi).  
The pV2A-T backbone was linearized by EcoRV to introduce a target gene into the pV2A-
T system. Meanwhile, using primers designed with a 30 bp homologous sequence specific 
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to the ends of the linearized backbone (Fig. 32A. i), the target gene was amplified from the 
template DNA and ligated with the pV2A-T backbone (Fig. 32A. ii) through seamless 
cloning. In this manner, the gene coding for TEVp was amplified from the template 
plasmid pRK793 (Kapust et al., 2001) with primers [13]/[14] and integrated into pV2A-T 
to build the plasmid pSH001. The pSH014 was built using same method: with primers 
[15]/[16], the mRuby gene sequence was amplified from the mRuby-N1 plasmid (Addgene 
#54581) and integrated into the pV2A-T. Based on the pV2A-T assembly pipeline (Fig. 
32C), the plasmid pSH015 was generated from the SwaI-digested pV2A-T and the PmeI-
cut pSH014. 
4.2.1.3 Plasmid construction for TEVp function test in vivo 
The DNA sequence containing TEF1p, URA3, and 2µ ori features was amplified from the 
template plasmid pYes2Tef2 using primers [17] and [18]. In parallel, pSH001, pSH014, 
and pSH015 were linearized by PacI. On account of the described manner of the final step 
assembly (Fig. 32C. v and vi), pSH016, pSH017, and pSH018 construction were carried 
out based on TAR cloning, respectively. The yeast strains that harbor pSH016, pSH017, 
and pSH018 are named as tSH16, tSH17, and tSH18, respectively. 
4.2.1.4 Polycistronic construction of the aus and psi gene clusters 
To evaluate the pV2A-T system for expression of multiple genes, ausP, ausO, ausT, and 
ausV from the aus biosynthetic cluster were selected to complete the austinoids production 
(Mattern et al., 2017) in A. nidulans. First of all, ausP, ausO, ausT, and ausV were isolated 
from A. calidoustus genomic DNA using primer pairs [19]/[20], [21]/[22], [23]/[24], and 
[25]/[26], respectively. Each gene was ligated separately into EcoRV-opened pV2A-T to 
build plasmids pJL001, pJL002, pJL003, and pJL004. The pJL05 that contains ausP and 
the gene TEV encoding TEVp was created by fusion of SwaI-digested pSH001 and PmeI-
restricted pJL001. Similarly, pJL002 and pJL003 were fused to generate pJL006, 
containing ausO and ausT. Furthermore, plasmids pJL005 and pJL006 were combined to 
yield the pJL007, which was modified once again by adding the ausV from pJL004 to get 
the plasmid pJL008. The DNA fragments including the xylP promoter, argB and the URA3 
auxotrophic selection markers were amplified by PCR with primer pairs [27]/[28] and 
[29]/[30] from pSH012. Moreover, these two fragments were ligated into the PacI-
linearized pJL008 using TAR cloning, which resulted in the final expression vector pJL009 
(Fig. 33A).  
For psilocybin heterologous expression, primer pairs [36]/[37], [32]/[33], [34]/[35], and 





template plasmids pJF25, pJF23, pFJ24, and pFB13, respectively (Fricke et al., 2017). The 
amplified cDNA sequences of psiH, psiD, psiK and psiM were joined into opened pV2A-
T, leading to plasmids pJF26, pJF27, pJF28, and pJF29. Using the pV2A-T assembling 
method, pJF26 and pJF27 were fused to get plasmid pJF30; similarly, pJF28 and pJF29 
were combined for vector pJF31. Afterwards, pJF30 and pJF31 were ligated to produce the 
vector pJF32, which harbors the complete psi gene cluster. The pSH001 was also merged 
with pJF32 to give the TEV for plasmid pJF33.  
Since the heterologous expression of the psilocybin gene cluster is controlled under the 
Teton promoter, the Teton sequence with argB and URA3 were together amplified from the 
template plasmid pSH013 with oligo primers [27] and [31], and this PCR-yielded fragment 
was coalesced into PacI-linearized pJF33 to fabricate the expression vector pJF36 (Fig. 
33C). Additionally, pSH001 was fused with the same PCR-generated sequence, resulting 
in the plasmid pJL010 (Fig. 33B). 
For heterologous production of psilocybin in yeast, the fragment containing TEF1p, 2µ ori, 
and URA3, was isolated from the parent vector pYesTef2 by PCR using primer pair 
[17]/[18]. Secondly, the PCR product was inserted into pJF33, which was in advance 
linearized by PacI, and yielded the yeast expression vector pJF34 (Fig. 33D). 
 
Fig. 33. Schematic structures of plasmids pJL009, pJL010, pJF36 and pJF34. (A) Aus gene 
cluster including one PKS gene and four genes encoding for tailoring enzymes controlled by an 
inducible xylP promoter, and the argB cassette, which is also part of pJL010 (B) and pJF36 (C), as 
selective marker gene for A. nidulans transformation. (B) Expression of Venus N, Venus C, and 
TEV genes is controlled by the Teton promoter that is induced with Dox. Psilocybin biosynthesis is 
fulfilled by expressing psiH, psiD, psiK, and psiM. For the heterologous expression of the psi gene 
cluster in A. nidulans, Teton promoter is employed (C); and for the heterologous production in S. 
cerevisiae, the yeast constitutive TEF1p promoter is utilized (D). The white frame indicates the 
GAL1p that belongs to the pYesTef2 backbone and was not used for the heterologous expression in 
A. nidulans. The gene drawn on the schematic diagram does not represent in the actual size scale. 
4.2.1.5 pV2A-T-pcCPR and pJF77 plasmid construction 
mRNA of pcCPR was extracted from P. cubensis using InviTrap Spin Plant RNA Mini Kit 
(Invitek Molecular GmbH, Germany) and reverse transcribed to cDNA using ProtoScript® 
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II First Strand cDNA Synthesis Kit (NEB, Germany). The obtained cDNA fragment was 
then PCR-amplified using primers [69] and [70], which created overhangs for ligation of 
this cDNA in the pV2A-T backbone, and then the fragment was inserted in the EcoRV-
restricted pV2A-T to form pV2A-T-pcCPR. To further assemble the pcCPR in the pV2A-T 
based expression vector pJF34, pV2A-T-pcCPR was cut by PmeI and constructed after the 
psi gene cluster in the SwaI-digested pJF34 to achieve the final expression plasmid pJF77. 
4.2.2 Generation of cassette fragments ΔARO8_LEU2, ΔBNA2_HIS3, ΔTRP4_MET15 
and pcCPR_2A_MET15 
For the deletion of ARO8, BNA2, and TRP4, as well as the insertion of pcCPR into the 
genome of yeast, the upstream and downstream flanking regions (>500 bp each) as well as 
the required homologous overhangs of every targeted gene, i.e., ARO8, BNA2, TRP4, and 
MET15, were amplified by standard PCR using gDNA of the prototrophic yeast strain 
STH00331.  
The upstream flank and downstream flank of ARO8 were obtained using primer pairs 
[48]/[49] and [52]/[53], respectively. The isolation of the upstream flank and the 
downstream flank of BNA2 was achieved with [54]/[55] and [56]/[57]. The same was done 
for the amplification of the upstream and the downstream overlapping regions of TRP4, 
where primers [73]/[76] and [74]/[75] were applied. The auxotrophic selection makers for 
the gene deletions, which are LEU2, HIS3 (including promoter and terminator) and 
MET15, were amplified with the primer pairs [50]/[51], [61]/[62], and [71]/[72], 
respectively. 
The assembly of ΔARO8_LEU2 DNA fragment (Fig. 34A) was done by fusion PCR using 
obtained upstream/downstream flanks and marker gene LEU2 as mixed templates with 
outer primers [48] and [53]. The processing of ΔBNA2_HIS3 was achieved by TAR 
cloning. Yeast strain BY4741 was transformed with three gained PCR fragments including 
the flanking regions, HIS3 and HindIII/XbaI-linearized pYes2 plasmid, resulting in vector 
pΔbna2. Later, ΔBNA2_HIS3 (Fig. 34B) was amplified using [54]/[57] from plasmid 
pΔbna2, which was removed later from the PCR product by DpnI restriction digestion. 
ΔTRP4_MET15 (Fig. 34C) was built with two flanking sequences and MET15 using 
outside primers [73] and [74]. 
To approach the pcCPR_2A_MET15 DNA fragment, the upper flanking region before 
MET15, including necessary overhang sequences, was isolated with [65] and [64], and the 
MET15 together with the downside flanking sequence was copied using primer pair 





from the pV2A-T-pcCPR template vector, that was already mentioned in the previous 
section 4.2.1.5. These three PCR products were re-assembled into one complete cassette 
fragment pcCPR_2A_MET15 (Fig. 34D), in which pcCPR and MET15 were spaced by a 
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Fig. 34. Assembly of four DNA fragments for genetic deletion and insertion. Three auxotrophic 
selective makers LEU2, HIS3 and MET15 were chosen for the deletions of the ARO8 (A), BNA2 (B) 
and TRP4 (C) genes. (D) pcCPR merged with the 2A sequence and MET15 for the insertion of 
pcCPR into the MET15 locus in yeast gDNA. 
4.2.3 Genetic engineering of S. cerevisiae 
One of the yeast strains BY4741, according to its auxotrophic features for four markers 
(Δhis3/Δleu2/Δmet15/Δura3), was engineered for several manipulations that are explained 
in the following sections. All the yeast transformations followed the TAR cloning protocol 
as mentioned in Methods and Materials Section 4.2.1. The first selection of positive 
transformants and further plate cultivations were done using synthetic defined (SD) agar, 
which was prepared according to the published recipe  (Da et al., 2000) with specific 
amino acid(s) dropped out and 1% glucose as a carbon source, and if necessary, 
supplemented with geneticin (G418) (Invivogen, Germany). The Yeast Nitrogen Base 
without amino acids was purchased from Sigma-Aldrich (Germany) and all the required 
amino acids were obtained from SERVA (Germany). Different selective plates related for 







Table 6. The selective SD plates for the constructed yeast strains. 
strains SD agar plate 
S. cerevisiae tSH00 SD-Ura 
S. cerevisiae tSH16 SD-Ura 
S. cerevisiae tSH17 SD-Ura 
S. cerevisiae tSH18 SD-Ura 
S. cerevisiae YtSJ01 SD-Leu 
S. cerevisiae YtSJ02 SD- Leu-His 
S. cerevisiae YtSJ03 SD-Ura+G418 
S. cerevisiae YtSJ04 SD-Ura+G418 
S. cerevisiae YtSJ05 SD-Ura+G418 
S. cerevisiae YtSJ06 SD-Leu-Ura+G418 
S. cerevisiae YtSJ07 SD--Leu-His-Ura+G418 
S. cerevisiae YtJL02 SD-Leu-His-Met+G418 
S. cerevisiae YtJL04 SD-Leu-His-Met-Ura+G418 
S. cerevisiae YtJL06 SD-Leu-His-Ura+G418 
S. cerevisiae YtJL07 SD-His-Leu-Met+G418 
S. cerevisiae YtJL08 SD-His-Leu-Met-Ura+G418 
S. cerevisiae YtJL10 SD-Ura+G418 
 
4.2.3.1 Double deletion, triple deletion and quadruple deletion in yeast  
Strains Y04569, Y01965, and Y02556 were ordered from Euroscarf (Germany). All gene 
deletions/insertions into the genome of the yeast strains were processed by homologous 
recombination during yeast transformation. ARO8 was exchanged with LEU2 in the strain 
Y01965, using DNA fragment ΔARO8_LEU2, to construct the ARO8/ARO9 double 
deletion strain YtSJ01. Afterwards, in the strain YtSJ01, BNA2 was replaced with HIS3 
using DNA fragment ΔBNA2_HIS3 to form the triple deletion strain YtSJ02. TRP4 in the 
YtSJ02 was exchanged with MET15, which led to the strain YtJL07. 
After each step of deletion, two colonies of each strain were picked from the related 
selective plate, and the single colonies were purified through plate streaking twice. 
Importantly, each correct deletion via homologous recombination was proven by PCR 
diagnosis before manipulating the next deletion event (shown in Result Section 2.4.1 and 
Section 2.4.5.1). To check the strains YtSJ01 and YtSJ02, the parent strain BY4741 acted 
as a negative control for PCR; for the quadruple deletion strain YtJL07, the triple deletion 





confirmed using the outer primers [48]/[53]. Since the length of BNA2 and HIS3 are 
similar, a different strategy was applied to check the deletion of BNA2. A pair of diagnostic 
primers [58] and [61] was used to amplify the 5’ upstream plus HIS3, including promoter. 
Another primer pair [60]/[62] was utilized to amplify the downstream sequence with HIS3 
at the 3’ side. In parallel, a reverse primer [59] was designed in the BNA2 gene, together 
with a forward primer [58] to check if BNA2 is entirely removed from the deletion strain. 
To check the TRP4 deletion event, the XbaI restriction enzyme was applied to digest the 
DNA fragments that were amplified from the quadruple deletion colony and triple deletion 
strain using the same outer primer pair [73] and [74]. Colonies carrying the correct Δtrp4 
deletion feature showed two bands (~1.1 kb and ~2 kb) in the electrophoresis gel. 
4.2.3.2 Genomic integration of pcCPR into the triple deletion strain YtSJ02  
The triple deletion strain YtSJ02 featuring Δaro8/Δaro9/Δbna2 was transformed with the 
DNA fragment pcCPR_2A_MET15, so that the pcCPR was specifically inserted in the 
MET15 locus. The expression of pcCPR and MET15 was driven by the endogenous 
promoter of MET15. The newly built strain was named YtJL02. 
4.2.3.3 S. cerevisiae strains transformed with expression plasmids containing the psi 
gene cluster  
The transformation of shuttle vector pJF34/pJF77 was processed based on the same TAR 
cloning protocol, as described above. Strain Y04191 with a single deletion of TRP4 was 
purchased from Euroscarf (Germany). Y04569, Y01965, Y02556, and Y04191 commercial 
strains were transformed with the pJF34 plasmid to generate YtSJ03, YtSJ04, YtSJ05, and 
YtJL10, respectively. Strains YtSJ01, YtSJ02, and YtJL07 were transformed with pJF34 to 
construct the strains YtSJ06, YtSJ07, and YtJL08. Strains YtJL02 and YtSJ02 were 
transformed with pJF34 and pJF77, separately, to build strains YtJL04 and YtJL06. 
The transformants grown on the selective plates were screened further by fluorescence 
microscopy and diagnostic PCR, to check for the complete psi gene cluster in pJF34 and 
the same cluster plus pcCPR in pJF77. Details for the fluorescence screening can be found 
in Methods and Materials Section 4.6. The diagnostic PCR was performed with primers 
[77]/[78]. 
4.2.4 Genetic transformation of filamentous fungi 
For A. nidulans cultivation, the Aspergillus minimal medium (AMM) was prepared 
according to a recipe previously documented (Brakhage & Van den Brulle, 1995; 
Pontecorvo et al., 1953), except that the Hutner’s trace element  stock solution (1000×, pH 
6.5) was prepared different: ZnSO4 × 7 H2O, 22 g/L; H3BO4, 11 g/L, MnCl2 × 4 H2O, 5 
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g/L; FeSO4 × 7 H2O, 5 g/L; CoCl2 × 6 H2O, 1.6 g/L; CuSO4 × 5 H2O, 1.6 g/L; 
(NH4)Mo7O24 × 4 H2O, 1.1 g/L; EDTA, 5 g. 
A pre-culture of the A. nidulans RMS011 strain was prepared by inoculation of spores in 
the AMM supplied with 1% (w/v) glucose as the carbon source, 5 mM Arg, and 3 mg/L p-
aminobenzoic acid (PABA) to reach a final 1 × 106 conidia mL -1 concentration. This pre-
culture was incubated under 180 rpm shaking conditions for 15~17 h at 37°C. Afterwards, 
the protoplast formation and a PEG/CaCl2-mediated protoplast transformation were 
handled according to the protocol as reported in John & Peberdy (1984), except a few 
modifications. The lytic digestion was carried out using Vinotaste (100 mg/mL) 
(Novozymes, Copenhagen) and lysing enzymes (5 mg/mL) (Sigma-Aldrich, Germany), 
and incubated under shaking conditions (80 rpm) at 37°C for 3 h. A. nidulans RMS011 was 
transformed with 10 µg of the final expression vectors pJL010, pJL009, and pJF36 to 
achieve strains NidtJL01, NidtJL02, and NidtJF03, respectively. Within 5~7 days, 
transformants of each strain were grown on the prepared agar plates (AMM + 3 mg/L 
PABA + 1 M Sorbitol + 2% agar). Obtained transformants were streaked out for 
purification on the fresh selective plates (AMM + 3 mg/L PABA + 2% agar) twice to get 
single colonies.  
Conidia of each strain were harvested in sterilized double-distilled water, filtered through a 
cell strainer (Greiner Bio-One, Germany) and counted using a cell counter (Beckman 
Coulter, Germany). Harvested spores were stored in sterilized glycerol solution with a 30% 
(v/v) final concentration at -80°C. Transformants of NidtJL01, NidtJL02, and NidtJF03 
were checked by fluorescence screening (Methods and Materials Section 4.6). Southern 
hybridization analysis (Methods and Materials Section 4.2.5) was applied to verify the 
correct integration of the aus gene cluster in the strain NidtJL02.  
4.2.5 Southern hybridization analysis of ectopic integration of aus gene cluster in A. 
nidulans 
A. nidulans strain RMS011 was pre-cultured as described in Methods and Materials 
Section 4.2.4, as were the four mutants NidtJL02_V2, V3, V4, and V15 but without Arg 
supplementation, to obtain mycelium for total chromosomal DNA extraction. The genomic 
DNA extraction followed the manual of MasterPure™ Yeast DNA Purification Kit (LGC 
Biosearch Technologies, Germany). Isolated gDNA was treated with the restriction 
enzyme DraI. Digested DNA fragments were separated by size during gel electrophoresis 
(Smith, 1996), in which the ethidium bromide was replaced by the HDGreen DNA dye 





(Bioline, Germany), and the DIG-11-dUTP (Jena Bioscience, Germany) were used to 
prepare probes P1 to P4. Manipulation of agarose gel capillary blotting was detailed in the 
protocol (Smith & Murphy, 1996) using a Hybond N+ membrane (Carl Roth, Germany). 
The hybridization, stringency washes, and detection of DNA probes were performed based 
on Kelsell’s protocol (Kelsell, 1996) and the CDA-Star ready-to-use (Roche, Germany) 
manufacturer’s protocol. The chemiluminescence imaging was carried out by Fusion Fx 
(Vilber, Germany).  
4.3 Protein extraction and immunoblot 
Yeast transformants (tSH00, tSH16, tSH17 and tSH18) were set up as described in 
Methods and Materials Section 4.5.2 for proteins extraction. A lysis solution (pH 6) 
containing 150 mM NaCl and 20 mM sodium phosphate buffer (0.5 M of Na2HPO4 and 
NaH2PO4) was prepared in advance. The following day, the cell pellets were collected 
from each culture and suspended in the lysis solution, to which 10 mg of lysing enzymes 
(Sigma-Aldrich, Germany) were added. After 3 h incubation at 30°C, the ultrasonic 
homogenizer (BANDELIN, Germany) was utilized to disrupt the cells, which were placed 
on ice. A 90 s of sonication was run two times for each sample. Afterwards, each sample 
was transferred to 2 mL tube and centrifuged at 4°C at maximum speed for 15 min, to 
pellet the cell debris. The supernatant was then transferred to a fresh tube. The 
concentration of total extracted proteins was determined via the Bradford protein assay 
(Pierce Coomassie Plus Assay Kit, ThermoFisher Scientific, Germany). 5 µg of protein 
from each sample were loaded onto a Bolt Bis-Tris Plus Gel with 4-12% gradient 
polyacrylamide (ThermoFisher Scientific, Germany) for electrophoretic separation (180 V, 
30 min), and was transferred onto a nitrocellulose membrane using the iBlot2 Blotting 
System (ThermoFisher Scientific). The blocking solution was prepared using 5% (w/v) 
skimmed milk powder in the Tris Buffered Saline with Tween-20 (TBST) (Tris, 6.1 g/L; 
NaCl, 8.68 g/L; Tween-20, 0.05% (v/v); pH 8) and applied to prevent non-specific binding. 
A goat anti-rabbit IgG-HRP secondary antibody (sc-2004, Santa Cruz Biotechnology, US) 
was bound to the commercial anti-2A antibody (ABS31, Merck, Germany), that was used 
to detect the 2A peptides in the membrane. For the detection of horseradish peroxidase, the 
membrane was incubated with WesternSure PREMIUM Chemiluminescent Substrate (LI-
COR Biosciences, Germany) and Fusion Fx (Vilber, Germany) was employed for imaging. 




4.4 Trp sensitivity assay 
For phenotype analysis of the ARO8, ARO9 and BNA2 deletion strains, a Trp sensitivity 
assay was performed. Each strain was pre-cultured in 15 mL of SD medium at 30°C for 24 
h, and afterwards, pre-culture was ten-fold serial diluted from OD600 of 0.1 to OD600 of 10
-
4. 10 µl of each dilution was dropped on the solid SD medium containing 0 mM, 1 mM, 5 
mM and 10 mM of Trp, individually. The plates were incubated at 30°C for 3 days. 
4.5 Cultivation and analytical methods 
4.5.1 Cultivation conditions of A. nidulans  
The fungal strains were grown in a complex medium or AMM with an initial spore 
concentration of 5 × 106 conidia mL-1. 
For austinoids production, the negative control strain NidtJL01 and the constructed 
mutants NidtJL02 were inoculated and statically grown in the complex medium the same 
as described in Mattern et al. (2017). For the inducing condition, 2% (w/v) D-xylose was 
supplemented. 
The cultivation of NidtJF03 and NidtJL01 for psilocybin production was performed in 
AMM with supplementation of 3 mg/L PABA and the growth lasted for 4 days at 37°C 
under rotary shaking conditions (180 rpm). For the inducing condition, 50 µg/mL of Dox 
was appended 48 h after spores’ inoculation to induce the expression of the psi gene 
cluster; oppositely, the non-inducing condition was carried out without Dox 
supplementation.  
4.5.2 Growth conditions of budding yeast strains  
For protein extraction, tSH00, tSH16, tSH17 and tSH18 were cultured over-night in the 
uracil/uridine omitted SD medium (SD-Ura) with 1% glucose at 30°C at 180 rpm.  
All the strains for psilocybin production were streaked out freshly on new plates, and the 
cells streaked within a week were taken for inoculation. A 24 h pre-culture of SD-Ura 
medium (15 mL) was required for the growth of psilocybin-producing yeast strains in 100 
mL Erlenmeyer flasks with four baffles. The following day, the main-culture was set up 
from pre-culture and inoculated with the initial OD600 of 0.5 in 20 mL of SD-Ura medium 
supplied with 1 mM Trp. Each strain was set up with three biological replicates of the main 
culture growing in the 100 mL Erlenmeyer flasks with three baffles at 180 rpm at 30°C for 
48 h. And the OD600 was measured at the initial time point (0 h), after 6 h, and after 48 h to 
check the yeast growth. 





Trp was replaced with L-[13C11]Trp (Eurisotop, Germany) in both the media of pre-culture 
and main culture. 
4.5.3 Chemical extraction and analysis methods 
4.5.3.1 Extraction and detection of austinoids from the A. nidulans strains 
Crude extracts were prepared from A. nidulans strains NidtJL01, NidtJL02_V2 and 
NidtJL02_V15 with equal volumes of ethyl acetate (v/v) twice from fungal culture that 
was homogenized using an Ultra-turrax T25 (IKA-Werke, Germany). Sample preparation, 
injection and analyses of HRMS were performed as previously records (Mattern et al., 
2017; Valiante et al., 2017). 
4.5.3.2 Extraction and quantification of indole alkaloids from A. nidulans strains and 
S. cerevisiae strains 
The handling of psilocybin and its analogs is authorized according to the Narcotics Act of 
the Federal Republic of Germany. For A. nidulans strains NidtJL01 and NidtJF03, that 
were cultured with and without Dox addition, mycelia of each sample were filtered with 
Miracloth (Merck, Germany), and mycelia were lyophilized overnight. Mortar and pestle 
were applied to homogenize the dried mycelium, which was subsequently mixed 
thoroughly with 50 mL of methanol (MeOH). The extracted solvent was evaporated using 
a rotary evaporator (Rotavapor R-100, BÜCHI, Germany) and was dissolved in 5 mL of 
Milli-Q water. This aqueous sample was then washed with an equal volume of 
cyclohexane and was freeze-dried. Thereupon, the sample of each strain was dissolved in 1 
mL of water:acetonitrile (ACN) (99:1, v/v). For extraction from S. cerevisiae strains 
YtSJ03-07, YtJL04, YtJL06, YtJL08, and YtJL10, each culture of yeast was harvested in a 
50 mL reaction tube whose net weight was measured beforehand. After centrifugation, the 
liquid phase was transferred to a new tube, and both samples were lyophilized for two 
days. Cell pellets were weighed to calculate the biomass. Both freeze-dried cell pellets and 
liquid phase of the culture were mixed thoroughly with a total volume of 50 mL MeOH. 
The organic solvent was removed by reduced-pressure evaporation; the extracted sample 
was then dissolved in 2 mL of water with 0.1% formic acid (FA) and filtered before 
analysis. 1 µL of each sample was needed for further chromatographic analyses. 
To detect the heterologously produced [13C10] psilocybin and its isotope-labeled analogs, 
HRMS analysis was performed on a liquid chromatography (Accela; ThermoFisher 
Scientific, Germany) with a C18-phase column (Grom-Sil ODS-0 AB, 100 Å, 3 µm, 250 × 
4.6 µm; GROM, Germany). They were connected to the Exactive Orbitrap spectrometer 
coupled to an electrospray ionization (ESI) source, and mass spectra were registered in 
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both positive- and negative-ion modes. Mobile phases A (H2O) and B (ACN) containing 
0.1% (v/v) FA were applied on liquid chromatography with a flow rate of 1 mL/min, and 
the gradient was started with 5% B and followed by a linear rise to 100% B within 15 min. 
The quantification of psilocybin, baeocystin, norpsilocin, KYN, and KA were achieved 
using ultra-high-performance liquid chromatography (UHPLC) (Agilent 1290 Infinity II 
LC System; Agilent, Germany) concatenated to an Omega Polar C18 column (Luna, 100 
Å, 1.6 µm, 100 × 2.1 µm; Phenomenex, Germany) for separation. A diode-array detector 
(DAD) was used for absorbance data from 200 nm to 400 nm, and an Agilent 6130 mass 
spectrometer with ESI was handled in positive- and negative-ion modes. Mobile phases A 
(H2O) and B (ACN) containing 0.1% (v/v) FA were applied on the liquid chromatography 
with a flow rate of 0.5 mL/min. The gradient was set up as follows: initiate with 1% B, and 
increase to 10% B in 3 min, further change to 100% B for 1 min. The chromatograms of 
psilocybin and its analogs were detected at a wavelength of 280 nm. The titers of 
psilocybin, baeocystin, norpsilocin, KYN, and KA were quantified by the AUC in the 
chromatography. They were calculated relative to the amount of biomass (mg/g) and 
culture volume (mg/L) using the standard curves of authentic compounds as references. 
4.6 Fluorescence microscopy screening method 
To detect the fluorescence signals in the cells, the Axiostar plus microscope equipped with 
different filter sets and a 506 mono Axiocam (Carl Zeiss, Germany) was used. For the 
imaging of yeast strains tSH17 and tSH18, the cultures were carried out in 15 mL of SD-
Ura medium overnight. The nucleic staining of cells with Hoechst 33342 (Invitrogen, US) 
followed the manufacturer’s instructions, and then the cells were fixed in a 1.5 mL 
centrifuge tube with 4% (v/v) formaldehyde before being applied on object slides. 5 µL 
cell solution of each strain was dropped for fluorescence detection using a 63 x oil 
objective and covered with a cover glass. The Hoechst staining, mRuby signal and YFP 
signal were detected at emission wavelengths of λ = 461 nm, 605 nm, and 527 nm, 
respectively.  
Yeast cells and filamentous fungi were prepared in different ways for the YFP 
fluorescence screening. Every single transformant of budding yeast was pre-cultured in 
SD-Ura medium overnight. This culture was then diluted 1:10 with fresh SD-Ura medium 
in a 2 mL centrifuge tube punctured with a sterile needle. The cells were incubated under 
shaking conditions (500 rpm) for another 4 h to reach the log phase. 3 µL of this main 
culture was applied on an object slide for YFP signal detection with a 63 x oil objective. 





agar were prepared. The AMM agar was supplied either with 20 µg/mL Dox and 3 mg/L 
PABA, or with 2% D-xylose plus 3 mg/L PABA, depending on the strain. Spore solution 
with 103 conidia/mL concentration was drawn on a fresh plate using an inoculation loop. 
The agar plates were then incubated for 15~17 h at 37°C for germination. The following 
day, the 0.8 cm diameter agar piece containing germinated spores was removed from the 
petri dish, placed on the object slide, covered with a cover glass, and the YFP signal was 
detected. To observe the fluorescence signal from the mycelium grown in AMM broth 
(Fig. 8B), the spores were inoculated in AMM (106 conidia/mL) in a 2 mL tube with 
supplementation of 3 mg/L PABA, and additional 2% D-xylose or 20 µg/mL Dox was 
added, according to the strain. The tube was incubated for 15~17 h at 37°C. The following 
day, 10 µL of the cell culture were dropped on an object slide, covered with a cover glass, 
and observed in a same manner. 
4.7 Software and databases 
The nucleic acid sequences of target genes from gDNA of budding yeast were downloaded 
from the Saccharomyces Genome Database (https://www.yeastgenome.org/). VectorNTI 
advanced software (version 11.5, Life Technologies, Germany) was employed for the 
design of plasmids for expression and DNA fragments for deletion. NCBI CD-search 
database (Marchler-Bauer et al., 2016) (www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi) 
was used to check the conserved domain (CD) of putative PKS. The fluorescence imaging 
and post-processing of the obtained images was done by ZEN lite (Zeiss, Germany). HPLC 
chromatograms and MS data analyses were carried out using LabSolutions (Shimadzu, 










List of References 
Adams, AM, et al. (2019). In vivo production of psilocybin in E. coli. Metab Eng, 56, 111-119. 
Anyaogu, DC, & Mortensen, UH. (2015). Heterologous production of fungal secondary 
metabolites in Aspergilli. Front Microbiol, 6, 77. 
Baghban, R, et al. (2018). New developments in Pichia pastoris expression system, review and 
update. Curr Pharm Biotechnol, 19(6), 451-467. 
Bartolucci, S, et al. (2016). Observations concerning the synthesis of tryptamine homologues and 
branched tryptamine derivatives via the borrowing hydrogen process: synthesis of psilocin, 
bufotenin, and serotonin. Tetrahedron, 72(18), 2233-2238. 
Bassard, JE, et al. (2012). A novel method for monitoring the localization of cytochromes P450 
and other endoplasmic reticulum membrane associated proteins: a tool for investigating the 
formation of metabolons. FEBS J, 279(9), 1576-1583. 
Becherer, KA, et al. (1996). Novel syntaxin homologue, Pep12p, required for the sorting of 
lumenal hydrolases to the lysosome-like vacuole in yeast. Mol Biol Cell, 7(4), 579-594. 
Binder, A, et al. (2014). A modular plasmid assembly kit for multigene expression, gene silencing 
and silencing rescue in plants. PLoS One, 9(2), e88218. 
Blei, F, et al. (2018). Biocatalytic production of psilocybin and derivatives in tryptophan synthase-
enhanced reactions. Chem Eur J, 24(40), 10028-10031. 
Blin, K, et al. (2019). antiSMASH 5.0: updates to the secondary metabolite genome mining 
pipeline. Nucleic Acids Res, 47(W1), W81-W87. 
Bok, JW, et al. (2015). Fungal artificial chromosomes for mining of the fungal secondary 
metabolome. BMC Genomics, 16(1), 343. 
Brakhage, AA. (2013). Regulation of fungal secondary metabolism. Nat Rev Microbiol, 11(1), 21-
32. 
Brakhage, AA, & Van den Brulle, J. (1995). Use of reporter genes to identify recessive trans-acting 
mutations specifically involved in the regulation of Aspergillus nidulans penicillin 
biosynthesis genes. J Bacteriol, 177(10), 2781-2788. 
Brown, S, et al. (2015). De novo production of the plant-derived alkaloid strictosidine in yeast. 
PNAS, 112(11), 3205-3210. 
Bulfer, SL, et al. (2013). Crystal structure of Saccharomyces cerevisiae Aro8, a putative alpha-
aminoadipate aminotransferase. Protein Sci, 22(10), 1417-1424. 
Burmeister, HR, et al. (1974). Antibiotic produced by Fusarium Equiseti NRRL 5537. Antimicrob 
Agents Chemother, 5(6), 634-639. 
Cederbaum, AI. (2015). Molecular mechanisms of the microsomal mixed function oxidases and 
biological and pathological implications. Redox Biol, 4, 60-73. 
Cesaratto, F, et al. (2016). Tobacco etch virus protease: a shortcut across biotechnologies. J 
Biotechnol, 231, 239-249. 
Chen, X, et al. (2010). TEV protease-facilitated stoichiometric delivery of multiple genes using a 
single expression vector. Protein Sci, 19(12), 2379-2388. 
Cherest, H, et al. (1969). Genetic and regulatory aspects of methionine biosynthesis in 
Saccharomyces cerevisiae. J Bacteriol, 97(1), 328-336. 
Chiang, YM, et al. (2013). An efficient system for heterologous expression of secondary 
metabolite genes in Aspergillus nidulans. J Am Chem Soc, 135(20), 7720-7731. 
Choi, KR, et al. (2019). Systems metabolic engineering strategies: integrating systems and 
synthetic biology with metabolic engineering. Trends Biotechnol, 37(8), 817-837. 
Clevenger, KD, et al. (2017). A scalable platform to identify fungal secondary metabolites and 
their gene clusters. Nat Chem Biol, 13(8), 895-901. 
Da, B, et al. (2000). Methods in yeast genetics. In Dan, B (Ed.), a Cold Spring Harbor Laboratory 





Da Silva, NA, & Srikrishnan, S. (2012). Introduction and expression of genes for metabolic 
engineering applications in Saccharomyces cerevisiae. FEMS Yeast Res, 12(2), 197-214. 
Daicho, K, et al. (2009). Sorting defects of the tryptophan permease Tat2 in an erg2 yeast mutant. 
FEMS Microbiol Lett, 298(2), 218-227. 
Daniels, RW, et al. (2014). Expression of multiple transgenes from a single construct using viral 
2A peptides in Drosophila. PLoS One, 9(6), e100637. 
Davy, AM, et al. (2017). Cell factory engineering. Cell Syst, 4(3), 262-275. 
de Felipe, P, & Ryan, MD. (2004). Targeting of proteins derived from self-processing polyproteins 
containing multiple signal sequences. Traffic, 5(8), 616-626. 
Deed, RC, et al. (2019). The role of yeast ARO8, ARO9 and ARO10 genes in the biosynthesis of 3-
(methylthio)-1-propanol from L-methionine during fermentation in synthetic grape medium. 
FEMS Yeast Res, 19(2), foy109. 
DeLoache, WC, et al. (2015). An enzyme-coupled biosensor enables (S)-reticuline production in 
yeast from glucose. Nat Chem Biol, 11(7), 465-471. 
Deng, H, et al. (2017). CRISPR system in filamentous fungi: current achievements and future 
directions. Gene, 627, 212-221. 
Dickinson, JR, et al. (2003). The catabolism of amino acids to long chain and complex alcohols in 
Saccharomyces cerevisiae. J Biol Chem, 278(10), 8028-8034. 
Dohn, J, et al. (2018). New multi-marker strains and complementing genes for Aspergillus nidulans 
molecular biology. Fungal Genet Biol, 111, 1-6. 
Durairaj, P, et al. (2015). Comparative functional characterization of a novel benzoate hydroxylase 
cytochrome P450 of Fusarium oxysporum. Enzyme Microb Technol, 70, 58-65. 
Ebrecht, AC, et al. (2019). Biochemical and structural insights into the cytochrome P450 reductase 
from Candida tropicalis. Sci Rep, 9(1), 20088. 
Ehrlich, F. (1907). Über die Bedingungen der Fuselölbildung und über ihren Zusammenhang mit 
dem Eiweißaufbau der Hefe. Berichte der deutschen chemischen Gesellschaft, 40(1), 1027-
1047. 
Engler, C, et al. (2014). A golden gate modular cloning toolbox for plants. ACS Synth Biol, 3(11), 
839-843. 
Fernandes, JD, et al. (2015). The role of amino acid permeases and tryptophan biosynthesis in 
Cryptococcus neoformans survival. PLoS One, 10(7), e0132369. 
Forsberg, H, & Ljungdahl, PO. (2001). Genetic and biochemical analysis of the yeast plasma 
membrane Ssy1p-Ptr3p-Ssy5p sensor of extracellular amino acids. Mol Cell Biol, 21(3), 
814-826. 
Fricke, J, et al. (2017). Enzymatic synthesis of psilocybin. Angew Chem Int Ed, 56(40), 12352-
12355. 
Fricke, J, et al. (2020). Scalable hybrid synthetic/biocatalytic route to psilocybin. Chemistry. (Just 
accepted) 
Fricke, J, et al. (2019). Production options for psilocybin: making of the magic. Chemistry, 25(4), 
897-903. 
Fujita, K, et al. (2006). The genome-wide screening of yeast deletion mutants to identify the genes 
required for tolerance to ethanol and other alcohols. FEMS Yeast Res, 6(5), 744-750. 
Galanie, S, et al. (2015). Complete biosynthesis of opioids in yeast. Science, 349(6252), 1095-1100. 
Gmes, D, et al. (1991). An autonomously replicating plasmid transforms Aspergillus nidulans at 
high frequency. Genes, 98(1), 61-67. 
Ghiaci, P, et al. (2014). 2-Butanol and butanone production in Saccharomyces cerevisiae through 
combination of a B12 dependent dehydratase and a secondary alcohol dehydrogenase using 
a TEV-based expression system. PLoS One, 9(7), e102774. 
Gibson, DG, et al. (2009). Enzymatic assembly of DNA molecules up to several hundred kilobases. 
Nature Methods, 6(5), 343-345. 
Grinkova, YV, et al. (2010). Functional reconstitution of monomeric CYP3A4 with multiple 
cytochrome P450 reductase molecules in Nanodiscs. Biochem Biophys Res Commun, 
398(2), 194-198. 
Hamid, HA, et al. (2017). Indole alkaloids from plants as potential leads for antidepressant drugs: a 
mini review. Front Pharmacol, 8, 96. 
Harvey, CJB, et al. (2018). HEx: a heterologous expression platform for the discovery of fungal 
natural products. Sci Adv, 4(4), eaar5459. 
 
86  
Hazelwood, LA, et al. (2008). The Ehrlich pathway for fusel alcohol production: a century of 
research on Saccharomyces cerevisiae metabolism. Appl Environ Microbiol, 74(8), 2259-
2266. 
He, B, et al. (2019). Functional genomics of Aspergillus oryzae: strategies and progress. 
Microorganisms, 7(4), 103. 
He, Y, et al. (2018). Recent advances in reconstructing microbial secondary metabolites 
biosynthesis in Aspergillus spp. Biotechnol Adv, 36(3), 739-783. 
Hendrickson, L, et al., (1999). Lovastatin biosynthesis in Aspergillus terreus: characterization of 
blocked mutants, enzyme activities and a multifunctional polyketide synthase gene. Chem 
Biol, 6(7), 429-439. 
Hertweck, C. (2009). The biosynthetic logic of polyketide diversity. Angew Chem Int Ed, 48(26), 
4688-4716. 
Hirasawa, T, et al. (2007). Identification of target genes conferring ethanol stress tolerance to 
Saccharomyces cerevisiae based on DNA microarray data analysis. J Biotechnol, 131(1), 
34-44. 
Hoefgen, S, et al. (2018). Facile assembly and fluorescence-based screening method for 
heterologous expression of biosynthetic pathways in fungi. Metab Eng, 48, 44-51. 
Homer, JA, & Sperry, J. (2017). Mushroom-derived indole alkaloids. J Nat Prod, 80(7), 2178-2187. 
Hommes, FA. (1966). Mechanism of the Crabtree effect in yeast grown with different glucose 
concentrations. Arch Biochem Biophys, 113(2), 324-330. 
Horn, F, et al. (2016). Draft genome sequences of fungus Aspergillus calidoustus. Genome 
Announc, 4(2), e00102- e00116. 
Hrycay, E, & Bandiera, S. (2015). Monooxygenase, peroxidase and peroxygenase properties and 
reaction mechanisms of cytochrome P450 enzymes. in Hrycay, EG (Ed.) Advances in 
Experimental Medicine and Biology (851, pp. 1-61). Heidelberg: Springer Nature. 
Hu, J, et al. (2014). Characterization of two acetyltransferase genes in the pyripyropene 
biosynthetic gene cluster from Penicillium coprobium. Biotechnol Biotechnol Equip, 28(5), 
818-826. 
Hu, XH, et al. (2007). Genetic dissection of ethanol tolerance in the budding yeast Saccharomyces 
cerevisiae. Genetics, 175(3), 1479-1487. 
Ignea, C, et al. (2016). Carnosic acid biosynthesis elucidated by a synthetic biology platform. 
PNAS 113(13), 3681-3686. 
Iraqui, I, et al. (1998). Characterisation of Saccharomyces cerevisiae ARO8 and ARO9 genes 
encoding aromatic aminotransferases I and II reveals a new aminotransferase subfamily. 
Mol Gen Genet, 257(2), 238-248. 
Jensen, PR. (2016). Natural products and the gene cluster revolution. Trends Microbiol, 24(12), 
968-977. 
John, MA, & Peberdy, JF. (1984). Transformation of Aspergillus nidulans using the argB gene. 
Enzyme Microb Technol, 6(9), 386-389. 
Kalderon, D, et al. (1984) A short amino acid sequence able to specify nuclear location. Cell, 39, 
499-509. 
Kapust, RB, et al. (2001). Tobacco etch virus protease: mechanism of autolysis and rational design 
of stable mutants with wild-type catalytic proficiency. Protein Eng Des Sel, 14(12), 993-
1000. 
Karim, AS, et al. (2013). Characterization of plasmid burden and copy number in Saccharomyces 
cerevisiae for optimization of metabolic engineering applications. FEMS Yeast Res, 13(1), 
107-116. 
Karim, K. (2019). Polymerase Chain Reaction (PCR): Principle and Applications. In Nagpal, ML 
(Ed.), Synthetic Biology: New Interdisciplinary Science. London: IntechOpen. 
Kataoka, S, et al. (2011). Three austin family compounds from Penicillium brasilianum exhibit 
selective blocking action on cockroach nicotinic acetylcholine receptors. Neurotoxicology, 
32(1), 123-129. 
Kautsar, SA, et al. (2019). MIBiG 2.0: a repository for biosynthetic gene clusters of known 
function. Nucleic Acids Res, 48(D1), D454-D458. 






Keller, NP. (2019). Fungal secondary metabolism: regulation, function and drug discovery. Nat 
Rev Microbiol, 17(3), 167-180. 
Keller, NP, et al. (2005). Fungal secondary metabolism - from biochemistry to genomics. Nat Rev 
Microbiol, 3(12), 937-947. 
Kelsell, RE. (1996). Hybridization and competition hybridization of Southern blots. In A. J. 
Harwood (Ed.), Basic DNA and RNA Protocols (pp. 31-39). Totowa, NJ: Humana Press. 
Kim, JH, et al. (2011). High cleavage efficiency of a 2A peptide derived from porcine teschovirus-
1 in human cell lines, zebrafish and mice. PLoS One, 6(4), e18556. 
Kistler, HC, & Broz, K. (2015). Cellular compartmentalization of secondary metabolism. Front 
Microbiol, 6, 68. 
Knight, T. (2003). Idempotent vector design for standard assembly of BioBricks. MIT Synthetic 
Biology Working Group Technical Reports. 
Koh, EYC, et al. (2013). An internal ribosome entry site (IRES) mutant library for tuning 
expression level of multiple genes in mammalian cells. PloS One, 8(12), e82100-e82100. 
Kotopka, BJ, et al. (2018). Synthetic biology strategies toward heterologous phytochemical 
production. Nat Prod Rep, 35(9), 902-920. 
Kouprina, N, & Larionov, V. (2008). Selective isolation of genomic loci from complex genomes by 
transformation-associated recombination cloning in the yeast Saccharomyces cerevisiae. 
Nat Protoc, 3(3), 371-377. 
Kriz, A, et al. (2010). A plasmid-based multigene expression system for mammalian cells. Nat 
Commun, 1, 120. 
Kubota, S, et al. (2004). Effect of ethanol on cell growth of budding yeast: genes that are important 
for cell growth in the presence of ethanol. Biosci Biotechnol Biochem, 68(4), 968-972. 
Kudla, J, & Bock, R. (2016). Lighting the Way to Protein-Protein Interactions: Recommendations 
on Best Practices for Bimolecular Fluorescence Complementation Analyses. Plant Cell, 
28(5), 1002-1008. 
Kurnasov, O, et al. (2003). NAD biosynthesis: identification of the tryptophan to quinolinate 
pathway in bacteria. Chem Biol, 10(12), 1195-1204. 
Lah, L, et al. (2008). High diversity and complex evolution of fungal cytochrome P450 reductase: 
cytochrome P450 systems. Fungal Genet Biol, 45(4), 446-458. 
Lenz, C, et al. (2020). Injury-triggered blueing reactions of psilocybe "magic" mushrooms. Angew 
Chem Int Ed, 59(4), 1450-1454. 
Leonard, E, et al. (2005). Investigation of two distinct flavone synthases for plant-specific flavone 
biosynthesis in Saccharomyces cerevisiae. Appl Environ Microbiol, 71(12), 8241-8248. 
Li, M, et al. (2016). Engineering yeast for high-level production of stilbenoid antioxidants. Sci Rep, 
6, 36827. 
Li, S, et al. (2012). Biochemical characterization of NotB as an FAD-dependent oxidase in the 
biosynthesis of notoamide indole alkaloids. J Am Chem Soc, 134(2), 788-791. 
Li, S, et al. (2018). Strategies for microbial synthesis of high-value phytochemicals. Nat Chem, 
10(4), 395-404. 
Li, Y, & Smolke, CD. (2016). Engineering biosynthesis of the anticancer alkaloid noscapine in 
yeast. Nat Commun, 7, 12137. 
Lian, J, et al. (2014). Design and construction of acetyl-CoA overproducing Saccharomyces 
cerevisiae strains. Metab Eng, 24, 139-149. 
Lin, L, et al. (2003). Efficient linking and transfer of multiple genes by a multigene assembly and 
transformation vector system. PNAS, 100(10), 5962-5967. 
Lin, TS, et al. (2016). Biosynthetic pathway of the reduced polyketide product citreoviridin in 
Aspergillus terreus var. aureus revealed by heterologous expression in Aspergillus 
nidulans. Org Lett, 18(6), 1366-1369. 
Liu, J, et al. (2014). Unusual acetylation-dependent reaction cascade in the biosynthesis of the 
pyrroloindole drug physostigmine. Angew Chem Int Ed, 53(1), 136-139. 
Liu, X, et al. (2017a). Engineering microbial cell factories for the production of plant natural 
products: from design principles to industrial-scale production. Microb Cell Fact, 16(1), 
125-133. 
Liu, Z, et al. (2017b). Systematic comparison of 2A peptides for cloning multi-genes in a 
polycistronic vector. Sci Rep, 7(1), 2193. 
 
88  
Lo, HC, et al. (2012). Two separate gene clusters encode the biosynthetic pathway for the 
meroterpenoids austinol and dehydroaustinol in Aspergillus nidulans. J Am Chem Soc, 
134(10), 4709-4720. 
Lu, C, & Jeffries, T. (2007). Shuffling of promoters for multiple genes to optimize xylose 
fermentation in an engineered Saccharomyces cerevisiae strain. Appl Environ Microbiol, 
73(19), 6072-6077. 
Lundemo, MT, & Woodley, JM. (2015). Guidelines for development and implementation of 
biocatalytic P450 processes. Appl Microbiol Biotechnol, 99(6), 2465-2483. 
Lv, X, et al. (2016). Dual regulation of cytoplasmic and mitochondrial acetyl-CoA utilization for 
improved isoprene production in Saccharomyces cerevisiae. Nat Commun, 7, 12851. 
Magliery, TJ, et al. (2005). Detecting protein−protein interactions with a green fluorescent protein 
fragment reassembly trap:  scope and mechanism. J Am Chem Soc, 127(1), 146-157. 
Mahmood, ZA. (2013). Bioactive alkaloids from fungi: psilocybin. In Ramawat, KG (Ed.), Natural 
Products: Phytochemistry, Botany and Metabolism of Alkaloids, Phenolics and Terpenes 
(pp. 523-552). Berlin, Heidelberg: Springer Berlin Heidelberg. 
Mansouri, M, & Berger, P. (2014). Strategies for multigene expression in eukaryotic cells. Plasmid, 
75, 12-17. 
Mao, X-M, et al. (2015). Efficient biosynthesis of fungal polyketides containing the dioxabicyclo-
octane ring system. J Am Chem Soc, 137(37), 11904-11907. 
Marchler-Bauer, A, et al. (2016). CDD/SPARCLE: functional classification of proteins via 
subfamily domain architectures. Nucleic Acids Res, 45(D1), D200-D203. 
Matsuda, Y, & Abe, I. (2016). Biosynthesis of fungal meroterpenoids. Nat Prod Rep, 33(1), 26-53. 
Matsuda, Y, et al. (2013). Spiro-ring formation is catalyzed by a multifunctional dioxygenase in 
austinol biosynthesis. J Am Chem Soc, 135(30), 10962-10965. 
Matsuda, Y, et al. (2016). Discovery of key dioxygenases that diverged the paraherquonin and 
acetoxydehydroaustin pathways in Penicillium brasilianum. J Am Chem Soc, 138(38), 
12671-12677. 
Mattern, DJ, et al. (2017). Rewiring of the austinoid biosynthetic pathway in filamentous fungi. 
ACS Chem Biol, 12(12), 2927-2933. 
Mattern, DJ, et al. (2015). Synthetic biology of fungal natural products. Front Microbiol, 6, 775. 
Meijer, WH, et al. (2010). Peroxisomes are required for efficient penicillin biosynthesis in 
Penicillium chrysogenum. Appl Environ Microbiol, 76(17), 5702-5709. 
Metzger, U, et al. (2009). The structure of dimethylallyl tryptophan synthase reveals a common 
architecture of aromatic prenyltransferases in fungi and bacteria. Proc Natl Acad Sci U S A, 
106(34), 14309-14314. 
Meyer, V, et al. (2011). Fungal gene expression on demand: an inducible, tunable, and metabolism-
independent expression system for Aspergillus niger. Appl Environ Microbiol, 77(9), 2975-
2983. 
Mignon, C, et al. (2015). Antibiotic-free selection in biotherapeutics: now and forever. Pathogens, 
4(2), 157-181. 
Milne, N, et al. (2020). Metabolic engineering of Saccharomyces cerevisiae for the de novo 
production of psilocybin and related tryptamine derivatives. Metab Eng, 60, 25-36. 
Miozzari, G, et al. (1978). Tryptophan biosynthesis in Saccharomyces cerevisiae: control of the 
flux through the pathway. J Bacteriol, 134(1), 48-59. 
Mumberg, D, et al. (1994). Regulatable promoters of Saccharomyces cerevisiae: comparison of 
transcriptional activity and their use for heterologous expression. Nucleic Acids Res, 22(25), 
5767-5768. 
Nayak, T, et al. (2006). A versatile and efficient gene-targeting system for Aspergillus nidulans. 
Genetics, 172(3), 1557-1566. 
Nielsen, J. (2015). Yeast cell factories on the horizon. Science, 349(6252), 1050-1051. 
Ohashi, K, et al. (2017). Kynurenine aminotransferase activity of Aro8/Aro9 engage tryptophan 
degradation by producing kynurenic acid in Saccharomyces cerevisiae. Sci Rep, 7(1), 
12180. 
Paddon, CJ, et al. (2013). High-level semi-synthetic production of the potent antimalarial 
artemisinin. Nature, 496(7446), 528-532. 
Panozzo, C, et al. (2002). Aerobic and anaerobic NAD+ metabolism in Saccharomyces cerevisiae. 





Peng, B, et al. (2017). Coupling gene regulatory patterns to bioprocess conditions to optimize 
synthetic metabolic modules for improved sesquiterpene production in yeast. Biotechnol 
Biofuels, 10, 43. 
Peng, B, et al. (2018). An expanded heterologous GAL promoter collection for diauxie-inducible 
expression in Saccharomyces cerevisiae. ACS Synth Biol, 7(2), 748-751. 
Petersen, LM, et al. (2014). Dereplication guided discovery of secondary metabolites of mixed 
biosynthetic origin from Aspergillus aculeatus. Molecules, 19(8), 10898-10921. 
Pontecorvo, G, et al. (1953). The Genetics of Aspergillus nidulans. In M. Demerec (Ed.), Advances 
in Genetics (5, pp. 141-238), New York: Academic Press. 
Presnyak, V, et al. (2015). Codon optimality is a major determinant of mRNA stability. Cell, 
160(6), 1111-1124. 
Puig, S, et al. (1998). Optimized method to obtain stable food-safe recombinant wine zeast strains. 
J Agric Food Chem, 46(4), 1689-1693. 
Quan, J, & Tian, J. (2009). Circular polymerase extension cloning of complex gene libraries and 
pathways. PLoS One, 4(7), e6441. 
Quinn, R. (2013). Rethinking antibiotic research and development: World War II and the penicillin 
collaborative. Am J Public Health, 103(3), 426-434. 
Richter, L, et al. (2014). Engineering of Aspergillus niger for the production of secondary 
metabolites. Fungal Biol Biotechnol, 1, 1-13. 
Riquelme, M, & Sánchez-León, E. (2014). The Spitzenkörper: a choreographer of fungal growth 
and morphogenesis. Curr Opin Microbiol, 20, 27-33. 
Rokas, A, et al. (2018). The birth, evolution and death of metabolic gene clusters in fungi. Nat Rev 
Microbiol, 16(12), 731-744. 
Romagnoli, G, et al. (2015). Deletion of the Saccharomyces cerevisiae ARO8 gene, encoding an 
aromatic amino acid transaminase, enhances phenylethanol production from glucose. Yeast, 
32(1), 29-45. 
Romei, MG, & Boxer, SG. (2019). Split green fluorescent proteins: scope, limitations, and outlook. 
Annu Rev Biophys, 48, 19-44. 
Rząd, K, et al. (2017). Versatility of putative aromatic aminotransferases from Candida albicans. 
Fungal Genet Biol, 110, 26-37 
Sanchez, MI, & Ting, AY. (2020). Directed evolution improves the catalytic efficiency of TEV 
protease. Nat Methods, 17(2), 167-174. 
Schmidt, A, et al. (1994). Two FK506 resistance-conferring genes in Saccharomyces cerevisiae, 
TAT1 and TAT2, encode amino acid permeases mediating tyrosine and tryptophan uptake. 
Mol Cell Biol, 14(10), 6597-6606. 
Schneider, P, et al. (2008). The Aspergillus nidulans enzyme TdiB catalyzes prenyltransfer to the 
precursor of bioactive asterriquinones. Fungal Genet Biol, 45(3), 302-309. 
Schottel, JL, et al. (1981). Cloning and expression in Streptomyces lividans of antibiotic resistance 
genes derived from Escherichia coli. J Bacteriol, 146(1), 360-368. 
Schuetze, T, & Meyer, V. (2017). Polycistronic gene expression in Aspergillus niger. Microb Cell 
Fact, 16(1), 162. 
Sharma, P, et al. (2012). 2A peptides provide distinct solutions to driving stop-carry on 
translational recoding. Nucleic Acids Res, 40(7), 3143-3151. 
Sherwood, AM, et al. (2020). Synthesis and biological evaluation of tryptamines found in 
hallucinogenic mushrooms: norbaeocystin, baeocystin, norpsilocin, and aeruginascin. J Nat 
Prod, 83(2), 461-467. 
Shetty, RP, et al. (2008). Engineering BioBrick vectors from BioBrick parts. J Biol Eng, 2, 5. 
Shih, YP, et al. (2005). Self-cleavage of fusion protein in vivo using TEV protease to yield native 
protein. Protein Sci, 14(4), 936-941. 
Shirota, O, et al. (2003). Concise large-scale synthesis of psilocin and psilocybin, principal 
hallucinogenic constituents of “magic mushroom”. J Nat Prod, 66(6), 885-887. 
Silberstein, SD, & Hargreaves, RJ. (2000). The history and pharmacology of ergotamine and 
dihydroergotamine. In: Diener HC (Ed.), Drug treatment of migraine and other headaches 
(pp. 52–65). Basel: Karger. 
Smith, D. (1996). Agarose gel electrophoresis. In Harwood, AJ (Ed.), Basic DNA and RNA 
Protocols (pp. 17-21). Totowa, NJ: Humana Press. 
Smith, D, & Murphy, D. (1996). Capillary blotting of agarose gels. Methods Mol Biol, 58, 23-25. 
 
90  
Souza-Moreira, TM, et al. (2018). Screening of 2A peptides for polycistronic gene expression in 
yeast. FEMS Yeast Res, 18(5), foy036. 
Sporty, J, et al. (2009). Quantitation of NAD+ biosynthesis from the salvage pathway in 
Saccharomyces cerevisiae. Yeast, 26(7), 363-369. 
Srinivasan, P, & Smolke, CD. (2019). Engineering a microbial biosynthesis platform for de novo 
production of tropane alkaloids. Nat Commun, 10(1), 3634. 
Stringer, MA, et al. (1991). Rodletless, a new Aspergillus developmental mutant induced by 
directed gene inactivation. Genes Dev, 5(7), 1161-1171. 
Stroe, MC, et al. (2020). Targeted induction of a silent fungal gene cluster encoding the bacteria-
specific germination inhibitor fumigermin. Elife, 9, e52541. 
Subramanian, V, et al. (2017). A versatile 2A peptide-based bicistronic protein expressing platform 
for the industrial cellulase producing fungus, Trichoderma reesei. Biotechnol Biofuels, 10, 
34. 
Sun, J, et al. (2012). Cloning and characterization of a panel of constitutive promoters for 
applications in pathway engineering in Saccharomyces cerevisiae. Biotechnol Bioeng, 
109(8), 2082-2092. 
Szymczak, AL, & Vignali, DAA. (2005). Development of 2A peptide-based strategies in the design 
of multicistronic vectors. Expert Opin Biol Ther, 5(5), 627-638. 
Taylor, GM, et al. (2019). Start-Stop Assembly: a functionally scarless DNA assembly system 
optimized for metabolic engineering. Nucleic Acids Res, 47(3), e17. 
Toyn, J, et al. (2000). A counterselection for the tryptophan pathway in yeast: 5-Fluoroanthranilic 
acid resistance. Yeast, 16(6), 553-560. 
Trenchard, IJ, & Smolke, CD. (2015). Engineering strategies for the fermentative production of 
plant alkaloids in yeast. Metab Eng, 30, 96-104. 
Trotta, E. (2013). Selection on codon bias in yeast: a transcriptional hypothesis. Nucleic Acids Res, 
41(20), 9382-9395. 
Umebayashi, K, & Nakano, A. (2003). Ergosterol is required for targeting of tryptophan permease 
to the yeast plasma membrane. J Cell Biol, 161(6), 1117-1131. 
Unkles, SE, et al. (2014). Synthetic biology tools for bioprospecting of natural products in 
eukaryotes. Chem Biol, 21(4), 502-508. 
Upshall, A. (1986). Genetic and molecular characterization of argB+ transformants of Aspergillus 
nidulans. Curr Genet, 10(8), 593-599. 
Valiante, V, et al. (2017). Discovery of an extended austinoid biosynthetic pathway in Aspergillus 
calidoustus. ACS Chem Biol, 12(5), 1227-1234. 
Varshavsky, A. (2011). The N-end rule pathway and regulation by proteolysis. Protein Sci, 20(8), 
1298-1345. 
Vecchione, S, & Fritz, G. (2019). CRIMoClo plasmids for modular assembly and orthogonal 
chromosomal integration of synthetic circuits in Escherichia coli. J Biol Eng, 13, 92. 
Wach, A, et al. (1994). New heterologous modules for classical or PCR-based gene disruptions in 
Saccharomyces cerevisiae. Yeast, 10(13), 1793-1808. 
Wang, Y, et al. (2015). 2A self-cleaving peptide-based multi-gene expression system in the 
silkworm Bombyx mori. Sci Rep, 5(1), 16273. 
Wang, Y, et al. (2019). Fine-tuning the expression of target genes using a DDI2 promoter gene 
switch in budding yeast. Sci Rep, 9(1), 12538. 
Warrilow, AGS, et al. (2002). Phanerochaete chrysosporium NADPH-cytochrome P450 reductase 
kinetic mechanism. Biochem Biophys Res Commun, 299(2), 189-195. 
Waugh, DS. (2011). An overview of enzymatic reagents for the removal of affinity tags. Protein 
Expr Purif, 80(2), 283-293. 
Wong, YK, et al. (2017). Artemisinin as an anticancer drug: recent advances in target profiling and 
mechanisms of action. Med Res Rev, 37(6), 1492-1517. 
Xia, C, et al. (2019). Structural and functional studies of the membrane-binding domain of 
NADPH-cytochrome P450 oxidoreductase. Biochemistry, 58(19), 2408-2418. 
Xia, N, et al. (2017). Antioxidant effects of resveratrol in the cardiovascular system. Br J 
Pharmacol, 174(12), 1633-1646. 
Xu, P, et al. (2012). ePathBrick: a synthetic biology platform for engineering metabolic pathways 
in E. coli. ACS Synth Biol, 1(7), 256-266. 





Xu, Z, & Tsurugi, K. (2006). A potential mechanism of energy-metabolism oscillation in an 
aerobic chemostat culture of the yeast Saccharomyces cerevisiae. FEBS J, 273(8), 1696-
1709. 
Yang, J, et al. (2018). Polyprotein strategy for stoichiometric assembly of nitrogen fixation 
components for synthetic biology. PNAS, 115(36), E8509-E8517. 
Yanisch-Perron, C, et al. (1985). Improved M13 phage cloning vectors and host strains: nucleotide 
sequences of the M13mpl8 and pUC19 vectors. Gene, 33(1), 103-119. 
Yuan, J, et al. (2019). De Novo biosynthesis of (S)- and (R)-phenylethanediol in zeast via artificial 
enzyme cascades. ACS Synth Biol, 8(8), 1801-1808. 
Zadra, I. (2000). xylP promoter-based expression system and its use for antisense downregulation 
of the Penicillium chrysogenum nitrogen regulator NRE. Appl Environ Microbiol, 66(11), 
4810-4816. 
Zhang, S, et al. (2017). Self-excising Cre/mutant lox marker recycling system for multiple gene 
integrations and consecutive gene deletions in Aspergillus oryzae. J Biosci Bioeng, 123(4), 
403-411. 
Zhao, F, et al. (2016). Optimization of a cytochrome P450 oxidation system for enhancing 
protopanaxadiol production in Saccharomyces cerevisiae. Biotechnol Bioeng, 113(8), 
1787-1795. 
Zhou, Z, et al. (2016). Codon usage is an important determinant of gene expression levels largely 
through its effects on transcription. PNAS, 113(41), E6117-E6125. 
Zhu, K, et al. (2017). Cleavage of fusion proteins on the affinity resins using the TEV protease 
variant. Protein Expr Purif, 131, 27-33. 
Zhu, L, et al. (2013). Further enhanced production of heterologous proteins by double-gene 
disruption (ΔAosedD ΔAovps10) in a hyper-producing mutant of Aspergillus oryzae. Appl 













List of abbreviations 
Abbreviation Full description 
°C degree Celsius 




ADH alcohol dehydrogenase gene 
AMM Aspergillus minimal medium 
ampR ampicillin resistant gene marker; bla gene 
Arg L-arginine 
argB gene coding for ornithine carbamoyltransferase in A. nidulans 
ARO aromatic amino acid gene 
AUC area under the curve 
BGC biosynthetic gene cluster 
BNA gene for biosynthesis of nicotinic acid 
bp base pairs 
CD conserved domain 
cDNA complementary DNA 
CoA coenzyme A 
CPR NADPH-dependent cytochrome P450 reductase 
CRISPR-Cas 9 
clustered regularly interspaced short palindromic repeats and CRISPR-
associated protein 9 
CYC gene coding cytochrome C 
CYP cytochromes P450 
DAD diode-array detector 
DMAPP dimethylallyl pyrophosphate 
Dox doxycycline 
4-DMAT 4-dimethylallyl tryptophan 
DNA deoxyribonucleic acid 
EIC extracted ion chromatogram 
ER endoplasmic reticulum 
ESI electrospray ionization 
et al. et aliī (“and others”) 
FA formic acid 
g gram 
G418 geneticin 
GALp galactose-inducible promoter 
GFP green fluorescent protein 
h hour 






HPLC high-performance liquid chromatography 
HRMS high resolution mass spectrometry 
IGP indole-3-glycerol-phosphate 
IPA indole-3-pyruvate 
KA kynurenic acid or kynurenate 
KanR kanamycin-resistant gene marker; aph gene 
kb kilobase pairs 
KYN kynurenine 
L liter 
LB Lysogeny broth 
L-DOPA l-3,4-dihydroxyphenylalanine 
LEU gene for biosynthesis of leucine 
Leu L-leucine 
Lys L-lysine 
LzA leucine zipper helix A 
LzB leucine zipper helix B 
LZD leucine zipper domain 
M molar (mol/L) 
m/z mass-to-charge ratio 
MAT mating types 
MeOH methanol 
MET gene for biosynthesis of methionine 
Met methionine 




mM millimolar (mmol/L) 
mRNA messenger RNA 
MS mass spectrometry 
NAD+ oxidized form of nicotinamide adenine dinucleotide 
NADH reduced form of nicotinamide adenine dinucleotide 
NADP nicotinamide adenine dinucleotide phosphate 
NADPH reduced form of nicotinamide adenine dinucleotide phosphate 
NC negative control 
NCBI National Center for Biotechnology Information 
ng nanogram 
NHEJ non-homologous end joining 
NLS nuclear localization signal 
nm nanometer 
NRP non-ribosomal peptide 
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NRPS non-ribosomal peptide synthetase 
OD600 the optical density of a sample measured at a wavelength of 600 nm 
ORF open reading frame 
ori origin of replication 
PABA para-aminobenzoic acid 
PCR polymerase chain reaction 
Phe L-phenylalanine 
PK polyketide 
PKS polyketide synthases 
PLP pyridoxal phosphate 
PP phosphate 
PYK1p promoter of gene coding pyruvate kinase 
DMSO dimethyl sulfoxide 
RNA ribonucleic acid 
ROS reactive oxygen species 
rpm revolutions per minute 
S. Saccharomyces 
scCPR yeast S. cerevisiae endogenous CPR 
SD medium / agar synthetic defined medium / agar 
SM secondary metabolite 
spp. species pluralis (spp.), Latin for multiple species 
SV40 simian vacuolating virus 40 
TAR transformation-associated recombination 
TDH3p promoter of gene coding isozyme 3 
TEF1p promoter of gene coding elongation factor 1-alpha 1 
Teton tetracycline (Tet)-inducible promoter 
TEV tobacco etch virus 
tev TEVp cleavage site 
TEV gene coding TEV protease 
TEVp TEV protease 
TRP gene for biosynthesis of tryptophan 
Trp L-tryptophan 
Tyr L-tyrosine 
UHPLC ultra-high-performance liquid chromatography 
URA gene for biosynthesis of uridine / uracil 
Ura uracil / uridine 
v/v volume per volume 
w/v weight per volume 
wt wild type 
xylP xylose-inducible promoter 
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